AUSTRALIA Medical Devices Report Q2 2014
Australia Medical Devices Report ISSN 2053-8030 © Copyright 2014 Espicom Business Intelligence All rights reserved. No part of this publication may be reproduced or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping or storage in information retrieval systems without the express permission of the publisher.
Every care has been taken to ensure that the information contained in this report is correct. The publisher accepts no liability for decisions made on the basis of information contained herein.
British Library Cataloguing in Publication Data.
A catalogue record for this report is available from the British Library.
© Espicom Business Intelligence
Australia Medical Devices Report Q2 2014
CONTENTS Espicom Industry View ....................................................................................................... 7 SWOT .................................................................................................................................... 9 Medical Device Market ............................................................................................................................... 9 Political ................................................................................................................................................. 10 Economic ............................................................................................................................................... 11 Business Environment .............................................................................................................................. 12
Industry Forecast .............................................................................................................. 14 Medical Device Market Forecast ................................................................................................................ 14 Table: Projected Medical Device Market, 2013-2018 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 Table: Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Table: Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Consumables Market Forecast ................................................................................................................... 31 Table: Consumables Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 Table: Consumables Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Table: Consumables Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Diagnostic Imaging Market Forecast .......................................................................................................... 36 Table: Diagnostic Imaging Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 Table: Diagnostic Imaging Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 Table: Diagnostic Imaging Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Dental Products Market Forecast ............................................................................................................... 42 Table: Dental Products Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Table: Dental Products Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Table: Dental Products Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Orthopaedics & Prosthetics Market Forecast ................................................................................................ 46 Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 Table: Orthopaedics & Prosthetics Market, 2009-2018 (USmn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Patient Aids Market Forecast ..................................................................................................................... 49 Table: Patient Aids Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 Table: Patient Aids Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 Table: Patient Aids Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
Other Medical Devices Market Forecast ...................................................................................................... 53 Table: Other Medical Devices Market, 2008-2018 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54 Table: Other Medical Devices Market, 2008-2018 (US$ Per Capita) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55 Table: Other Medical Devices Market, 2009-2018 (US$mn % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
Annual Medical Device Imports ................................................................................................................. 59 Table: Medical Device Imports By Product Area, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62 Table: Medical Device Imports By Product Area 2008-2012 (US$000s, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63 Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
© Espicom Business Intelligence
Page 4
Australia Medical Devices Report Q2 2014 Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65 Table: Medical Device Imports By Product Area, 2008-2012 (% Distribution) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66 Table: Leading Medical Device Suppliers By Product Area (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67 Table: Leading Medical Device Suppliers By Product Area (% Distribution) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68 Table: Top 20 Medical Device Suppliers (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69 Table: Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70 Table: Detailed Medical Device Import Trends By Product Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73 Table: Detailed Leading Medical Device Suppliers By Product Area (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
Monthly Medical Device Imports ................................................................................................................ 80 Table: Monthly Medical Device Imports By Product Area, September 2010-October 2013 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Annual Medical Device Exports ................................................................................................................. 83 Table: Medical Device Exports By Product Area, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85 Table: Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86 Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87 Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88 Table: Medical Device Exports By Product Area, 2008-2012 (% Distribution) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89 Table: Leading Medical Device Destinations By Product Area (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90 Table: Leading Medical Device Destinations By Product Area (% Distribution) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91 Table: Top 20 Medical Device Destinations (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92 Table: Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93 Table: Detailed Medical Device Export Trends By Product Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96 Table: Detailed Leading Medical Device Destinations By Product Area (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100 Table: Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Monthly Medical Device Exports .............................................................................................................. 106 Table: Monthly Medical Device Exports By Product Area, September 2010-October 2013 (US$mn) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Macroeconomic Forecasts ............................................................................................. 108 Ongoing Misallocation Of Capital Increases Risks ..................................................................................... 110 Increasing Pressures For Greater Macro-Prudential Rules .......................................................................... 111 Table: Australia - Economic Activity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
Industry Risk Reward Ratings ........................................................................................ 114 Table: Asia Pacific Medical Device Risk/Reward Ratings, Q214 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
Market Overview ............................................................................................................. 116 Medical Device Market Overview ............................................................................................................. 116 Table: Medical Device Market, Key Ratios . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117 Table: Medical Device Market By Product Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Healthcare Overview .............................................................................................................................. 119 Health Status ....................................................................................................................................... 119 Healthcare System ................................................................................................................................ 119 Healthcare Funding .............................................................................................................................. 121 Healthcare Resources ........................................................................................................................... 122 Table: Diagnostic Imaging Technology By Type, 2006-2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123 Table: Diagnostic Imaging Technology Per Million Population By Type, 2006-2012 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
Healthcare Activity ............................................................................................................................... 124 Healthcare Personnel ........................................................................................................................... 124 Key Data ............................................................................................................................................ 124 Table: Key Data, 2008-2013 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
© Espicom Business Intelligence
Page 5
Australia Medical Devices Report Q2 2014
Industry Trends & Developments .................................................................................. 127 Industry Trends & Developments .............................................................................................................. 127
Regulatory Development ................................................................................................ 132 Medical Device Regulations .................................................................................................................... Competent Authority ............................................................................................................................. Regulations ......................................................................................................................................... Australia New Zealand Therapeutic Products Authority ..............................................................................
132 132 132 134
Competitive Landscape .................................................................................................. 136 Domestic Medical Device Production ........................................................................................................ National Medical Device Manufacturers .................................................................................................... Multinational Medical Device Manufacturers ............................................................................................. Multinational Market Activity ..................................................................................................................
136 136 140 142
Table: Multinational Market Activity, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Methodology .................................................................................................................... 144 Medical Device Market Methodology ....................................................................................................... 144 Trade Code Classifications .................................................................................................................... 145 Table: Used HS Trade Codes, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145 Table: Rearranged HS Trade Codes, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
Risk/Reward Ratings Methodology .......................................................................................................... 150 Table: Medical Devices Risk/Reward Ratings Indicators, 2014 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Sources .............................................................................................................................................. 152 Contact .............................................................................................................................................. 153
© Espicom Business Intelligence
Page 6
Australia Medical Devices Report Q2 2014
Espicom Industry View Espicom Industry View: The Australian market has performed well in recent years, driven by a stronglygrowing economy and the requirements of an increasingly elderly population. However, a weakening of the Australian dollar over the next five years is expected to bring the momentum in the market to a halt.
Headline Industry Forecasts ■
At US$4.8bn, the market ranks amongst the top 20 largest in the world, while per capita spending is on a par with European markets such as the Netherlands or Finland. Growth for the 2013-2018 period is expected to be subdued; estimated at a CAGR of 0.1% in US$ terms which will raise the market to US $4,836.5mn by 2018.
■
Since 2001, medical device imports have seen a period of sustained rapid growth. In 2012, imports reached a new high of US$4,523.6mn, rising by 3.9% over 2011. In CAGR terms, growth was 10.8% between 2007 and 2012. The running annual total reached US$4.6bn in the 12 months to October 2013, representing y-on-y growth of 2.2%.
■
Medical device exports bounced back strongly from the dip in 2009, recording strong growth over the 2010-2012 period. In 2012, exports rose by 10.5% to reach US$1,696.0mn. The running annual total reached US$1.7bn in the 12 months to October 2013, representing y-on-y growth of 1.7%. In 2012, the balance of trade deficit edged up to US$2,828mn.
• Australia has a large number of small manufacturers, mostly making hospital consumables and supplies. Production is generally high quality, but low tech; advanced products are almost always imported. The majority of production is consumed locally.
Headline Industry Risk/Reward Rating ■
Australia is the most attractive market in the Asia Pacific region for commercialising a medical device, according to BMI Espicom's Medical Device Risk/Reward Ratings (RRRs). The country's overall score for Q214 is 75.8 out of 100, which is marginally ahead of Japan (75.7).
Headline Healthcare Overview ■
Australia's population stands at over 23mn and is currently growing at an annual rate of 1.3%. The population aged 65 years and over represents 14.3% of the total and Australian life expectancy is amongst the world's highest at 80.0 years for men and 84.5 years for women.
■
In 2013, Espicom estimates Australian healthcare expenditure at US$138.1bn, equal to US$5,917 per capita. Australia has long had a relatively high level of health spending and in 2013 it stood at 9.1% of GDP, having grown at a CAGR of 0.6% over the 2008-2013 period. Spending in US$ per capita terms has doubled since 2003.
■
The number of hospitals is increasing, with an additional nine opening in 2013 to take the total to 1,363. The number of hospital beds remains steady at 3.8 per thousand population. The number of doctors is also rising in line with population growth, reaching almost 80,000 in 2013, a rate of 3.4 physicians per thousand population.
© Espicom Business Intelligence
Page 7
Australia Medical Devices Report Q2 2014
Headline Industry Trends & Developments ■
Medical device imports grew by 1.2% in US dollar terms in the three months to October 2013, with growth led by the patient aids and orthopaedics & prosthetics segments which grew by 15.1% and 4.1% respectively.
■
Medical device exports grew by 1.7% in US dollar terms in the three months to October 2013, with growth led by a 17.2% increase in the other medical devices segment.
■
In August 2011, after months of negotiation, the Commonwealth Government signed an agreement with all States and Territories to formalise the National Health Reform plan. Designed to improve funding to hospitals and to reduce patient waiting times, the plan will see the Commonwealth Government invest at least A$16.4bn (US$16.0bn) in additional funding for public hospitals over the period 2014-15 to 2019-20. The Commonwealth Government will match 45% of efficient growth funding from July 2014, and 50% of efficient growth from July 2017.
■
According to the MTAA (Medical Technology Association of Australia), the Australian industry includes over 500 medical technology companies with products listed on the Australian Register of Therapeutic Goods (ARTG). It employs around 19,000 people with turnover of around A$10.8bn in 2010-11, although this includes distribution activity.
BMI Political View: A Newspoll's December 8 popularity poll reflected the significant decline in the popularity of Liberal-National Coalition and Prime Minister Tony Abbott since they were elected into parliament on September 7 2013. The lack of progress on items such as carbon tax and mineral resource rent tax (although largely due to opposition parties holding the agenda hostage) have certainly shook voters' confidence in the new government to deliver and weighed on the party's popularity. While these polls have no consequence on the government's decisions or policies, further declines in popularity could reignite internal struggles within the coalition and cause more policy paralysis. BMI Economic View: Several domestic and external factors have served to boost the level of economic activity in Australia. While BMI revised its GDP growth forecasts for 2014 to 2.0% from 1.8% previously, this change masks its concerns for the ever-growing risks within the Australian economy. Given that an increasing proportion of capital is being invested in the housing sector despite the weak performance of business spending, (a turnaround in which is required to generate wage growth), this misallocation of capital increases the economy's vulnerability to external shocks, on top of the ongoing weakness in the mining sector.
© Espicom Business Intelligence
Page 8
Australia Medical Devices Report Q2 2014
SWOT Medical Device Market SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
■
One of world's top 20 medical device markets
■
High per capita spending
■
Market is predominantly supplied by imports
■
Universal health coverage
■
An ageing and affluent population
■
Market fragmentation due to vast geographic size
■
Market limited by population size
■
Receptive to new technologies
■
Strong academic R&D community
■
Government support for manufacturing sector
■
Imports rising
■
National Health Reform plan supporting investment in healthcare
■
Continued focus on cost containment in the public healthcare sector
© Espicom Business Intelligence
Page 9
Australia Medical Devices Report Q2 2014
Political SWOT Analysis
Strengths
■
Australia is a mature democracy with a broadly stable party system.
■
Economic stability over recent years supports the current political system and radical groups are unlikely to gain substantial support.
Weaknesses
■
As one of the region's largest and most stable states, the country attracts many refugees and economic migrants. The issue is a key source of domestic tension and has been hotly debated in parliament in recent times as the capsizing of a boat led to the death of a number of refugees. The issue continues to be debated in the federal parliament with no sign of political parties co-operating to find an alternative that would ensure the safe passage and fair processing of the refugees, while reducing the possibility of people smuggling.
■
The fragility of the state governments' finances compared to the large infrastructure projects that they need to undertake has led to questions with regards to the compatibility of the federal-state system with the country's current development needs.
Opportunities
■
Australia has historically enjoyed close military ties with the US. However, with the rise of regional economic powers such as China, it will need to balance competing military and economic ties.
Threats
■
Australia's early support for the US 'War on Terror', among other things, has made Australians abroad a target for Islamic extremists.
■
Australia's close alliance with the US, particularly under John Howard, has left a lingering feeling among some Asian governments that it is America's 'deputy sheriff' in the region.
© Espicom Business Intelligence
Page 10
Australia Medical Devices Report Q2 2014
Economic SWOT Analysis
Strengths
■
A free-market economy supported by a highly educated workforce.
■
Blessed with rich natural resources, Australia's economic activity has been augmented by demand for commodity exports and the investments made in the mining sector.
Weaknesses
■
The persistent current account deficit increases vulnerability to capital flows and, by extension, currency volatility.
■
The export basket is highly concentrated in commodities, and consequently exposes the economy and currency to fluctuations in world prices for metals, coal and agricultural goods.
Opportunities
■
The rapid expansion of Asian economies in recent years offers new opportunities for diversifying trading ties from core European markets.
■
A low level of government debt has provided a certain amount of flexibility in fiscal policy to support domestic demand through the downturn.
Threats
■
The high level of private sector debt - especially mortgage loans - fuelled by overseas funding poses a threat to sustained growth.
■
A collapse in exports from a drop in resource demand from China and other resourcehungry countries would severely impact headline GDP growth.
■
Australia is vulnerable to extreme weather that may lead to droughts and floods, which have become increasingly severe in past years as a result of global climate change.
© Espicom Business Intelligence
Page 11
Australia Medical Devices Report Q2 2014
Business Environment SWOT Analysis
Strengths
■
A highly educated workforce and comparatively modern transport infrastructure underpin economic prospects.
■
A number of free trade agreements with countries such as New Zealand, Thailand and the US serve as a boon for trading activities.
Weaknesses
■
Despite its openness, Australia requires the Foreign Investment Review Board to approve any commercial real estate investment by a foreign company or individual valued at US$5mn or more.
■
With a population of just over 22mn, the domestic consumer base is small by regional standards.
Opportunities
■
Australia is currently in talks with China, Malaysia, the Gulf Co-operation Council, Indonesia, India, Japan and South Korea regarding potential bilateral free trade agreements. It is also part of negotiations for the Trans-Pacific Partnership and a regional south pacific pact, PACER plus.
■
Upgrade and expansion of urban infrastructure will be needed to sustain population growth in Australia's main cities, providing opportunities for public-private partnerships in the future. The government is also targeting infrastructure improvements to rural areas.
■
More healthcare infrastructure will be needed to support the ageing population, and with the introduction of the federal government's National Disability Insurance Scheme, the industry is likely to see increasing demand for services.
Threats
■
Corporate taxes for foreign investors in Australia remain higher than in other countries, and it seems unlikely that the government will succeed to reduce the rates in the near future.
■
Recent investment proposals by Chinese firms regarding the agricultural and resource extraction sector have raised fears that strategic assets will be lost to foreign players. This has led to more conditions attached to the sale agreements, which is likely to
© Espicom Business Intelligence
Page 12
Australia Medical Devices Report Q2 2014
SWOT Analysis - Continued
reduce the attractiveness of these assets. It remains to be seen if the recent implementation of a database to increase transparency around foreign-owned Australian assets will spur more regulation.
© Espicom Business Intelligence
Page 13
Australia Medical Devices Report Q2 2014
Industry Forecast Medical Device Market Forecast Past Performance 2008-2013
The Australian market has performed well in recent years, driven by a strongly-growing economy and the requirements of an increasingly elderly population. Growth for the 2008-2013 period is estimated at a CAGR of 7.8% in US$ terms, but 4.0% when measured in Australian dollars. Strong growth, of 15.9% and 18.2% was recorded in 2010 and 2011, but this was primarily a result of exchange rate volatility.
Medical Device Market, 2009-2018 % Change
Source: BMI Espicom
© Espicom Business Intelligence
Page 14
Australia Medical Devices Report Q2 2014
CAGR Of The Historical Medical Device Market By Product Area %
Source: BMI Espicom
Future Performance 2013-2018
A weakening of the Australian dollar over the next five years is expected to result in a reversal of the growth trend experienced over the 2008-2012 period, with the market projected to stagnate in US dollar terms, but growing by 6.0% when measured in local currency.
A CAGR for 2013-2018 of 0.1% is projected to take the overall market to US$4,836.5mn by 2018, equal to US$196 per capita. This will place Australia amongst the top 20 largest markets in the world by 2018.
© Espicom Business Intelligence
Page 15
Australia Medical Devices Report Q2 2014
Table: Projected Medical Device Market, 2013-2018
Total (US$mn)
Per Capita (US$)
Total (Local Currency mn)
Per Capita (Local Currency)
2013
4,814.3
207.4
4,815.7
207.5
2014
4,542.0
193.3
5,074.9
215.9
2015
4,246.5
178.5
5,375.3
225.9
2016
4,278.5
177.6
5,704.6
236.8
2017
4,547.9
186.5
6,063.9
248.7
2018
4,836.5
196.0
6,448.7
261.4
Source: BMI Espicom
Projected Medical Device Market, 2013-2018 US$mn
Source: BMI Espicom
© Espicom Business Intelligence
Page 16
Australia Medical Devices Report Q2 2014
CAGR Of The Projected Medical Device Market By Product Area , 2013-2018 %
Source: BMI Espicom
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$mn)
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
CONSUMABLES
457.5
468.1
529.4
649.0
648.4
646.8
598.3
548.5
542.0
565.2
589.9
BANDAGES & DRESSINGS
114.5
112.5
138.6
189.0
151.0
150.0
138.1
125.9
123.7
128.1
132.6
Medical dressings (adhesive)
50.6
48.4
56.6
71.1
70.1
70.5
65.7
60.6
60.3
63.2
66.2
Medical dressings (nonadhesive)
64.0
64.1
82.0
117.8
80.9
79.5
72.4
65.3
63.4
64.9
66.4
SUTURING MATERIALS
61.5
60.2
62.1
76.7
92.7
95.4
90.9
85.7
87.0
93.2
99.8
© Espicom Business Intelligence
Page 17
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (US$mn) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
257.1
256.9
263.4
307.4
327.3
322.7
294.8
266.7
260.0
267.3
274.8
Syringes (with/without needles)
36.4
45.5
47.5
52.0
51.9
52.6
49.3
45.9
45.9
48.5
51.2
Tubular metal needles/ needles for sutures
28.5
32.4
30.7
36.2
38.4
38.4
35.6
32.7
32.3
33.7
35.1
Other needles, catheters, cannulae etc
192.1
179.1
185.2
219.2
237.0
231.7
209.8
188.2
181.8
185.1
188.5
OTHER CONSUMABLES
24.4
38.5
65.3
75.9
77.4
78.8
74.6
70.2
71.3
76.6
82.7
Blood-grouping reagents
6.5
4.3
4.9
6.8
5.5
5.4
5.0
4.5
4.4
4.5
4.7
First-aid boxes & kits
2.9
2.4
3.7
4.6
6.9
8.0
8.6
9.1
10.4
12.6
15.2
Ostomy products
0.9
18.3
36.9
36.8
41.4
40.5
36.7
33.0
31.9
32.5
33.2
14.1
13.4
19.8
27.6
23.5
24.9
24.3
23.5
24.6
27.0
29.7
DIAGNOSTIC IMAGING
498.0
510.5
587.4
640.5
726.3
735.2
690.0
641.6
642.9
679.8
719.1
ELECTRODIAGNOSTIC APPARATUS
242.2
252.9
288.0
313.0
328.6
335.9
318.3
298.8
302.3
322.8
344.7
9.9
10.0
13.3
15.5
15.1
15.6
14.9
14.0
14.3
15.3
16.5
Ultrasound
76.7
80.7
84.2
90.6
89.5
89.8
83.4
76.8
76.2
79.6
83.2
MRI
27.4
46.3
52.2
56.0
72.8
77.5
76.5
74.7
78.5
87.0
96.4
Scintigraphic apparatus
2.2
1.7
4.0
3.5
4.1
4.4
4.4
4.4
4.6
5.2
5.9
Other electrodiagnostic apparatus
126.0
114.3
134.3
147.4
147.2
148.6
139.1
129.0
128.8
135.6
142.7
RADIATION APPARATUS
119.5
128.3
147.8
154.1
218.9
221.9
208.4
193.9
194.3
205.5
217.4
CT scanners
23.7
32.8
43.6
64.3
93.4
97.1
93.5
89.1
91.5
99.0
107.1
Other medical x-ray apparatus
88.0
94.1
101.4
86.6
116.9
116.3
107.3
97.9
96.2
99.7
103.4
7.8
1.4
2.8
3.2
8.6
8.4
7.6
6.9
6.7
6.8
6.9
136.3
129.3
151.6
173.4
178.7
177.4
163.3
148.9
146.2
151.5
157.0
Contrast media
26.8
25.2
31.1
32.1
33.9
33.3
30.3
27.3
26.5
27.2
27.8
Medical x-ray film (flat)
21.0
22.0
23.4
25.5
23.5
22.4
19.8
17.3
16.3
16.1
16.0
SYRINGES, NEEDLES & CATHETERS
Surgical gloves
Electrocardiographs
A, B, C ray apparatus
IMAGING PARTS & ACCESSORIES
© Espicom Business Intelligence
Page 18
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (US$mn) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
0.3
0.2
0.2
0.2
0.4
0.4
0.4
0.3
0.4
0.4
0.4
X-ray tubes
16.8
18.5
19.9
21.5
24.8
25.3
24.0
22.5
22.7
24.2
25.7
Other imaging parts & accessories
71.4
63.4
77.1
94.1
96.1
96.0
88.8
81.4
80.4
83.7
87.1
DENTAL PRODUCTS
172.2
186.8
205.1
226.0
240.0
247.1
236.2
224.0
229.2
247.7
268.1
CAPITAL EQUIPMENT
20.3
25.6
35.7
28.4
28.8
30.1
29.1
27.9
28.9
31.5
34.4
Dental drills
1.7
3.1
3.5
2.4
2.1
2.0
1.8
1.6
1.6
1.6
1.6
Dental chairs
8.6
8.5
12.7
10.2
9.2
9.3
8.6
7.9
7.9
8.2
8.6
Dental x-ray
9.9
14.0
19.5
15.8
17.5
18.8
18.7
18.3
19.4
21.7
24.2
151.9
161.2
169.4
197.7
211.2
217.1
207.1
196.0
200.3
216.1
233.7
Dental cements
32.2
34.2
37.0
53.6
59.8
64.3
64.2
63.5
67.7
76.0
85.4
Dental instruments
74.0
81.6
78.0
87.1
92.5
90.7
82.4
74.2
71.9
73.5
75.1
Teeth & other fittings
45.7
45.3
54.4
57.0
59.0
62.0
60.4
58.3
60.7
66.6
73.1
5.3
5.5
11.4
12.5
13.5
13.6
12.6
11.6
11.5
12.1
12.6
Other dental fittings
40.4
39.8
43.0
44.5
45.4
48.4
47.8
46.7
49.1
54.5
60.5
ORTHOPAEDICS & PROSTHETICS
539.8
557.2
656.7
850.6
835.0
864.7
829.8
788.3
806.7
870.5
939.5
FIXATION DEVICES
141.2
110.4
134.4
219.9
201.5
204.2
191.8
178.3
178.5
188.5
198.9
ARTIFICIAL JOINTS
171.0
156.6
194.2
245.0
280.2
294.4
286.6
276.2
286.6
313.5
343.0
OTHER ARTIFICIAL BODY PARTS
227.6
290.2
328.0
385.7
353.3
366.0
351.3
333.8
341.6
368.5
397.6
PATIENT AIDS
626.8
551.6
682.5
810.0
787.8
792.1
738.8
683.6
681.7
717.2
755.0
PORTABLE AIDS
475.3
408.5
470.3
576.4
563.1
562.5
521.1
478.7
473.9
494.8
516.8
Hearing aids
111.8
96.4
116.8
143.4
138.1
139.0
129.8
120.6
120.7
127.4
134.4
Pacemakers
121.5
116.6
130.9
147.2
177.8
181.5
171.6
160.6
161.9
172.0
182.8
Other portable aids
242.1
195.5
222.6
285.8
247.1
242.0
219.6
197.5
191.3
195.4
199.6
Medical x-ray film (rolled)
INSTRUMENTS & SUPPLIES
Artificial teeth
© Espicom Business Intelligence
Page 19
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (US$mn) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
151.4
143.1
212.2
233.6
224.7
229.7
217.8
204.9
207.8
222.4
238.2
Mechano-therapy apparatus
63.8
54.0
61.3
70.2
81.2
80.0
73.0
65.9
64.1
65.7
67.4
Therapeutic respiration apparatus
87.7
89.1
150.9
163.4
143.5
149.7
144.8
139.0
143.7
156.6
170.7
THERAPEUTIC APPLIANCES
OTHERS
1,011.8 1,054.0 1,195.3 1,381.0 1,493.9 1,528.3 1,448.9 1,360.6 1,376.1 1,467.5 1,564.9
WHEELCHAIRS
26.5
24.4
28.0
31.2
32.2
32.7
30.7
28.7
28.8
30.5
32.4
Wheelchairs, not mechanically propelled
11.2
10.0
10.7
12.9
13.4
14.1
13.6
13.1
13.5
14.7
16.1
Wheelchairs, mechanically propelled
15.3
14.4
17.3
18.3
18.8
18.6
17.1
15.6
15.3
15.8
16.3
OPHTHALMIC INSTRUMENTS
65.1
65.8
68.5
85.3
96.5
98.8
93.7
88.0
89.0
95.0
101.3
HOSPITAL FURNITURE
41.0
35.0
41.6
50.1
58.6
59.5
55.9
52.0
52.1
55.0
58.1
MEDICAL, SURGICAL STERILISERS
16.5
17.3
18.9
20.3
22.4
22.5
20.9
19.2
19.0
19.8
20.7
1.8
1.5
2.4
2.3
4.0
4.2
4.0
3.8
3.9
4.3
4.6
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
OTHER INSTRUMENTS & APPLIANCES Anaesthetic apparatus and instruments
TOTAL
860.9 86.5
910.0 1,035.9 1,191.8 1,280.1 1,310.8 1,243.8 1,169.0 1,183.3 1,262.9 1,347.7 91.4
98.4
96.2
120.7
121.7
113.7
105.1
104.7
109.9
115.3
3,306.0 3,328.2 3,856.4 4,557.1 4,731.4 4,814.3 4,542.0 4,246.5 4,278.5 4,547.9 4,836.5
Source: BMI Espicom
© Espicom Business Intelligence
Page 20
Australia Medical Devices Report Q2 2014
Table: Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita)
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
21.3
21.4
23.8
28.7
28.3
27.9
25.5
23.1
22.5
23.2
23.9
BANDAGES & DRESSINGS
5.3
5.1
6.2
8.4
6.6
6.5
5.9
5.3
5.1
5.3
5.4
Medical dressings (adhesive)
2.3
2.2
2.5
3.1
3.1
3.0
2.8
2.5
2.5
2.6
2.7
Medical dressings (nonadhesive)
3.0
2.9
3.7
5.2
3.5
3.4
3.1
2.7
2.6
2.7
2.7
SUTURING MATERIALS
2.9
2.7
2.8
3.4
4.0
4.1
3.9
3.6
3.6
3.8
4.0
SYRINGES, NEEDLES & CATHETERS
11.9
11.7
11.8
13.6
14.3
13.9
12.5
11.2
10.8
11.0
11.1
Syringes (with/without needles)
1.7
2.1
2.1
2.3
2.3
2.3
2.1
1.9
1.9
2.0
2.1
Tubular metal needles/ needles for sutures
1.3
1.5
1.4
1.6
1.7
1.7
1.5
1.4
1.3
1.4
1.4
Other needles, catheters, cannulae etc
8.9
8.2
8.3
9.7
10.3
10.0
8.9
7.9
7.5
7.6
7.6
OTHER CONSUMABLES
1.1
1.8
2.9
3.4
3.4
3.4
3.2
2.9
3.0
3.1
3.4
Blood-grouping reagents
0.3
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
First-aid boxes & kits
0.1
0.1
0.2
0.2
0.3
0.3
0.4
0.4
0.4
0.5
0.6
Ostomy products
0.0
0.8
1.7
1.6
1.8
1.7
1.6
1.4
1.3
1.3
1.3
Surgical gloves
0.7
0.6
0.9
1.2
1.0
1.1
1.0
1.0
1.0
1.1
1.2
DIAGNOSTIC IMAGING
23.1
23.3
26.4
28.3
31.7
31.7
29.4
27.0
26.7
27.9
29.1
ELECTRODIAGNOSTIC APPARATUS
11.3
11.5
12.9
13.8
14.3
14.5
13.5
12.6
12.6
13.2
14.0
Electrocardiographs
0.5
0.5
0.6
0.7
0.7
0.7
0.6
0.6
0.6
0.6
0.7
Ultrasound
3.6
3.7
3.8
4.0
3.9
3.9
3.5
3.2
3.2
3.3
3.4
MRI
1.3
2.1
2.3
2.5
3.2
3.3
3.3
3.1
3.3
3.6
3.9
Scintigraphic apparatus
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
CONSUMABLES
© Espicom Business Intelligence
Page 21
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Other electrodiagnostic apparatus
5.9
5.2
6.0
6.5
6.4
6.4
5.9
5.4
5.3
5.6
5.8
RADIATION APPARATUS
5.6
5.9
6.6
6.8
9.6
9.6
8.9
8.1
8.1
8.4
8.8
CT scanners
1.1
1.5
2.0
2.8
4.1
4.2
4.0
3.7
3.8
4.1
4.3
Other medical x-ray apparatus
4.1
4.3
4.6
3.8
5.1
5.0
4.6
4.1
4.0
4.1
4.2
A, B, C ray apparatus
0.4
0.1
0.1
0.1
0.4
0.4
0.3
0.3
0.3
0.3
0.3
IMAGING PARTS & ACCESSORIES
6.3
5.9
6.8
7.7
7.8
7.6
6.9
6.3
6.1
6.2
6.4
Contrast media
1.2
1.2
1.4
1.4
1.5
1.4
1.3
1.1
1.1
1.1
1.1
Medical x-ray film (flat)
1.0
1.0
1.0
1.1
1.0
1.0
0.8
0.7
0.7
0.7
0.6
Medical x-ray film (rolled)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
X-ray tubes
0.8
0.8
0.9
1.0
1.1
1.1
1.0
0.9
0.9
1.0
1.0
Other imaging parts & accessories
3.3
2.9
3.5
4.2
4.2
4.1
3.8
3.4
3.3
3.4
3.5
DENTAL PRODUCTS
8.0
8.5
9.2
10.0
10.5
10.6
10.0
9.4
9.5
10.2
10.9
CAPITAL EQUIPMENT
0.9
1.2
1.6
1.3
1.3
1.3
1.2
1.2
1.2
1.3
1.4
Dental drills
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Dental chairs
0.4
0.4
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.3
Dental x-ray
0.5
0.6
0.9
0.7
0.8
0.8
0.8
0.8
0.8
0.9
1.0
INSTRUMENTS & SUPPLIES
7.1
7.4
7.6
8.7
9.2
9.4
8.8
8.2
8.3
8.9
9.5
Dental cements
1.5
1.6
1.7
2.4
2.6
2.8
2.7
2.7
2.8
3.1
3.5
Dental instruments
3.4
3.7
3.5
3.9
4.0
3.9
3.5
3.1
3.0
3.0
3.0
Teeth & other fittings
2.1
2.1
2.4
2.5
2.6
2.7
2.6
2.5
2.5
2.7
3.0
Artificial teeth
0.2
0.3
0.5
0.6
0.6
0.6
0.5
0.5
0.5
0.5
0.5
Other dental fittings
1.9
1.8
1.9
2.0
2.0
2.1
2.0
2.0
2.0
2.2
2.5
ORTHOPAEDICS & PROSTHETICS
25.1
25.4
29.5
37.6
36.4
37.2
35.3
33.1
33.5
35.7
38.1
© Espicom Business Intelligence
Page 22
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
FIXATION DEVICES
6.6
5.0
6.0
9.7
8.8
8.8
8.2
7.5
7.4
7.7
8.1
ARTIFICIAL JOINTS
7.9
7.1
8.7
10.8
12.2
12.7
12.2
11.6
11.9
12.9
13.9
OTHER ARTIFICIAL BODY PARTS
10.6
13.3
14.7
17.1
15.4
15.8
14.9
14.0
14.2
15.1
16.1
PATIENT AIDS
29.1
25.2
30.6
35.8
34.4
34.1
31.4
28.7
28.3
29.4
30.6
PORTABLE AIDS
22.1
18.7
21.1
25.5
24.6
24.2
22.2
20.1
19.7
20.3
20.9
Hearing aids
5.2
4.4
5.2
6.3
6.0
6.0
5.5
5.1
5.0
5.2
5.4
Pacemakers
5.6
5.3
5.9
6.5
7.8
7.8
7.3
6.8
6.7
7.1
7.4
11.3
8.9
10.0
12.6
10.8
10.4
9.3
8.3
7.9
8.0
8.1
THERAPEUTIC APPLIANCES
7.0
6.5
9.5
10.3
9.8
9.9
9.3
8.6
8.6
9.1
9.7
Mechano-therapy apparatus
3.0
2.5
2.8
3.1
3.5
3.4
3.1
2.8
2.7
2.7
2.7
Therapeutic respiration apparatus
4.1
4.1
6.8
7.2
6.3
6.4
6.2
5.8
6.0
6.4
6.9
47.0
48.1
53.7
61.1
65.2
65.8
61.6
57.2
57.1
60.2
63.4
WHEELCHAIRS
1.2
1.1
1.3
1.4
1.4
1.4
1.3
1.2
1.2
1.3
1.3
Wheelchairs, not mechanically propelled
0.5
0.5
0.5
0.6
0.6
0.6
0.6
0.5
0.6
0.6
0.7
Wheelchairs, mechanically propelled
0.7
0.7
0.8
0.8
0.8
0.8
0.7
0.7
0.6
0.6
0.7
OPHTHALMIC INSTRUMENTS
3.0
3.0
3.1
3.8
4.2
4.3
4.0
3.7
3.7
3.9
4.1
HOSPITAL FURNITURE
1.9
1.6
1.9
2.2
2.6
2.6
2.4
2.2
2.2
2.3
2.4
MEDICAL, SURGICAL STERILISERS
0.8
0.8
0.8
0.9
1.0
1.0
0.9
0.8
0.8
0.8
0.8
Other portable aids
OTHERS
© Espicom Business Intelligence
Page 23
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (US$ Per Capita) - Continued
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
OTHER INSTRUMENTS & APPLIANCES Anaesthetic apparatus and instruments
TOTAL
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
40.0
41.5
46.5
52.7
55.9
56.5
52.9
49.1
49.1
51.8
54.6
4.0
4.2
4.4
4.3
5.3
5.2
4.8
4.4
4.3
4.5
4.7
153.7
152.0
173.2
201.6
206.4
207.4
193.3
178.5
177.6
186.5
196.0
Source: BMI Espicom
Table: Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total)
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
13.8
14.1
13.7
14.2
13.7
13.4
13.2
12.9
12.7
12.4
12.2
BANDAGES & DRESSINGS
3.5
3.4
3.6
4.1
3.2
3.1
3.0
3.0
2.9
2.8
2.7
Medical dressings (adhesive)
1.5
1.5
1.5
1.6
1.5
1.5
1.4
1.4
1.4
1.4
1.4
Medical dressings (nonadhesive)
1.9
1.9
2.1
2.6
1.7
1.7
1.6
1.5
1.5
1.4
1.4
SUTURING MATERIALS
1.9
1.8
1.6
1.7
2.0
2.0
2.0
2.0
2.0
2.0
2.1
SYRINGES, NEEDLES & CATHETERS
7.8
7.7
6.8
6.7
6.9
6.7
6.5
6.3
6.1
5.9
5.7
Syringes (with/without needles)
1.1
1.4
1.2
1.1
1.1
1.1
1.1
1.1
1.1
1.1
1.1
Tubular metal needles/ needles for sutures
0.9
1.0
0.8
0.8
0.8
0.8
0.8
0.8
0.8
0.7
0.7
Other needles, catheters, cannulae etc
5.8
5.4
4.8
4.8
5.0
4.8
4.6
4.4
4.2
4.1
3.9
CONSUMABLES
© Espicom Business Intelligence
Page 24
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
OTHER CONSUMABLES
0.7
1.2
1.7
1.7
1.6
1.6
1.6
1.7
1.7
1.7
1.7
Blood-grouping reagents
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
First-aid boxes & kits
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.3
0.3
Ostomy products
0.0
0.5
1.0
0.8
0.9
0.8
0.8
0.8
0.7
0.7
0.7
Surgical gloves
0.4
0.4
0.5
0.6
0.5
0.5
0.5
0.6
0.6
0.6
0.6
DIAGNOSTIC IMAGING
15.1
15.3
15.2
14.1
15.3
15.3
15.2
15.1
15.0
14.9
14.9
ELECTRODIAGNOSTIC APPARATUS
7.3
7.6
7.5
6.9
6.9
7.0
7.0
7.0
7.1
7.1
7.1
Electrocardiographs
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
Ultrasound
2.3
2.4
2.2
2.0
1.9
1.9
1.8
1.8
1.8
1.8
1.7
MRI
0.8
1.4
1.4
1.2
1.5
1.6
1.7
1.8
1.8
1.9
2.0
Scintigraphic apparatus
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Other electrodiagnostic apparatus
3.8
3.4
3.5
3.2
3.1
3.1
3.1
3.0
3.0
3.0
3.0
RADIATION APPARATUS
3.6
3.9
3.8
3.4
4.6
4.6
4.6
4.6
4.5
4.5
4.5
CT scanners
0.7
1.0
1.1
1.4
2.0
2.0
2.1
2.1
2.1
2.2
2.2
Other medical x-ray apparatus
2.7
2.8
2.6
1.9
2.5
2.4
2.4
2.3
2.2
2.2
2.1
A, B, C ray apparatus
0.2
0.0
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.1
0.1
IMAGING PARTS & ACCESSORIES
4.1
3.9
3.9
3.8
3.8
3.7
3.6
3.5
3.4
3.3
3.2
Contrast media
0.8
0.8
0.8
0.7
0.7
0.7
0.7
0.6
0.6
0.6
0.6
Medical x-ray film (flat)
0.6
0.7
0.6
0.6
0.5
0.5
0.4
0.4
0.4
0.4
0.3
Medical x-ray film (rolled)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
X-ray tubes
0.5
0.6
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
0.5
Other imaging parts & accessories
2.2
1.9
2.0
2.1
2.0
2.0
2.0
1.9
1.9
1.8
1.8
DENTAL PRODUCTS
5.2
5.6
5.3
5.0
5.1
5.1
5.2
5.3
5.4
5.4
5.5
© Espicom Business Intelligence
Page 25
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
CAPITAL EQUIPMENT
0.6
0.8
0.9
0.6
0.6
0.6
0.6
0.7
0.7
0.7
0.7
Dental drills
0.1
0.1
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Dental chairs
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
Dental x-ray
0.3
0.4
0.5
0.3
0.4
0.4
0.4
0.4
0.5
0.5
0.5
INSTRUMENTS & SUPPLIES
4.6
4.8
4.4
4.3
4.5
4.5
4.6
4.6
4.7
4.8
4.8
Dental cements
1.0
1.0
1.0
1.2
1.3
1.3
1.4
1.5
1.6
1.7
1.8
Dental instruments
2.2
2.5
2.0
1.9
2.0
1.9
1.8
1.7
1.7
1.6
1.6
Teeth & other fittings
1.4
1.4
1.4
1.3
1.2
1.3
1.3
1.4
1.4
1.5
1.5
Artificial teeth
0.2
0.2
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
Other dental fittings
1.2
1.2
1.1
1.0
1.0
1.0
1.1
1.1
1.1
1.2
1.3
ORTHOPAEDICS & PROSTHETICS
16.3
16.7
17.0
18.7
17.6
18.0
18.3
18.6
18.9
19.1
19.4
FIXATION DEVICES
4.3
3.3
3.5
4.8
4.3
4.2
4.2
4.2
4.2
4.1
4.1
ARTIFICIAL JOINTS
5.2
4.7
5.0
5.4
5.9
6.1
6.3
6.5
6.7
6.9
7.1
OTHER ARTIFICIAL BODY PARTS
6.9
8.7
8.5
8.5
7.5
7.6
7.7
7.9
8.0
8.1
8.2
PATIENT AIDS
19.0
16.6
17.7
17.8
16.7
16.5
16.3
16.1
15.9
15.8
15.6
PORTABLE AIDS
14.4
12.3
12.2
12.6
11.9
11.7
11.5
11.3
11.1
10.9
10.7
Hearing aids
3.4
2.9
3.0
3.1
2.9
2.9
2.9
2.8
2.8
2.8
2.8
Pacemakers
3.7
3.5
3.4
3.2
3.8
3.8
3.8
3.8
3.8
3.8
3.8
Other portable aids
7.3
5.9
5.8
6.3
5.2
5.0
4.8
4.7
4.5
4.3
4.1
THERAPEUTIC APPLIANCES
4.6
4.3
5.5
5.1
4.8
4.8
4.8
4.8
4.9
4.9
4.9
Mechano-therapy apparatus
1.9
1.6
1.6
1.5
1.7
1.7
1.6
1.6
1.5
1.4
1.4
Therapeutic respiration apparatus
2.7
2.7
3.9
3.6
3.0
3.1
3.2
3.3
3.4
3.4
3.5
30.6
31.7
31.0
30.3
31.6
31.7
31.9
32.0
32.2
32.3
32.4
OTHERS
© Espicom Business Intelligence
Page 26
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2008-2018 (% Of Total) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
WHEELCHAIRS
0.8
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
Wheelchairs, not mechanically propelled
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
Wheelchairs, mechanically propelled
0.5
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.4
0.3
0.3
OPHTHALMIC INSTRUMENTS
2.0
2.0
1.8
1.9
2.0
2.1
2.1
2.1
2.1
2.1
2.1
HOSPITAL FURNITURE
1.2
1.1
1.1
1.1
1.2
1.2
1.2
1.2
1.2
1.2
1.2
MEDICAL, SURGICAL STERILISERS
0.5
0.5
0.5
0.4
0.5
0.5
0.5
0.5
0.4
0.4
0.4
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
0.1
0.0
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
26.0
27.3
26.9
26.2
27.1
27.2
27.4
27.5
27.7
27.8
27.9
2.6
2.7
2.6
2.1
2.6
2.5
2.5
2.5
2.4
2.4
2.4
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
100.0
OTHER INSTRUMENTS & APPLIANCES Anaesthetic apparatus and instruments
TOTAL
Source: BMI Espicom
© Espicom Business Intelligence
Page 27
Australia Medical Devices Report Q2 2014
Table: Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change)
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2.3
13.1
22.6
-0.1
-0.2
-7.5
-8.3
-1.2
4.3
4.4
BANDAGES & DRESSINGS
-1.7
23.2
36.3
-20.1
-0.6
-7.9
-8.8
-1.8
3.6
3.6
Medical dressings (adhesive)
-4.2
16.9
25.6
-1.5
0.6
-6.8
-7.7
-0.6
4.8
4.8
Medical dressings (nonadhesive)
0.2
27.9
43.7
-31.3
-1.7
-8.9
-9.8
-2.9
2.4
2.4
SUTURING MATERIALS
-2.1
3.2
23.5
20.9
2.8
-4.7
-5.7
1.6
7.1
7.1
SYRINGES, NEEDLES & CATHETERS
-0.1
2.5
16.7
6.5
-1.4
-8.6
-9.5
-2.5
2.8
2.8
Syringes (with/without needles)
24.9
4.4
9.5
-0.2
1.3
-6.1
-7.0
0.1
5.6
5.6
Tubular metal needles/ needles for sutures
13.4
-5.0
17.8
6.2
-0.1
-7.4
-8.2
-1.1
4.3
4.2
Other needles, catheters, cannulae etc
-6.8
3.4
18.4
8.1
-2.2
-9.4
-10.3
-3.4
1.9
1.8
OTHER CONSUMABLES
57.7
69.7
16.2
2.0
1.9
-5.3
-6.0
1.6
7.5
7.9
Blood-grouping reagents
-32.8
13.4
38.1
-19.2
-1.2
-8.5
-9.3
-2.3
3.0
3.0
First-aid boxes & kits
-14.8
51.0
24.6
50.5
15.7
7.3
6.2
14.3
20.5
20.5
1,823.6
102.0
-0.1
12.4
-2.2
-9.3
-10.2
-3.3
2.0
2.0
-4.9
47.5
39.7
-14.8
5.6
-2.2
-3.2
4.3
9.9
9.9
DIAGNOSTIC IMAGING
2.5
15.1
9.0
13.4
1.2
-6.2
-7.0
0.2
5.7
5.8
ELECTRODIAGNOSTIC APPARATUS
4.4
13.9
8.7
5.0
2.2
-5.2
-6.1
1.2
6.7
6.8
Electrocardiographs
0.2
33.6
16.3
-2.5
3.0
-4.6
-5.5
1.8
7.3
7.3
Ultrasound
5.2
4.3
7.7
-1.3
0.3
-7.0
-7.9
-0.9
4.5
4.5
69.2
12.8
7.1
30.1
6.5
-1.4
-2.4
5.1
10.9
10.8
Scintigraphic apparatus
-23.5
134.0
-12.8
16.8
8.0
0.0
-1.0
6.6
12.4
12.4
Other electrodiagnostic apparatus
-9.3
17.5
9.8
-0.2
1.0
-6.4
-7.3
-0.1
5.3
5.3
CONSUMABLES
Ostomy products Surgical gloves
MRI
© Espicom Business Intelligence
Page 28
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change) - Continued
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
7.3
15.2
4.3
42.1
1.3
-6.1
-7.0
0.2
5.7
5.8
38.1
33.1
47.3
45.4
3.9
-3.7
-4.7
2.6
8.2
8.2
6.9
7.7
-14.5
35.0
-0.5
-7.8
-8.7
-1.7
3.6
3.6
-81.5
94.8
15.1
166.8
-2.1
-9.3
-10.1
-3.2
2.1
2.1
IMAGING PARTS & ACCESSORIES
-5.1
17.3
14.4
3.0
-0.7
-8.0
-8.8
-1.8
3.6
3.6
Contrast media
-5.9
23.2
3.3
5.5
-1.7
-9.0
-9.9
-2.9
2.3
2.3
4.7
6.4
9.1
-7.8
-4.7
-11.7
-12.6
-5.9
-0.7
-0.7
-28.8
-18.1
29.3
95.0
2.1
-5.4
-6.2
1.0
6.5
6.5
10.1
7.3
8.3
15.2
2.2
-5.3
-6.2
1.0
6.5
6.5
Other imaging parts & accessories
-11.2
21.6
22.0
2.2
-0.1
-7.4
-8.3
-1.3
4.1
4.1
DENTAL PRODUCTS
8.5
9.8
10.2
6.2
2.9
-4.4
-5.2
2.3
8.1
8.3
CAPITAL EQUIPMENT
26.5
39.3
-20.5
1.6
4.3
-3.2
-4.1
3.4
9.2
9.3
Dental drills
77.7
13.8
-32.4
-14.0
-2.3
-9.5
-10.3
-3.4
1.8
1.8
Dental chairs
-1.2
48.3
-19.4
-9.4
0.4
-7.0
-7.9
-0.8
4.6
4.6
Dental x-ray
41.6
39.5
-19.1
11.0
7.2
-0.7
-1.7
5.9
11.6
11.6
INSTRUMENTS & SUPPLIES
6.1
5.1
16.7
6.9
2.8
-4.6
-5.3
2.2
7.9
8.1
Dental cements
6.3
8.0
44.8
11.6
7.7
-0.2
-1.1
6.5
12.3
12.3
Dental instruments
10.3
-4.5
11.7
6.2
-1.9
-9.1
-10.0
-3.1
2.2
2.2
Teeth & other fittings
-0.8
20.0
4.8
3.4
5.1
-2.5
-3.5
4.0
9.7
9.8
4.5
105.6
10.0
8.1
0.4
-7.0
-7.9
-0.8
4.6
4.5
Other dental fittings
-1.5
8.1
3.4
2.1
6.5
-1.3
-2.3
5.2
11.0
10.9
ORTHOPAEDICS & PROSTHETICS
3.2
17.9
29.5
-1.8
3.6
-4.0
-5.0
2.3
7.9
7.9
FIXATION DEVICES
-21.8
21.8
63.6
-8.4
1.4
-6.1
-7.0
0.1
5.6
5.6
ARTIFICIAL JOINTS
-8.4
24.1
26.1
14.4
5.1
-2.6
-3.6
3.8
9.4
9.4
RADIATION APPARATUS CT scanners Other medical x-ray apparatus A, B, C ray apparatus
Medical x-ray film (flat) Medical x-ray film (rolled) X-ray tubes
Artificial teeth
© Espicom Business Intelligence
Page 29
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change) - Continued
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
27.5
13.0
17.6
-8.4
3.6
-4.0
-5.0
2.3
7.9
7.9
PATIENT AIDS
-12.0
23.7
18.7
-2.7
0.5
-6.7
-7.5
-0.3
5.2
5.3
PORTABLE AIDS
-14.1
15.1
22.6
-2.3
-0.1
-7.4
-8.1
-1.0
4.4
4.4
Hearing aids
-13.7
21.1
22.8
-3.7
0.6
-6.6
-7.1
0.1
5.5
5.5
Pacemakers
-4.0
12.3
12.4
20.8
2.1
-5.5
-6.4
0.8
6.3
6.3
-19.2
13.9
28.4
-13.5
-2.1
-9.2
-10.1
-3.1
2.1
2.1
-5.5
48.3
10.1
-3.8
2.2
-5.2
-5.9
1.4
7.0
7.1
-15.4
13.6
14.5
15.8
-1.5
-8.8
-9.7
-2.7
2.6
2.6
Therapeutic respiration apparatus
1.6
69.4
8.3
-12.2
4.3
-3.3
-4.0
3.4
9.0
9.0
OTHERS
4.2
13.4
15.5
8.2
2.3
-5.2
-6.1
1.1
6.6
6.6
-7.9
14.8
11.5
3.2
1.5
-5.9
-6.8
0.5
6.0
6.1
-11.1
7.3
21.0
3.9
4.7
-3.0
-4.0
3.4
9.0
9.0
-5.6
19.9
5.6
2.7
-0.8
-8.1
-9.0
-2.0
3.4
3.4
1.1
4.0
24.6
13.2
2.3
-5.2
-6.1
1.2
6.7
6.7
-14.8
19.1
20.4
17.0
1.4
-6.0
-7.0
0.2
5.7
5.6
5.0
9.1
7.6
10.5
0.2
-7.2
-8.1
-1.0
4.4
4.4
-14.5
56.5
-5.7
75.3
4.1
-3.6
-4.5
2.8
8.4
8.4
5.7
13.8
15.0
7.4
2.4
-5.1
-6.0
1.2
6.7
6.7
OTHER ARTIFICIAL BODY PARTS
Other portable aids
THERAPEUTIC APPLIANCES Mechano-therapy apparatus
WHEELCHAIRS Wheelchairs, not mechanically propelled Wheelchairs, mechanically propelled
OPHTHALMIC INSTRUMENTS
HOSPITAL FURNITURE
MEDICAL, SURGICAL STERILISERS
ULTRA-VIOLET OR INFRARED RAY APPARATUS
OTHER INSTRUMENTS & APPLIANCES
© Espicom Business Intelligence
Page 30
Australia Medical Devices Report Q2 2014
Detailed Medical Device Market By Product Area, 2009-2018 (US$, % Change) - Continued
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Anaesthetic apparatus and instruments
5.7
7.7
-2.3
25.6
0.8
-6.6
-7.5
-0.4
5.0
5.0
TOTAL
0.7
15.9
18.2
3.8
1.8
-5.7
-6.5
0.8
6.3
6.3
Source: BMI Espicom
Consumables Market Forecast The Australian market for consumable products is estimated at US$646.8mn in 2013, equal to US$27.9 per capita and 13.4% of the total market. Within this, syringes, needles & catheters account for US$322.7mn and bandages & dressings for US$150.0mn.
There is some local production of items such as bandages and syringes, but this tends to be for export. As a result, the market is largely reliant on imports. The principal supplier is the USA, followed by China, Ireland and Germany.
The sector grew at a CAGR of 7.2% over the 2008-2013 period. Espicom projects a CAGR of -1.8% for the 2013-2018 period, with the market declining to US$589.9mn by 2018, equal to US$23.9 per capita.
© Espicom Business Intelligence
Page 31
Australia Medical Devices Report Q2 2014
Table: Consumables Market, 2008-2018 (US$mn)
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
CAGR CAGR 2018 2008-13 2013-18
CONSUMABLES
457.5 468.1 529.4 649.0 648.4 646.8 598.3 548.5 542.0 565.2 589.9
7.2
-1.8
BANDAGES & DRESSINGS
114.5 112.5 138.6 189.0 151.0 150.0 138.1 125.9 123.7 128.1 132.6
5.5
-2.4
Medical dressings (adhesive)
50.6
48.4
56.6
71.1
70.1
70.5
65.7
60.6
60.3
63.2
66.2
6.9
-1.3
Medical dressings (non-adhesive)
64.0
64.1
82.0 117.8
80.9
79.5
72.4
65.3
63.4
64.9
66.4
4.5
-3.5
SUTURING MATERIALS
61.5
60.2
62.1
92.7
95.4
90.9
85.7
87.0
93.2
99.8
9.2
0.9
257.1 256.9 263.4 307.4 327.3 322.7 294.8 266.7 260.0 267.3 274.8
4.6
-3.2
SYRINGES, NEEDLES & CATHETERS
76.7
Syringes (with/ without needles)
36.4
45.5
47.5
52.0
51.9
52.6
49.3
45.9
45.9
48.5
51.2
7.6
-0.5
Tubular metal needles/needles for sutures
28.5
32.4
30.7
36.2
38.4
38.4
35.6
32.7
32.3
33.7
35.1
6.1
-1.8
192.1 179.1 185.2 219.2 237.0 231.7 209.8 188.2 181.8 185.1 188.5
3.8
-4.0
Other needles, catheters, cannulae etc
OTHER CONSUMABLES
24.4
38.5
65.3
75.9
77.4
78.8
74.6
70.2
71.3
76.6
82.7
26.4
1.0
Blood-grouping reagents
6.5
4.3
4.9
6.8
5.5
5.4
5.0
4.5
4.4
4.5
4.7
-3.4
-3.0
First-aid boxes & kits
2.9
2.4
3.7
4.6
6.9
8.0
8.6
9.1
10.4
12.6
15.2
22.8
13.6
Ostomy products
0.9
18.3
36.9
36.8
41.4
40.5
36.7
33.0
31.9
32.5
33.2
111.9
-3.9
14.1
13.4
19.8
27.6
23.5
24.9
24.3
23.5
24.6
27.0
29.7
12.0
3.6
Surgical gloves
Source: BMI Espicom
© Espicom Business Intelligence
Page 32
Australia Medical Devices Report Q2 2014
Table: Consumables Market, 2008-2018 (US$ Per Capita)
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
CAGR CAGR 2018 2008-13 2013-18
21.3
21.4
23.8
28.7
28.3
27.9
25.5
23.1
22.5
23.2
23.9
5.6
-3.0
BANDAGES & DRESSINGS
5.3
5.1
6.2
8.4
6.6
6.5
5.9
5.3
5.1
5.3
5.4
4.0
-3.6
Medical dressings (adhesive)
2.3
2.2
2.5
3.1
3.1
3.0
2.8
2.5
2.5
2.6
2.7
5.3
-2.4
Medical dressings (non-adhesive)
3.0
2.9
3.7
5.2
3.5
3.4
3.1
2.7
2.6
2.7
2.7
2.9
-4.7
SUTURING MATERIALS
2.9
2.7
2.8
3.4
4.0
4.1
3.9
3.6
3.6
3.8
4.0
7.5
-0.3
SYRINGES, NEEDLES & CATHETERS
11.9
11.7
11.8
13.6
14.3
13.9
12.5
11.2
10.8
11.0
11.1
3.1
-4.3
Syringes (with/ without needles)
1.7
2.1
2.1
2.3
2.3
2.3
2.1
1.9
1.9
2.0
2.1
6.0
-1.7
Tubular metal needles/needles for sutures
1.3
1.5
1.4
1.6
1.7
1.7
1.5
1.4
1.3
1.4
1.4
4.5
-3.0
Other needles, catheters, cannulae etc
8.9
8.2
8.3
9.7
10.3
10.0
8.9
7.9
7.5
7.6
7.6
2.2
-5.2
OTHER CONSUMABLES
1.1
1.8
2.9
3.4
3.4
3.4
3.2
2.9
3.0
3.1
3.4
24.5
-0.3
Blood-grouping reagents
0.3
0.2
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.2
0.2
-4.9
-4.1
First-aid boxes & kits
0.1
0.1
0.2
0.2
0.3
0.3
0.4
0.4
0.4
0.5
0.6
20.9
12.2
Ostomy products
0.0
0.8
1.7
1.6
1.8
1.7
1.6
1.4
1.3
1.3
1.3
108.7
-5.1
Surgical gloves
0.7
0.6
0.9
1.2
1.0
1.1
1.0
1.0
1.0
1.1
1.2
10.3
2.3
CONSUMABLES
Source: BMI Espicom
© Espicom Business Intelligence
Page 33
Australia Medical Devices Report Q2 2014
Table: Consumables Market, 2009-2018 (US$mn % Change)
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2.3
13.1
22.6
-0.1
-0.2
-7.5
-8.3
-1.2
4.3
4.4
BANDAGES & DRESSINGS
-1.7
23.2
36.3
-20.1
-0.6
-7.9
-8.8
-1.8
3.6
3.6
Medical dressings (adhesive)
-4.2
16.9
25.6
-1.5
0.6
-6.8
-7.7
-0.6
4.8
4.8
Medical dressings (nonadhesive)
0.2
27.9
43.7
-31.3
-1.7
-8.9
-9.8
-2.9
2.4
2.4
SUTURING MATERIALS
-2.1
3.2
23.5
20.9
2.8
-4.7
-5.7
1.6
7.1
7.1
SYRINGES, NEEDLES & CATHETERS
-0.1
2.5
16.7
6.5
-1.4
-8.6
-9.5
-2.5
2.8
2.8
Syringes (with/without needles)
24.9
4.4
9.5
-0.2
1.3
-6.1
-7.0
0.1
5.6
5.6
Tubular metal needles/ needles for sutures
13.4
-5.0
17.8
6.2
-0.1
-7.4
-8.2
-1.1
4.3
4.2
Other needles, catheters, cannulae etc
-6.8
3.4
18.4
8.1
-2.2
-9.4
-10.3
-3.4
1.9
1.8
OTHER CONSUMABLES
57.7
69.7
16.2
2.0
1.9
-5.3
-6.0
1.6
7.5
7.9
Blood-grouping reagents
-32.8
13.4
38.1
-19.2
-1.2
-8.5
-9.3
-2.3
3.0
3.0
First-aid boxes & kits
-14.8
51.0
24.6
50.5
15.7
7.3
6.2
14.3
20.5
20.5
1,823.6
102.0
-0.1
12.4
-2.2
-9.3
-10.2
-3.3
2.0
2.0
-4.9
47.5
39.7
-14.8
5.6
-2.2
-3.2
4.3
9.9
9.9
CONSUMABLES
Ostomy products Surgical gloves
Source: BMI Espicom
© Espicom Business Intelligence
Page 34
Australia Medical Devices Report Q2 2014
Consumables Market 2008-2018 US$mn
Source: BMI Espicom
© Espicom Business Intelligence
Page 35
Australia Medical Devices Report Q2 2014
Consumables Market, 2009--2018 US$mn CAGR
Source: BMI Espicom
Diagnostic Imaging Market Forecast The Australian market for diagnostic imaging is estimated at US$735.2mn in 2013, equal to US$31.7 per capita and 15.3% of the total market. Within the sector, electrodiagnostic apparatus accounts for US $335.9mn and X-ray/other radiation apparatus for a further US$221.9mn. Almost all requirements are imported. These are supplied primarily from the USA, Germany and China.
The sector grew strongly over the 2008-13 period, at a CAGR of 6.5%. Within this, high tech areas such as MRI and CT were the best performers. A slowdown in growth across the diagnostic sector is expected, however; Espicom projects a CAGR of 0.4% for the 2013-18 period. This will take the market to US $719.1mn by 2018, equal to US$29.1 per capita. The only growth will remain in the high tech areas, notably MRI and scintigraphic apparatus.
© Espicom Business Intelligence
Page 36
Australia Medical Devices Report Q2 2014
Electrodiagnostic Apparatus Sector
The market for electrodiagnostic apparatus is estimated at US$335.9mn in 2013, equal to US$31.7 per capita. Almost all of the market is imported.
Other electrodiagnostic apparatus, including patient monitoring equipment, is the largest segment within the electrodiagnostic market, with sales of US$148.6mn in 2013, followed by ultrasound apparatus with sales of US$89.8mn and MRI units to a value of US$77.5mn. The electrodiagnostic apparatus market increased at a CAGR of 6.8% between 2008 and 2013, with the strongest growth (23.1%) coming in the MRI segment.
A slowdown in growth to a CAGR of just 0.5% is forecast to take the market to US$719.1mn over the 2013-2018 period, with scintigraphic apparatus expected to have the highest growth at 5.9%.
Radiation Apparatus Sector
The market for radiation apparatus, including X-ray apparatus and CT scanners, totals an estimated US $221.9mn in 2013. Other medical X-ray apparatus forms the largest sector of the market, with sales estimated at US$116.3mn in 2013, followed by CT scanners at US$97.1mn. Almost all of the market is imported.
The market increased at an estimated CAGR of 13.2% over the 2008-2013 period. Demand for CT scanners increased significantly over the period, rising at a CAGR of 32.6%.
The sector is projected to show a small decline over the 2013-2018 period, with the only area expected to show any growth being the CT scanner segment which is forecast to increase at a CAGR of just under 2%.
Imaging Parts & Accessories Sector
The market for imaging parts & accessories is estimated at US$177.4mn in 2013, equal to US$7.6 per capita. The market is almost entirely reliant upon imports.
The market increased at an estimated CAGR of 5.4% between 2008 and 2013, with all segments registering growth. Both the rolled X-ray film and X-ray tube segments achieved a CAGR of 8.5% over the period. Looking ahead, the sector is expected to shrink at a CAGR of 2.4% between 2013 and 2018 with only the rolled X-ray film and X-ray tube segments forecast to achieve any growth at all.
© Espicom Business Intelligence
Page 37
Australia Medical Devices Report Q2 2014
Table: Diagnostic Imaging Market, 2008-2018 (US$mn)
CAGR CAGR 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2008-13 2013-18
DIAGNOSTIC IMAGING 498.0 510.5 587.4 640.5 726.3 735.2 690.0 641.6 642.9 679.8 719.1
8.1
-0.4
ELECTRODIAGNOSTIC APPARATUS
6.8
0.5
Electrocardiographs
242.2 252.9 288.0 313.0 328.6 335.9 318.3 298.8 302.3 322.8 344.7 9.9
10.0
13.3
15.5
15.1
15.6
14.9
14.0
14.3
15.3
16.5
9.4
1.1
Ultrasound
76.7
80.7
84.2
90.6
89.5
89.8
83.4
76.8
76.2
79.6
83.2
3.2
-1.5
MRI
27.4
46.3
52.2
56.0
72.8
77.5
76.5
74.7
78.5
87.0
96.4
23.1
4.5
2.2
1.7
4.0
3.5
4.1
4.4
4.4
4.4
4.6
5.2
5.9
14.5
5.9
Other electrodiagnostic apparatus
126.0 114.3 134.3 147.4 147.2 148.6 139.1 129.0 128.8 135.6 142.7
3.4
-0.8
RADIATION APPARATUS
119.5 128.3 147.8 154.1 218.9 221.9 208.4 193.9 194.3 205.5 217.4
13.16
-0.41
Scintigraphic apparatus
CT scanners
23.7
32.8
Other medical x-ray apparatus
88.0
94.1 101.4
A, B, C ray apparatus
IMAGING PARTS & ACCESSORIES
93.5
89.1
91.5
99.0 107.1
32.55
1.98
86.6 116.9 116.3 107.3
97.9
96.2
99.7 103.4
5.73
-2.34
6.9
6.7
6.9
1.61
-3.81
136.3 129.3 151.6 173.4 178.7 177.4 163.3 148.9 146.2 151.5 157.0
5.4
-2.4
7.8
1.4
43.6
2.8
64.3
3.2
93.4
8.6
97.1
8.4
7.6
6.8
Contrast media
26.8
25.2
31.1
32.1
33.9
33.3
30.3
27.3
26.5
27.2
27.8
4.4
-3.6
Medical x-ray film (flat)
21.0
22.0
23.4
25.5
23.5
22.4
19.8
17.3
16.3
16.1
16.0
1.3
-6.5
0.3
0.2
0.2
0.2
0.4
0.4
0.4
0.3
0.4
0.4
0.4
8.5
0.3
X-ray tubes
16.8
18.5
19.9
21.5
24.8
25.3
24.0
22.5
22.7
24.2
25.7
8.5
0.3
Other imaging parts & accessories
71.4
63.4
77.1
94.1
96.1
96.0
88.8
81.4
80.4
83.7
87.1
6.1
-1.9
Medical x-ray film (rolled)
Source: BMI Espicom
© Espicom Business Intelligence
Page 38
Australia Medical Devices Report Q2 2014
Table: Diagnostic Imaging Market, 2008-2018 (US$ Per Capita)
CAGR CAGR 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2008-13 2013-18
DIAGNOSTIC IMAGING
23.1
23.3
26.4
28.3
31.7
31.7
29.4
27.0
26.7
27.9
29.1
6.5
-1.6
ELECTRODIAGNOSTIC APPARATUS
11.3
11.5
12.9
13.8
14.3
14.5
13.5
12.6
12.6
13.2
14.0
5.1
-0.7
Electrocardiographs
0.5
0.5
0.6
0.7
0.7
0.7
0.6
0.6
0.6
0.6
0.7
7.7
-0.1
Ultrasound
3.6
3.7
3.8
4.0
3.9
3.9
3.5
3.2
3.2
3.3
3.4
1.6
-2.7
MRI
1.3
2.1
2.3
2.5
3.2
3.3
3.3
3.1
3.3
3.6
3.9
21.3
3.2
Scintigraphic apparatus
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
0.2
12.8
4.7
Other electrodiagnostic apparatus
5.9
5.2
6.0
6.5
6.4
6.4
5.9
5.4
5.3
5.6
5.8
1.8
-2.0
RADIATION APPARATUS
5.6
5.9
6.6
6.8
9.6
9.6
8.9
8.1
8.1
8.4
8.8
11.46
-1.61
CT scanners
1.1
1.5
2.0
2.8
4.1
4.2
4.0
3.7
3.8
4.1
4.3
30.55
0.74
Other medical x-ray apparatus
4.1
4.3
4.6
3.8
5.1
5.0
4.6
4.1
4.0
4.1
4.2
4.14
-3.52
A, B, C ray apparatus
0.4
0.1
0.1
0.1
0.4
0.4
0.3
0.3
0.3
0.3
0.3
0.07
-4.97
IMAGING PARTS & ACCESSORIES
6.3
5.9
6.8
7.7
7.8
7.6
6.9
6.3
6.1
6.2
6.4
3.8
-3.6
Contrast media
1.2
1.2
1.4
1.4
1.5
1.4
1.3
1.1
1.1
1.1
1.1
2.9
-4.7
Medical x-ray film (flat)
1.0
1.0
1.0
1.1
1.0
1.0
0.8
0.7
0.7
0.7
0.6
-0.2
-7.6
Medical x-ray film (rolled)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
6.8
-0.9
X-ray tubes
0.8
0.8
0.9
1.0
1.1
1.1
1.0
0.9
0.9
1.0
1.0
6.9
-0.9
Other imaging parts & accessories
3.3
2.9
3.5
4.2
4.2
4.1
3.8
3.4
3.3
3.4
3.5
4.5
-3.1
Source: BMI Espicom
© Espicom Business Intelligence
Page 39
Australia Medical Devices Report Q2 2014
Table: Diagnostic Imaging Market, 2009-2018 (US$mn % Change)
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
DIAGNOSTIC IMAGING
2.5
15.1
9.0
13.4
1.2
-6.2
-7.0
0.2
5.7
5.8
ELECTRODIAGNOSTIC APPARATUS
4.4
13.9
8.7
5.0
2.2
-5.2
-6.1
1.2
6.7
6.8
Electrocardiographs
0.2
33.6
16.3
-2.5
3.0
-4.6
-5.5
1.8
7.3
7.3
Ultrasound
5.2
4.3
7.7
-1.3
0.3
-7.0
-7.9
-0.9
4.5
4.5
69.2
12.8
7.1
30.1
6.5
-1.4
-2.4
5.1
10.9
10.8
-23.5
134.0
-12.8
16.8
8.0
0.0
-1.0
6.6
12.4
12.4
-9.3
17.5
9.8
-0.2
1.0
-6.4
-7.3
-0.1
5.3
5.3
7.3
15.2
4.3
42.1
1.3
-6.1
-7.0
0.2
5.7
5.8
38.1
33.1
47.3
45.4
3.9
-3.7
-4.7
2.6
8.2
8.2
6.9
7.7
-14.5
35.0
-0.5
-7.8
-8.7
-1.7
3.6
3.6
-81.5
94.8
15.1
166.8
-2.1
-9.3
-10.1
-3.2
2.1
2.1
IMAGING PARTS & ACCESSORIES
-5.1
17.3
14.4
3.0
-0.7
-8.0
-8.8
-1.8
3.6
3.6
Contrast media
-5.9
23.2
3.3
5.5
-1.7
-9.0
-9.9
-2.9
2.3
2.3
4.7
6.4
9.1
-7.8
-4.7
-11.7
-12.6
-5.9
-0.7
-0.7
-28.8
-18.1
29.3
95.0
2.1
-5.4
-6.2
1.0
6.5
6.5
10.1
7.3
8.3
15.2
2.2
-5.3
-6.2
1.0
6.5
6.5
-11.2
21.6
22.0
2.2
-0.1
-7.4
-8.3
-1.3
4.1
4.1
MRI Scintigraphic apparatus Other electrodiagnostic apparatus
RADIATION APPARATUS CT scanners Other medical x-ray apparatus A, B, C ray apparatus
Medical x-ray film (flat) Medical x-ray film (rolled) X-ray tubes Other imaging parts & accessories
Source: BMI Espicom
© Espicom Business Intelligence
Page 40
Australia Medical Devices Report Q2 2014
Diagnostic Imaging Market, 2008-2018 US$mn
Source: BMI Espicom
© Espicom Business Intelligence
Page 41
Australia Medical Devices Report Q2 2014
Diagnostic Imaging Market, 2009-2018 US$mn CAGR
Source: BMI Espicom
Dental Products Market Forecast The Australian dental market is estimated at US$247.1mn in 2013, equal to US$10.6 per capita and 5.1% of the total market. The market for instruments & supplies accounts for the majority of the dental market and is estimated at US$217.1mn in 2013. The capital equipment market, including drills, chairs and X-ray apparatus is estimated at US$30.1mn.
The dental market has outperformed the market as a whole in recent years as the government has been keen to boost dental provision across the country, and has taken steps to boost the numbers of dentists trained and recruited each year. After a CAGR of 7.5% over the 2008-13 period, Espicom projects a fall in the CAGR to 1.6% for the 2013-18 period, with capital equipment outperforming this (at a CAGR of 2.8%) as the number of dentists increases. This will take the dental market to US$268.1mn by 2018, equal to US$10.9 per capita.
The USA and Germany are the major suppliers of dental equipment, with Switzerland and Ireland also significant suppliers of dental instruments and fittings.
© Espicom Business Intelligence
Page 42
Australia Medical Devices Report Q2 2014
Table: Dental Products Market, 2008-2018 (US$mn)
2008
2009
2010
2011
187 205.1
226
2018
CAGR 2008-13
CAGR 2013-18
240 247.1 236.2
224 229.2 247.7 268.1
7.5
1.6
2012
2013
2014
2015
2016
2017
DENTAL PRODUCTS
172.2
CAPITAL EQUIPMENT
20.3
26
35.7
28.4
28.8
30.1
29.1
27.9
28.9
31.5
34.4
8.2
2.8
Dental drills
1.7
3
3.5
2.4
2.1
2
1.8
1.6
1.6
1.6
1.6
2.8
-4.1
Dental chairs
8.6
9
12.7
10.2
9.2
9.3
8.6
7.9
7.9
8.2
8.6
1.4
-1.5
Dental x-ray
10
14
19.5
15.8
17.5
18.8
18.7
18.3
19.4
21.7
24.2
13.7
5.2
196 200.3 216.1 233.7
7.4
1.5
INSTRUMENTS & SUPPLIES
151.9
Dental cements
32
34
37
53.6
59.8
64.3
64.2
63.5
67.7
76
85.4
14.8
5.8
Dental instruments
74
82
78
87.1
92.5
90.7
82.4
74.2
71.9
73.5
75.1
4.2
-3.7
Teeth & other fittings
45.7
45
54.4
57
59
62
60.4
58.3
60.7
66.6
73.1
6.3
3.4
Artificial teeth
5
6
11.4
12.5
13.5
13.6
12.6
11.6
11.5
12.1
12.6
20.7
-1.5
Other dental fittings
40
39.8
43
44.5
45.4
48.4
47.8
46.7
49.1
54.5
60.5
3.7
4.6
161 169.4 197.7 211.2 217.1 207.1
Source: BMI Espicom
Table: Dental Products Market, 2008-2018 (US$ Per Capita)
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
DENTAL PRODUCTS
CAGR 2008-13
CAGR 2013-18
8
9
9.2
10
10.5
10.6
10
9.4
9.5
10.2
10.9
7.5
1.6
CAPITAL EQUIPMENT
0.9
1
1.6
1.3
1.3
1.3
1.2
1.2
1.2
1.3
1.4
8.2
2.8
Dental drills
0.1
0
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
2.8
-4.1
0
0
0.6
0.5
0.4
0.4
0.4
0.3
0.3
0.3
0.3
1.4
-1.5
0.5
1
0.9
0.7
0.8
0.8
0.8
0.8
0.8
0.9
1
13.7
5.2
Dental chairs Dental x-ray
© Espicom Business Intelligence
Page 43
Australia Medical Devices Report Q2 2014
Dental Products Market, 2008-2018 (US$ Per Capita) - Continued
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR 2008-13
CAGR 2013-18
INSTRUMENTS & SUPPLIES
7
7
7.6
8.7
9.2
9.4
8.8
8.2
8.3
8.9
9.5
7.4
1.5
Dental cements
1.5
2
1.7
2.4
2.6
2.8
2.7
2.7
2.8
3.1
3.5
14.8
5.8
Dental instruments
3.4
4
3.5
3.9
4
3.9
3.5
3.1
3
3
3
4.2
-3.7
Teeth & other fittings
2
2
2.4
2.5
2.6
2.7
2.6
2.5
2.5
2.7
3
6.3
3.4
Artificial teeth
0
0.3
0.5
0.6
0.6
0.6
0.5
0.5
0.5
0.5
0.5
20.7
-1.5
Other dental fittings
2
1.8
1.9
2
2
2.1
2
2
2
2.2
2.5
3.7
4.6
Source: BMI Espicom
Table: Dental Products Market, 2009-2018 (US$mn % Change)
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
DENTAL PRODUCTS
8.5
9.8
10.2
6.2
2.9
-4.4
-5.2
2.3
8.1
8.3
CAPITAL EQUIPMENT
26.5
39.3
-20.5
1.6
4.3
-3.2
-4.1
3.4
9.2
9.3
Dental drills
77.7
13.8
-32.4
-14.0
-2.3
-9.5
-10.3
-3.4
1.8
1.8
Dental chairs
-1.2
48.3
-19.4
-9.4
0.4
-7.0
-7.9
-0.8
4.6
4.6
Dental x-ray
41.6
39.5
-19.1
11.0
7.2
-0.7
-1.7
5.9
11.6
11.6
INSTRUMENTS & SUPPLIES
6.1
5.1
16.7
6.9
2.8
-4.6
-5.3
2.2
7.9
8.1
Dental cements
6.3
8.0
44.8
11.6
7.7
-0.2
-1.1
6.5
12.3
12.3
Dental instruments
10.3
-4.5
11.7
6.2
-1.9
-9.1
-10.0
-3.1
2.2
2.2
Teeth & other fittings
-0.8
20.0
4.8
3.4
5.1
-2.5
-3.5
4.0
9.7
9.8
4.5
105.6
10.0
8.1
0.4
-7.0
-7.9
-0.8
4.6
4.5
-1.5
8.1
3.4
2.1
6.5
-1.3
-2.3
5.2
11.0
10.9
Artificial teeth Other dental fittings
Source: BMI Espicom
© Espicom Business Intelligence
Page 44
Australia Medical Devices Report Q2 2014
Dental Products Market, 2008-2018
Source: BMI Espicom
© Espicom Business Intelligence
Page 45
Australia Medical Devices Report Q2 2014
Dental Products Market, 2009-2018 US$mn CAGR
Source: BMI Espicom
Orthopaedics & Prosthetics Market Forecast The Australian orthopaedic & prosthetic market is estimated at US$864.7mn in 2013, equal to US$37.2 per capita and 18.0% of the total market.
Australia has a sizeable domestic orthopaedic & prosthetic production sector, but this concentrates on exports. Products used locally, especially at the advanced end of the technology scale, tend to be imported, principally from the USA, Ireland and Switzerland.
The orthopaedic & prosthetic market grew at a CAGR of 9.9% between 2008 and 2013. Driven by the ageing population and increasing availability of newer more expensive products, Espicom projects that this will be one of the better performing market segments in the coming years, albeit at a low CAGR of 1.7% over the 2013-18. This is expected to take the overall market to US$939.5mn by 2018, equal to US$38.1 per capita.
© Espicom Business Intelligence
Page 46
Australia Medical Devices Report Q2 2014
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$mn)
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
CAGR CAGR 2018 2008-13 2013-18
ORTHOPAEDICS & PROSTHETICS
539.8 557.2 656.7 850.6 835.0 864.7 829.8 788.3 806.7 870.5 939.5
9.9
1.7
FIXATION DEVICES
141.2 110.4 134.4 219.9 201.5 204.2 191.8 178.3 178.5 188.5 198.9
7.7
-0.5
ARTIFICIAL JOINTS
171.0 156.6 194.2 245.0 280.2 294.4 286.6 276.2 286.6 313.5 343.0
11.5
3.1
OTHER ARTIFICIAL BODY PARTS
227.6 290.2 328.0 385.7 353.3 366.0 351.3 333.8 341.6 368.5 397.6
10.0
1.7
Source: BMI Espicom
Table: Orthopaedics & Prosthetics Market, 2008-2018 (US$ Per Capita)
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
CAGR CAGR 2018 2008-13 2013-18
25.1
25.4
29.5
37.6
36.4
37.2
35.3
33.1
33.5
35.7
38.1
8.2
0.4
FIXATION DEVICES
6.6
5.0
6.0
9.7
8.8
8.8
8.2
7.5
7.4
7.7
8.1
6.0
-1.7
ARTIFICIAL JOINTS
7.9
7.1
8.7
10.8
12.2
12.7
12.2
11.6
11.9
12.9
13.9
9.8
1.9
10.6
13.3
14.7
17.1
15.4
15.8
14.9
14.0
14.2
15.1
16.1
8.3
0.4
ORTHOPAEDICS & PROSTHETICS
OTHER ARTIFICIAL BODY PARTS
Source: BMI Espicom
© Espicom Business Intelligence
Page 47
Australia Medical Devices Report Q2 2014
Table: Orthopaedics & Prosthetics Market, 2009-2018 (USmn % Change)
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
ORTHOPAEDICS & PROSTHETICS
3.2
17.9
29.5
-1.8
3.6
-4.0
-5.0
2.3
7.9
7.9
FIXATION DEVICES
-21.8
21.8
63.6
-8.4
1.4
-6.1
-7.0
0.1
5.6
5.6
ARTIFICIAL JOINTS
-8.4
24.1
26.1
14.4
5.1
-2.6
-3.6
3.8
9.4
9.4
OTHER ARTIFICIAL BODY PARTS
27.5
13.0
17.6
-8.4
3.6
-4.0
-5.0
2.3
7.9
7.9
Source: BMI Espicom
Orthopaedics & Prosthetics Market, 2008-2018
Source: BMI Espicom
© Espicom Business Intelligence
Page 48
Australia Medical Devices Report Q2 2014
Orthopaedics & Prosthetics Market, 2009-2018 US$mn CAGR
Source: BMI Espicom
Patient Aids Market Forecast The market for patient aids is estimated at US$792.1mn in 2013, equal to US$34.1 per capita and 18.0% of the total market. Within this, portable aids account for US$562.5mn and therapeutic appliances for US $229.7mn.
Australia has considerable production expertise in a number of these areas. Cochlear is one of the world's leading developers of digital hearing aids, while ResMed is a major manufacturer of therapeutic respiration products. Both companies make most of their sales in markets outside Australia, however. The Australian market is therefore largely reliant on imports, primarily from the USA, China, Switzerland and Ireland.
The market grew at a CAGR of 4.8% between 2008 and 2013, but is projected to decline at a CAGR of 1.0% to US$755.0mn by 2018. In recent years, the strongest growth has been seen in the therapeutic appliances segment, and this is the only area of the market expected to continue to show any growth over the next five years.
© Espicom Business Intelligence
Page 49
Australia Medical Devices Report Q2 2014
Table: Patient Aids Market, 2008-2018 (US$mn)
2018
CAGR 2008-13
CAGR 2013-18
626.8 551.6 682.5 810.0 787.8 792.1 738.8 683.6 681.7 717.2 755.0
4.8
-1.0
PORTABLE AIDS 475.3 408.5 470.3 576.4 563.1 562.5 521.1 478.7 473.9 494.8 516.8
3.4
-1.7
Hearing aids
111.8
96.4 116.8 143.4 138.1 139.0 129.8 120.6 120.7 127.4 134.4
4.4
-0.7
Pacemakers
121.5 116.6 130.9 147.2 177.8 181.5 171.6 160.6 161.9 172.0 182.8
8.4
0.1
Other portable aids
242.1 195.5 222.6 285.8 247.1 242.0 219.6 197.5 191.3 195.4 199.6
0.0
-3.8
THERAPEUTIC APPLIANCES
151.4 143.1 212.2 233.6 224.7 229.7 217.8 204.9 207.8 222.4 238.2
8.7
0.7
2008
PATIENT AIDS
2009
2010
2011
2012
2013
2014
2015
2016
2017
Mechanotherapy apparatus
63.8
54.0
67.4
4.6
-3.4
Therapeutic respiration apparatus
87.7
89.1 150.9 163.4 143.5 149.7 144.8 139.0 143.7 156.6 170.7
11.3
2.7
61.3
70.2
81.2
80.0
73.0
65.9
64.1
65.7
Source: BMI Espicom
Table: Patient Aids Market, 2008-2018 (US$ Per Capita)
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
CAGR 2008-13
CAGR 2013-18
PATIENT AIDS
29.1
25.2
30.6
35.8
34.4
34.1
31.4
28.7
28.3
29.4
30.6
3.2
-2.2
PORTABLE AIDS
22.1
18.7
21.1
25.5
24.6
24.2
22.2
20.1
19.7
20.3
20.9
1.9
-2.9
Hearing aids
5.2
4.4
5.2
6.3
6.0
6.0
5.5
5.1
5.0
5.2
5.4
2.9
-1.9
Pacemakers
5.6
5.3
5.9
6.5
7.8
7.8
7.3
6.8
6.7
7.1
7.4
6.7
-1.1
Other portable aids
11.3
8.9
10.0
12.6
10.8
10.4
9.3
8.3
7.9
8.0
8.1
-1.5
-4.9
THERAPEUTIC APPLIANCES
7.0
6.5
9.5
10.3
9.8
9.9
9.3
8.6
8.6
9.1
9.7
7.0
-0.5
Mechanotherapy apparatus
3.0
2.5
2.8
3.1
3.5
3.4
3.1
2.8
2.7
2.7
2.7
3.1
-4.5
© Espicom Business Intelligence
Page 50
Australia Medical Devices Report Q2 2014
Patient Aids Market, 2008-2018 (US$ Per Capita) - Continued
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
CAGR 2008-13
CAGR 2013-18
4.1
4.1
6.8
7.2
6.3
6.4
6.2
5.8
6.0
6.4
6.9
9.6
1.4
Therapeutic respiration apparatus
Source: BMI Espicom
Table: Patient Aids Market, 2009-2018 (US$mn % Change)
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
PATIENT AIDS
-12.0
23.7
18.7
-2.7
0.5
-6.7
-7.5
-0.3
5.2
5.3
PORTABLE AIDS
-14.1
15.1
22.6
-2.3
-0.1
-7.4
-8.1
-1.0
4.4
4.4
Hearing aids
-13.7
21.1
22.8
-3.7
0.6
-6.6
-7.1
0.1
5.5
5.5
Pacemakers
-4.0
12.3
12.4
20.8
2.1
-5.5
-6.4
0.8
6.3
6.3
-19.2
13.9
28.4
-13.5
-2.1
-9.2
-10.1
-3.1
2.1
2.1
THERAPEUTIC APPLIANCES
-5.5
48.3
10.1
-3.8
2.2
-5.2
-5.9
1.4
7.0
7.1
Mechano-therapy apparatus
-15.4
13.6
14.5
15.8
-1.5
-8.8
-9.7
-2.7
2.6
2.6
1.6
69.4
8.3
-12.2
4.3
-3.3
-4.0
3.4
9.0
9.0
Other portable aids
Therapeutic respiration apparatus
Source: BMI Espicom
© Espicom Business Intelligence
Page 51
Australia Medical Devices Report Q2 2014
Patient Aids Market, 2008-2018 US$mn
Source: BMI Espicom
© Espicom Business Intelligence
Page 52
Australia Medical Devices Report Q2 2014
Patient Aids Market, 2009-2018 US$mn CAGR
Source: BMI Espicom
Other Medical Devices Market Forecast The market for all other devices is estimated at US$1,528.3mn in 2013, equal to US$65.8 per capita and 31.7% of the total device market. Leading categories include endoscopy apparatus, ophthalmic instruments, dialysis apparatus and hospital furniture.
This segment of the market grew at a CAGR of 8.6% between 2008 and 2013, but is projected to fall back to a CAGR of just 0.5% over the next five years, to reach US$1,564.9mn in 2018.
Fresenius has a local plant in New South Wales which makes dialysis products, but beyond this, most requirements are imported, largely from the USA and Germany.
© Espicom Business Intelligence
Page 53
Australia Medical Devices Report Q2 2014
Table: Other Medical Devices Market, 2008-2018 (US$mn)
OTHERS
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR 2008-13
CAGR 2013-18
1,012 1,054 1,195 1,381 1,494 1,528 1,449 1,361 1,376 1,468 1,565
8.6
0.5
WHEELCHAIRS
26.5
24.4
28.0
31.2
32.2
32.7
30.7
28.7
28.8
30.5
32.4
4.3
-0.2
Wheelchairs, not mechanically propelled
11.2
10.0
10.7
12.9
13.4
14.1
13.6
13.1
13.5
14.7
16.1
4.7
2.7
Wheelchairs, mechanically propelled
15.3
14.4
17.3
18.3
18.8
18.6
17.1
15.6
15.3
15.8
16.3
4.0
-2.6
OPHTHALMIC INSTRUMENTS
65.1
65.8
68.5
85.3
96.5
98.8
93.7
88.0
89.0
95.0 101.3
8.7
0.5
HOSPITAL FURNITURE
41.0
35.0
41.6
50.1
58.6
59.5
55.9
52.0
52.1
55.0
58.1
7.7
-0.4
MEDICAL, SURGICAL STERILISERS
16.5
17.3
18.9
20.3
22.4
22.5
20.9
19.2
19.0
19.8
20.7
6.4
-1.7
1.8
1.5
2.4
2.3
4.0
4.2
4.0
3.8
3.9
4.3
4.6
18.2
2.2
OTHER INSTRUMENTS & APPLIANCES 860.9 910.0 1,036 1,192 1,280 1,311 1,244 1,169 1,183 1,263 1,348
8.8
0.6
Anaesthetic apparatus and instruments
7.1
-1.1
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
86.5
91.4
98.4
96.2 120.7 121.7 113.7 105.1 104.7 109.9 115.3
Source: BMI Espicom
© Espicom Business Intelligence
Page 54
Australia Medical Devices Report Q2 2014
Table: Other Medical Devices Market, 2008-2018 (US$ Per Capita)
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
CAGR 2008-13
CAGR 2013-18
OTHERS
47
48
53.7
61.1
65.2
65.8
61.6
57.2
57.1
60.2
63.4
8.6
0.5
WHEELCHAIRS
1.2
1
1.3
1.4
1.4
1.4
1.3
1.2
1.2
1.3
1.3
4.3
-0.2
Wheelchairs, not mechanically propelled
0.5
1
0.5
0.6
0.6
0.6
0.6
0.5
0.6
0.6
0.7
4.7
2.7
Wheelchairs, mechanically propelled
1
1
0.8
0.8
0.8
0.8
0.7
0.7
0.6
0.6
0.7
4
-2.6
OPHTHALMIC INSTRUMENTS
3
3
3.1
3.8
4.2
4.3
4
3.7
3.7
3.9
4.1
8.7
0.5
1.9
2
1.9
2.2
2.6
2.6
2.4
2.2
2.2
2.3
2.4
7.7
-0.4
MEDICAL, SURGICAL STERILISERS
1
1
0.8
0.9
1
1
0.9
0.8
0.8
0.8
0.8
6.4
-1.7
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
0
0.1
0.1
0.1
0.2
0.2
0.2
0.2
0.2
0.2
0.2
18.2
2.2
OTHER INSTRUMENTS & APPLIANCES
40
41.5
46.5
52.7
55.9
56.5
52.9
49.1
49.1
51.8
54.6
8.8
0.6
4
4.2
4.4
4.3
5.3
5.2
4.8
4.4
4.3
4.5
4.7
7.1
-1.1
HOSPITAL FURNITURE
Anaesthetic apparatus and instruments
Source: BMI Espicom
© Espicom Business Intelligence
Page 55
Australia Medical Devices Report Q2 2014
Table: Other Medical Devices Market, 2009-2018 (US$mn % Change)
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
4.2
13.4
15.5
8.2
2.3
-5.2
-6.1
1.1
6.6
6.6
-7.9
14.8
11.5
3.2
1.5
-5.9
-6.8
0.5
6.0
6.1
-11.1
7.3
21.0
3.9
4.7
-3.0
-4.0
3.4
9.0
9.0
-5.6
19.9
5.6
2.7
-0.8
-8.1
-9.0
-2.0
3.4
3.4
1.1
4.0
24.6
13.2
2.3
-5.2
-6.1
1.2
6.7
6.7
-14.8
19.1
20.4
17.0
1.4
-6.0
-7.0
0.2
5.7
5.6
MEDICAL, SURGICAL STERILISERS
5.0
9.1
7.6
10.5
0.2
-7.2
-8.1
-1.0
4.4
4.4
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
-14.5
56.5
-5.7
75.3
4.1
-3.6
-4.5
2.8
8.4
8.4
OTHER INSTRUMENTS & APPLIANCES
5.7
13.8
15.0
7.4
2.4
-5.1
-6.0
1.2
6.7
6.7
Anaesthetic apparatus and instruments
5.7
7.7
-2.3
25.6
0.8
-6.6
-7.5
-0.4
5.0
5.0
OTHERS
WHEELCHAIRS Wheelchairs, not mechanically propelled Wheelchairs, mechanically propelled
OPHTHALMIC INSTRUMENTS
HOSPITAL FURNITURE
Source: BMI Espicom
© Espicom Business Intelligence
Page 56
Australia Medical Devices Report Q2 2014
Other Medical Devices Market, 2008-2018 US$mn
Source: BMI Espicom
© Espicom Business Intelligence
Page 57
Australia Medical Devices Report Q2 2014
Other Medical Devices Market, 2008-2019 US$mn CAGR
Source: BMI Espicom
© Espicom Business Intelligence
Page 58
Australia Medical Devices Report Q2 2014
Annual Medical Device Imports Since 2001, Australian medical device imports have seen a period of sustained rapid growth. In 2012, imports reached a new high of US$4,523.6mn, rising by 3.9% over 2011. In CAGR terms, growth was 10.8% between 2007 and 2012.
Medical Device Imports, 2002-2012 US$mn
Source: BMI Espicom
© Espicom Business Intelligence
Page 59
Australia Medical Devices Report Q2 2014
Change In Medical Device Imports, 2003-2012 %
Source: BMI Espicom
Consumables
After two years of double-digit growth, imports of consumables fell by 0.1% to US$637.1mn in 2012. The decrease was due to a sudden drop in imports of bandages & dressings which fell by 20.1% in 2012, while all other segments of the consumables import sector achieved growth. Consumables account for over 14.0% of total medical device imports and expanded at a CAGR of 10.8% during the 2007-2012 period. Just over half of consumables imports in 2012 were in the form of syringes, needles & catheters which increased by 6.5% to total US$320.2mn.
© Espicom Business Intelligence
Page 60
Australia Medical Devices Report Q2 2014
Diagnostic Imaging
Imports of diagnostic imaging apparatus grew by 13.6% to reach US$710.3mn in 2012. The sector had a CAGR of 9.8% over the 2007-2012 period. Electrodiagnostic apparatus imports form the majority of the sector, and were valued at US$317.7mn in 2012, accounting for 44.7% of total diagnostic imaging imports. The fastest growing segment in 2012 was X-ray/radiation apparatus which increased by 41.5% to a value of US$217.7mn.
Dental Products
Dental product imports grew by 6.1% to reach US$228.7mn in 2012. The bulk of dental imports consist of instruments & supplies and it was this segment which underpinned the growth recorded in 2012, rising by 6.7% to US$200.2mn. Dental imports increased at a CAGR of 10.1% during the period.
Orthopaedics & Prosthetics
After a 29.6% rise in imports of orthopaedics & prosthetics in 2011, demand fell back by 1.8% to total US $830.2mn in 2012. Despite the decline, growth was seen in imports of artificial joints which increased by 14.4% to US$279.9mn. Imports classed under the fixation devices and other artificial body parts categories both fell by 8.4% during 2012, to US$ 201.1mn and US$349.2mn, respectively.
CAGR growth over the 2007-12 period was 12.9% for orthopaedic & prosthetic products, with only limited variance from this figure within the three segments.
Patient Aids
Imports of patient aids totalled US$692.5mn in 2012, a decrease of 3.0% from the previous year. Against this trend, a 20.8% increase was recorded in imports of pacemakers, which climbed to US$177.4mn.
Despite the fall in demand in 2012, imports of patient aids rose at a CAGR of 6.7% between 2008 and 2012, with pacemakers driving growth with a CAGR of 8.3% over the period.
© Espicom Business Intelligence
Page 61
Australia Medical Devices Report Q2 2014
Table: Medical Device Imports By Product Area, 2008-2012 (US$000s)
2008
2009
2010
2011
2012
CONSUMABLES
449,953
459,804
520,038
637,885
637,081
BANDAGES & DRESSINGS
113,412
111,442
137,261
187,099
149,530
61,158
59,873
61,776
76,309
92,225
251,618
251,132
257,615
300,683
320,161
OTHER CONSUMABLES
23,765
37,357
63,386
73,794
75,165
DIAGNOSTIC IMAGING
485,171
498,508
573,551
625,215
710,258
ELECTRODIAGNOSTIC APPARATUS
233,212
244,243
278,101
302,136
317,717
RADIATION APPARATUS
118,564
127,651
147,009
153,395
217,698
IMAGING PARTS & ACCESSORIES
133,395
126,614
148,441
169,684
174,843
DENTAL PRODUCTS
164,828
178,962
196,840
215,630
228,729
CAPITAL EQUIPMENT
20,011
25,340
35,290
28,038
28,500
INSTRUMENTS & SUPPLIES
144,817
153,622
161,550
187,592
200,229
ORTHOPAEDICS & PROSTHETICS
536,706
553,455
652,432
845,462
830,236
PATIENT AIDS
557,582
490,274
601,442
713,719
692,528
PORTABLE AIDS
422,793
364,011
417,392
510,670
494,795
THERAPEUTIC APPLIANCES
134,789
126,263
184,050
203,049
197,733
OTHERS
965,105
1,005,186
1,140,024
1,317,076
1,424,780
3,159,345
3,186,189
3,684,327
4,354,987
4,523,612
SUTURING MATERIALS SYRINGES, NEEDLES & CATHETERS
TOTAL
Source: BMI Espicom
© Espicom Business Intelligence
Page 62
Australia Medical Devices Report Q2 2014
Table: Medical Device Imports By Product Area 2008-2012 (US$000s, % Change)
2008
2009
2010
2011
2012
CONSUMABLES
17.8
2.2
13.1
22.7
-0.1
BANDAGES & DRESSINGS
20.2
-1.7
23.2
36.3
-20.1
SUTURING MATERIALS
16.1
-2.1
3.2
23.5
20.9
SYRINGES, NEEDLES & CATHETERS
18.5
-0.2
2.6
16.7
6.5
OTHER CONSUMABLES
4.9
57.2
69.7
16.4
1.9
DIAGNOSTIC IMAGING
9.2
2.7
15.1
9.0
13.6
ELECTRODIAGNOSTIC APPARATUS
0.4
4.7
13.9
8.6
5.2
34.6
7.7
15.2
4.3
41.9
7.8
-5.1
17.2
14.3
3.0
DENTAL PRODUCTS
16.8
8.6
10.0
9.5
6.1
CAPITAL EQUIPMENT
25.7
26.6
39.3
-20.5
1.6
INSTRUMENTS & SUPPLIES
15.7
6.1
5.2
16.1
6.7
ORTHOPAEDICS & PROSTHETICS
18.3
3.1
17.9
29.6
-1.8
PATIENT AIDS
11.6
-12.1
22.7
18.7
-3.0
PORTABLE AIDS
10.7
-13.9
14.7
22.3
-3.1
THERAPEUTIC APPLIANCES
14.5
-6.3
45.8
10.3
-2.6
OTHERS
22.9
4.2
13.4
15.5
8.2
TOTAL
16.8
0.8
15.6
18.2
3.9
RADIATION APPARATUS IMAGING PARTS & ACCESSORIES
Source: BMI Espicom
© Espicom Business Intelligence
Page 63
Australia Medical Devices Report Q2 2014
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s)
2008
2009
2010
2011
2012
CONSUMABLES
538,111
588,680
566,468
617,979
615,184
BANDAGES & DRESSINGS
135,632
142,678
149,516
181,260
144,391
73,140
76,655
67,292
73,928
89,055
300,917
321,521
280,616
291,300
309,157
OTHER CONSUMABLES
28,421
47,828
69,045
71,491
72,582
DIAGNOSTIC IMAGING
580,229
638,232
624,759
605,704
685,846
ELECTRODIAGNOSTIC APPARATUS
278,904
312,701
302,931
292,707
306,797
RADIATION APPARATUS
141,794
163,430
160,134
148,608
210,216
IMAGING PARTS & ACCESSORIES
159,531
162,102
161,694
164,389
168,834
DENTAL PRODUCTS
197,122
229,122
214,414
208,901
220,867
CAPITAL EQUIPMENT
23,932
32,442
38,441
27,163
27,520
INSTRUMENTS & SUPPLIES
173,190
196,680
175,974
181,738
193,347
ORTHOPAEDICS & PROSTHETICS
641,861
708,580
710,683
819,078
801,700
PATIENT AIDS
666,827
627,690
655,140
691,446
668,725
PORTABLE AIDS
505,629
466,038
454,658
494,734
477,789
THERAPEUTIC APPLIANCES
161,198
161,653
200,483
196,713
190,937
OTHERS
1,154,194
1,286,925
1,241,809
1,275,975
1,375,809
TOTAL
3,778,343
4,079,230
4,013,274
4,219,083
4,368,132
SUTURING MATERIALS SYRINGES, NEEDLES & CATHETERS
Source: BMI Espicom
© Espicom Business Intelligence
Page 64
Australia Medical Devices Report Q2 2014
Table: Medical Device Imports By Product Area, 2008-2012 (Local Currency 000s, % Change)
2008
2009
2010
2011
2012
CONSUMABLES
17.9
9.4
-3.8
9.1
-0.5
BANDAGES & DRESSINGS
20.3
5.2
4.8
21.2
-20.3
SUTURING MATERIALS
16.2
4.8
-12.2
9.9
20.5
SYRINGES, NEEDLES & CATHETERS
18.6
6.8
-12.7
3.8
6.1
OTHER CONSUMABLES
5.0
68.3
44.4
3.5
1.5
DIAGNOSTIC IMAGING
9.3
10.0
-2.1
-3.0
13.2
ELECTRODIAGNOSTIC APPARATUS
0.5
12.1
-3.1
-3.4
4.8
34.7
15.3
-2.0
-7.2
41.5
7.9
1.6
-0.3
1.7
2.7
DENTAL PRODUCTS
16.9
16.2
-6.4
-2.6
5.7
CAPITAL EQUIPMENT
25.8
35.6
18.5
-29.3
1.3
INSTRUMENTS & SUPPLIES
15.8
13.6
-10.5
3.3
6.4
ORTHOPAEDICS & PROSTHETICS
18.4
10.4
0.3
15.3
-2.1
PATIENT AIDS
11.7
-5.9
4.4
5.5
-3.3
PORTABLE AIDS
10.8
-7.8
-2.4
8.8
-3.4
THERAPEUTIC APPLIANCES
14.6
0.3
24.0
-1.9
-2.9
OTHERS
23.0
11.5
-3.5
2.8
7.8
TOTAL
16.9
8.0
-1.6
5.1
3.5
RADIATION APPARATUS IMAGING PARTS & ACCESSORIES
Source: BMI Espicom
© Espicom Business Intelligence
Page 65
Australia Medical Devices Report Q2 2014
Table: Medical Device Imports By Product Area, 2008-2012 (% Distribution)
2008
2009
2010
2011
2012
14.2
14.4
14.1
14.6
14.1
BANDAGES & DRESSINGS
3.6
3.5
3.7
4.3
3.3
SUTURING MATERIALS
1.9
1.9
1.7
1.8
2.0
SYRINGES, NEEDLES & CATHETERS
8.0
7.9
7.0
6.9
7.1
OTHER CONSUMABLES
0.8
1.2
1.7
1.7
1.7
DIAGNOSTIC IMAGING
15.4
15.6
15.6
14.4
15.7
ELECTRODIAGNOSTIC APPARATUS
7.4
7.7
7.5
6.9
7.0
RADIATION APPARATUS
3.8
4.0
4.0
3.5
4.8
IMAGING PARTS & ACCESSORIES
4.2
4.0
4.0
3.9
3.9
DENTAL PRODUCTS
5.2
5.6
5.3
5.0
5.1
CAPITAL EQUIPMENT
0.6
0.8
1.0
0.6
0.6
INSTRUMENTS & SUPPLIES
4.6
4.8
4.4
4.3
4.4
ORTHOPAEDICS & PROSTHETICS
17.0
17.4
17.7
19.4
18.4
PATIENT AIDS
17.6
15.4
16.3
16.4
15.3
PORTABLE AIDS
13.4
11.4
11.3
11.7
10.9
4.3
4.0
5.0
4.7
4.4
30.5
31.5
30.9
30.2
31.5
100.0
100.0
100.0
100.0
100.0
CONSUMABLES
THERAPEUTIC APPLIANCES
OTHERS
TOTAL
Source: BMI Espicom
The USA remains the dominant supplier. Total shipments from the USA amounted to US$1,701.1mn, equal to 37.6% in 2012. Germany (US$386.4mn), Ireland (US$367.6mn), China (US$306.7mn) and Switzerland
© Espicom Business Intelligence
Page 66
Australia Medical Devices Report Q2 2014
(US$291.6mn) were the other leading suppliers with shares of 8.5%, 8.1%, 6.8% and 6.4% respectively. Total shipments from the European Union amounted to US$1,406.4mn in 2012.
Table: Leading Medical Device Suppliers By Product Area (US$000s)
USA
Germany
Ireland
China
Switzerland
EU-27
251,379
19,050
24,802
49,871
16,311
172,728
91,182
9,109
711
34,704
4,783
79,281
145,122
9,740
23,706
8,461
9,084
69,388
OTHER CONSUMABLES
15,075
201
385
6,706
2,444
24,059
DIAGNOSTIC IMAGING
282,002
129,606
2,066
59,318
2,739
231,411
ELECTRODIAGNOSTIC APPARATUS
153,168
35,615
1,075
26,277
2,188
76,878
RADIATION APPARATUS
87,034
51,814
229
19,381
5
84,172
IMAGING PARTS & ACCESSORIES
41,800
42,177
762
13,660
546
70,361
DENTAL PRODUCTS
48,708
45,727
14,255
4,144
19,201
93,365
CAPITAL EQUIPMENT
7,592
5,789
0
1,125
65
15,331
41,116
39,938
14,255
3,019
19,136
78,034
12,432
106,660
300,112
CONSUMABLES BANDAGES & DRESSINGS SUTURING MATERIALS SYRINGES, NEEDLES & CATHETERS
INSTRUMENTS & SUPPLIES
ORTHOPAEDICS & PROSTHETICS
373,773
53,973 128,925
PATIENT AIDS
137,829
23,852
93,590 120,449
111,229
182,935
PORTABLE AIDS
106,234
16,838
89,485
34,274
109,803
159,292
31,595
7,014
4,105
86,175
1,426
23,643
114,175 103,948
60,511
35,431
425,827
386,383 367,586 306,725
291,571
1,406,378
THERAPEUTIC APPLIANCES
OTHERS
TOTAL
607,369
1,701,060
Source: BMI Espicom
© Espicom Business Intelligence
Page 67
Australia Medical Devices Report Q2 2014
Table: Leading Medical Device Suppliers By Product Area (% Distribution)
USA
Germany
Ireland
China
Switzerland
EU-27
CONSUMABLES
39.5
3.0
3.9
7.8
2.6
27.1
BANDAGES & DRESSINGS
13.1
4.2
0.5
23.2
0.7
42.5
SUTURING MATERIALS
77.6
3.1
0.0
0.0
4.1
17.0
SYRINGES, NEEDLES & CATHETERS
45.3
3.0
7.4
2.6
2.8
21.7
OTHER CONSUMABLES
20.1
0.3
0.5
8.9
3.3
32.0
DIAGNOSTIC IMAGING
39.7
18.2
0.3
8.4
0.4
32.6
ELECTRODIAGNOSTIC APPARATUS
48.2
11.2
0.3
8.3
0.7
24.2
RADIATION APPARATUS
40.0
23.8
0.1
8.9
0.0
38.7
IMAGING PARTS & ACCESSORIES
23.9
24.1
0.4
7.8
0.3
40.2
DENTAL PRODUCTS
21.3
20.0
6.2
1.8
8.4
40.8
CAPITAL EQUIPMENT
26.6
20.3
0.0
3.9
0.2
53.8
INSTRUMENTS & SUPPLIES
20.5
19.9
7.1
1.5
9.6
39.0
ORTHOPAEDICS & PROSTHETICS
45.0
6.5
15.5
1.5
12.8
36.1
PATIENT AIDS
19.9
3.4
13.5
17.4
16.1
26.4
PORTABLE AIDS
21.5
3.4
18.1
6.9
22.2
32.2
THERAPEUTIC APPLIANCES
16.0
3.5
2.1
43.6
0.7
12.0
OTHERS
42.6
8.0
7.3
4.2
2.5
29.9
TOTAL
37.6
8.5
8.1
6.8
6.4
31.1
Source: BMI Espicom
© Espicom Business Intelligence
Page 68
Australia Medical Devices Report Q2 2014
Table: Top 20 Medical Device Suppliers (US$000s)
Country
2012
% of Total
1,701,060
37.6
1
USA
2
Germany
386,383
8.5
3
Ireland
367,586
8.1
4
China
306,725
6.8
5
Switzerland
291,571
6.4
6
Japan
184,306
4.1
7
United Kingdom
163,147
3.6
8
Singapore
135,334
3.0
9
Mexico
111,859
2.5
10
France
84,872
1.9
11
Netherlands
83,440
1.8
12
Denmark
67,114
1.5
13
Italy
65,097
1.4
14
Malaysia
50,575
1.1
15
Finland
47,701
1.1
16
Sweden
42,964
0.9
17
Taiwan
42,402
0.9
18
Costa Rica
36,754
0.8
19
New Zealand
34,992
0.8
20
Canada
26,827
0.6
4,230,709
93.5
292,903
6.5
4,523,612
100.0
Subtotal
Others
Total
Source: BMI Espicom
© Espicom Business Intelligence
Page 69
Australia Medical Devices Report Q2 2014
Table: Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s)
2008
2009
2010
2011
2012
CONSUMABLES
449,953
459,804
520,038
637,885
637,081
BANDAGES & DRESSINGS
113,412
111,442
137,261
187,099
149,530
Medical dressings (adhesive)
50,161
48,049
56,174
70,564
69,520
Medical dressings (non-adhesive)
63,251
63,393
81,087
116,535
80,010
SUTURING MATERIALS
61,158
59,873
61,776
76,309
92,225
251,618
251,132
257,615
300,683
320,161
Syringes (with/without needles)
35,513
44,342
46,311
50,715
50,595
Tubular metal needles/needles for sutures
26,466
30,015
28,501
33,574
35,650
189,639
176,775
182,803
216,394
233,916
OTHER CONSUMABLES
23,765
37,357
63,386
73,794
75,165
Blood-grouping reagents
6,040
4,059
4,602
6,357
5,135
First-aid boxes & kits
2,797
2,383
3,598
4,483
6,748
914
17,582
35,519
35,483
39,872
14,014
13,333
19,667
27,471
23,410
DIAGNOSTIC IMAGING
485,171
498,508
573,551
625,215
710,258
ELECTRODIAGNOSTIC APPARATUS
233,212
244,243
278,101
302,136
317,717
9,765
9,785
13,075
15,211
14,838
Ultrasound
74,334
78,222
81,610
87,865
86,742
MRI
27,144
45,924
51,807
55,510
72,217
2,217
1,696
3,968
3,459
4,040
Other electrodiagnostic apparatus
119,752
108,616
127,641
140,091
139,880
RADIATION APPARATUS
118,564
127,651
147,009
153,395
217,698
CT scanners
23,716
32,748
43,599
64,238
93,374
Other medical x-ray apparatus
87,532
93,551
100,776
86,124
116,232
SYRINGES, NEEDLES & CATHETERS
Other needles, catheters, cannulae etc
Ostomy products Surgical gloves
Electrocardiographs
Scintigraphic apparatus
© Espicom Business Intelligence
Page 70
Australia Medical Devices Report Q2 2014
Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s) - Continued
2008
2009
2010
2011
2012
7,316
1,352
2,634
3,033
8,092
133,395
126,614
148,441
169,684
174,843
Contrast media
26,744
25,172
31,022
32,052
33,830
Medical x-ray film (flat)
20,741
21,707
23,104
25,202
23,235
240
171
140
181
353
X-ray tubes
16,493
18,166
19,497
21,106
24,315
Other imaging parts & accessories
69,177
61,398
74,678
91,143
93,110
DENTAL PRODUCTS
164,828
178,962
196,840
215,630
228,729
CAPITAL EQUIPMENT
20,011
25,340
35,290
28,038
28,500
Dental drills
1,730
3,075
3,499
2,367
2,036
Dental chairs
8,466
8,364
12,401
9,992
9,055
Dental x-ray
9,815
13,901
19,390
15,679
17,409
144,817
153,622
161,550
187,592
200,229
Dental cements
28,544
30,347
32,782
47,472
52,964
Dental instruments
71,208
78,563
75,056
83,815
89,012
Teeth & other fittings
45,065
44,712
53,712
56,305
58,253
5,296
5,534
11,380
12,516
13,524
39,769
39,178
42,332
43,789
44,729
ORTHOPAEDICS & PROSTHETICS
536,706
553,455
652,432
845,462
830,236
FIXATION DEVICES
141,003
110,224
134,204
219,541
201,138
ARTIFICIAL JOINTS
170,803
156,388
194,009
244,735
279,894
OTHER ARTIFICIAL BODY PARTS
224,900
286,843
324,219
381,186
349,204
PATIENT AIDS
557,582
490,274
601,442
713,719
692,528
PORTABLE AIDS
422,793
364,011
417,392
510,670
494,795
75,454
65,090
78,838
96,785
86,481
A, B, C ray apparatus
IMAGING PARTS & ACCESSORIES
Medical x-ray film (rolled)
INSTRUMENTS & SUPPLIES
Artificial teeth Other dental fittings
Hearing aids
© Espicom Business Intelligence
Page 71
Australia Medical Devices Report Q2 2014
Detailed Medical Device Imports By Product Area, 2008-2012 (US$000s) - Continued
2008
2009
2010
2011
2012
Pacemakers
121,172
116,281
130,614
146,838
177,406
Other portable aids
226,167
182,640
207,940
267,047
230,908
THERAPEUTIC APPLIANCES
134,789
126,263
184,050
203,049
197,733
Mechano-therapy apparatus
63,141
53,446
60,690
69,469
80,433
Therapeutic respiration apparatus
71,648
72,817
123,360
133,580
117,300
OTHERS
965,105 1,005,186 1,140,024 1,317,076 1,424,780
WHEELCHAIRS
25,773
23,724
27,203
30,355
31,320
Wheelchairs, not mechanically propelled
11,103
9,873
10,597
12,822
13,319
Wheelchairs, mechanically propelled
14,670
13,851
16,606
17,533
18,001
OPHTHALMIC INSTRUMENTS
60,986
61,683
64,173
79,971
90,491
HOSPITAL FURNITURE
39,883
33,979
40,470
48,719
56,998
MEDICAL, SURGICAL STERILISERS
16,051
16,848
18,379
19,769
21,846
1,764
1,509
2,362
2,228
3,906
OTHER INSTRUMENTS & APPLIANCES
820,648
867,443
Anaesthetic apparatus and instruments
86,450
91,379
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
TOTAL
987,437 1,136,034 1,220,219 98,407
96,152
120,742
3,159,345 3,186,189 3,684,327 4,354,987 4,523,612
Source: BMI Espicom
© Espicom Business Intelligence
Page 72
Australia Medical Devices Report Q2 2014
Table: Detailed Medical Device Import Trends By Product Area
2012 % of Total
CONSUMABLES
Latest Year % Latest Year % Change Change, US$ (Local Currency)
5 Year % CAGR, US$
5 Year % CAGR (Local Currency)
14.1
-0.1
-0.5
10.8
6.2
BANDAGES & DRESSINGS
3.3
-20.1
-20.3
9.6
5.1
Medical dressings (adhesive)
1.5
-1.5
-1.8
10.6
6.0
Medical dressings (nonadhesive)
1.8
-31.3
-31.6
8.8
4.3
SUTURING MATERIALS
2.0
20.9
20.5
11.8
7.2
SYRINGES, NEEDLES & CATHETERS
7.1
6.5
6.1
8.6
4.0
Syringes (with/without needles)
1.1
-0.2
-0.6
8.0
3.5
Tubular metal needles/ needles for sutures
0.8
6.2
5.8
14.5
9.8
Other needles, catheters, cannulae etc
5.2
8.1
7.7
7.9
3.4
OTHER CONSUMABLES
1.7
1.9
1.5
27.1
21.8
Blood-grouping reagents
0.1
-19.2
-19.5
1.0
-3.2
First-aid boxes & kits
0.1
50.5
50.0
34.3
28.7
Ostomy products
0.9
12.4
12.0
463.8
440.3
Surgical gloves
0.5
-14.8
-15.1
7.6
3.1
DIAGNOSTIC IMAGING
15.7
13.6
13.2
9.8
5.3
ELECTRODIAGNOSTIC APPARATUS
7.0
5.2
4.8
6.5
2.0
Electrocardiographs
0.3
-2.5
-2.8
6.3
1.9
Ultrasound
1.9
-1.3
-1.6
7.0
2.5
MRI
1.6
30.1
29.7
14.7
9.9
© Espicom Business Intelligence
Page 73
Australia Medical Devices Report Q2 2014
Detailed Medical Device Import Trends By Product Area - Continued
2012 % of Total
Latest Year % Latest Year % Change Change, US$ (Local Currency)
5 Year % CAGR, US$
5 Year % CAGR (Local Currency)
Scintigraphic apparatus
0.1
16.8
16.4
12.8
8.1
Other electrodiagnostic apparatus
3.1
-0.2
-0.5
2.9
-1.3
RADIATION APPARATUS
4.8
41.9
41.5
19.8
14.8
CT scanners
2.1
45.4
44.9
34.9
29.3
Other medical x-ray apparatus
2.6
35.0
34.5
12.8
8.1
A, B, C ray apparatus
0.2
166.8
165.9
17.7
12.8
IMAGING PARTS & ACCESSORIES
3.9
3.0
2.7
7.2
2.7
Contrast media
0.7
5.5
5.2
14.0
9.3
Medical x-ray film (flat)
0.5
-7.8
-8.1
-0.9
-5.0
Medical x-ray film (rolled)
0.0
95.0
94.4
19.3
14.3
X-ray tubes
0.5
15.2
14.8
7.8
3.3
Other imaging parts & accessories
2.1
2.2
1.8
7.5
3.0
DENTAL PRODUCTS
5.1
6.1
5.7
10.1
5.6
CAPITAL EQUIPMENT
0.6
1.6
1.3
12.4
7.7
Dental drills
0.0
-14.0
-14.3
11.3
6.7
Dental chairs
0.2
-9.4
-9.7
4.4
0.1
Dental x-ray
0.4
11.0
10.7
18.5
13.6
INSTRUMENTS & SUPPLIES
4.4
6.7
6.4
9.8
5.3
Dental cements
1.2
11.6
11.2
18.7
13.8
Dental instruments
2.0
6.2
5.9
6.0
1.6
Teeth & other fittings
1.3
3.5
3.1
9.9
5.3
Artificial teeth
0.3
8.1
7.7
24.9
19.7
Other dental fittings
1.0
2.1
1.8
7.0
2.5
© Espicom Business Intelligence
Page 74
Australia Medical Devices Report Q2 2014
Detailed Medical Device Import Trends By Product Area - Continued
2012 % of Total
Latest Year % Latest Year % Change Change, US$ (Local Currency)
5 Year % CAGR, US$
5 Year % CAGR (Local Currency)
ORTHOPAEDICS & PROSTHETICS
18.4
-1.8
-2.1
12.9
8.1
FIXATION DEVICES
4.4
-8.4
-8.7
11.1
6.4
ARTIFICIAL JOINTS
6.2
14.4
14.0
12.0
7.4
OTHER ARTIFICIAL BODY PARTS
7.7
-8.4
-8.7
14.7
9.9
PATIENT AIDS
15.3
-3.0
-3.3
6.7
2.3
PORTABLE AIDS
10.9
-3.1
-3.4
5.3
0.9
Hearing aids
1.9
-10.6
-10.9
5.6
1.2
Pacemakers
3.9
20.8
20.4
8.3
3.8
Other portable aids
5.1
-13.5
-13.8
3.2
-1.1
THERAPEUTIC APPLIANCES
4.4
-2.6
-2.9
10.9
6.3
Mechano-therapy apparatus
1.8
15.8
15.4
5.5
1.1
Therapeutic respiration apparatus
2.6
-12.2
-12.5
15.9
11.1
31.5
8.2
7.8
12.7
8.0
WHEELCHAIRS
0.7
3.2
2.8
8.0
3.5
Wheelchairs, not mechanically propelled
0.3
3.9
3.5
11.5
6.9
Wheelchairs, mechanically propelled
0.4
2.7
2.3
5.8
1.4
OPHTHALMIC INSTRUMENTS
2.0
13.2
12.8
12.4
7.7
HOSPITAL FURNITURE
1.3
17.0
16.6
12.7
8.0
MEDICAL, SURGICAL STERILISERS
0.5
10.5
10.1
12.0
7.4
OTHERS
© Espicom Business Intelligence
Page 75
Australia Medical Devices Report Q2 2014
Detailed Medical Device Import Trends By Product Area - Continued
2012 % of Total
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
5 Year % CAGR, US$
5 Year % CAGR (Local Currency)
0.1
75.3
74.7
11.0
6.3
27.0
7.4
7.1
12.8
8.1
2.7
25.6
25.2
10.1
5.5
100.0
3.9
3.5
10.8
6.2
OTHER INSTRUMENTS & APPLIANCES Anaesthetic apparatus and instruments
TOTAL
Latest Year % Latest Year % Change Change, US$ (Local Currency)
Source: BMI Espicom
Table: Detailed Leading Medical Device Suppliers By Product Area (US$000s)
USA
Germany
Ireland
China
Switzerland
EU-27
251,379
19,050
24,802
49,871
16,311
172,728
BANDAGES & DRESSINGS
19,642
6,250
711
34,665
1,034
63,594
Medical dressings (adhesive)
9,596
3,064
709
7,061
227
37,270
Medical dressings (non-adhesive)
10,046
3,186
2
27,604
807
26,324
SUTURING MATERIALS
71,540
2,859
0
39
3,749
15,687
145,122
9,740
23,706
8,461
9,084
69,388
18,690
864
1,595
2,862
532
10,132
7,798
1,104
3,813
656
98
9,517
118,634
7,772
18,298
4,943
8,454
49,739
OTHER CONSUMABLES
15,075
201
385
6,706
2,444
24,059
Blood-grouping reagents
2,371
64
0
0
2,261
472
CONSUMABLES
SYRINGES, NEEDLES & CATHETERS Syringes (with/without needles) Tubular metal needles/needles for sutures Other needles, catheters, cannulae etc
© Espicom Business Intelligence
Page 76
Australia Medical Devices Report Q2 2014
Detailed Leading Medical Device Suppliers By Product Area (US$000s) - Continued
USA
Germany
Ireland
China
Switzerland
EU-27
114
4
2
6,190
10
243
12,228
133
383
159
173
23,310
362
0
0
357
0
34
DIAGNOSTIC IMAGING
282,002
129,606
2,066
59,318
2,739
231,411
ELECTRODIAGNOSTIC APPARATUS
153,168
35,615
1,075
26,277
2,188
76,878
5,220
1,801
9
689
810
3,175
Ultrasound
54,998
634
0
4,630
104
4,634
MRI
23,056
14,670
0
13,142
0
34,369
3,155
51
0
12
0
100
Other electrodiagnostic apparatus
66,739
18,459
1,066
7,804
1,274
34,600
RADIATION APPARATUS
87,034
51,814
229
19,381
5
84,172
CT scanners
41,036
18,284
229
16,682
0
19,835
Other medical x-ray apparatus
42,174
33,398
0
2,699
5
63,867
3,824
132
0
0
0
470
41,800
42,177
762
13,660
546
70,361
Contrast media
3,723
9,265
605
6,533
0
19,506
Medical x-ray film (flat)
8,103
626
0
1
0
1,512
67
0
0
0
0
250
9,485
10,381
0
284
102
11,747
Other imaging parts & accessories
20,422
21,905
157
6,842
444
37,346
DENTAL PRODUCTS
48,708
45,727
14,255
4,144
19,201
93,365
CAPITAL EQUIPMENT
7,592
5,789
0
1,125
65
15,331
66
264
0
3
48
1,251
Dental chairs
4,238
734
0
1,122
15
2,368
Dental x-ray
3,288
4,791
0
0
2
11,712
41,116
39,938
14,255
3,019
19,136
78,034
First-aid boxes & kits Ostomy products Surgical gloves
Electrocardiographs
Scintigraphic apparatus
A, B, C ray apparatus
IMAGING PARTS & ACCESSORIES
Medical x-ray film (rolled) X-ray tubes
Dental drills
INSTRUMENTS & SUPPLIES
© Espicom Business Intelligence
Page 77
Australia Medical Devices Report Q2 2014
Detailed Leading Medical Device Suppliers By Product Area (US$000s) - Continued
USA
Germany
Ireland
China
Switzerland
EU-27
6,007
9,935
13,916
2
2,874
26,421
Dental instruments
22,175
28,073
234
2,801
9,374
42,253
Teeth & other fittings
12,934
1,930
105
216
6,888
9,360
358
0
0
195
39
1,009
12,576
1,930
105
21
6,849
8,351
ORTHOPAEDICS & PROSTHETICS
373,773
53,973
128,925
12,432
106,660
300,112
FIXATION DEVICES
108,395
17,686
394
7,395
48,113
26,474
ARTIFICIAL JOINTS
124,724
13,329
51,030
3,461
27,482
122,584
OTHER ARTIFICIAL BODY PARTS
140,654
22,958
77,501
1,576
31,065
151,054
PATIENT AIDS
137,829
23,852
93,590
120,449
111,229
182,935
PORTABLE AIDS
106,234
16,838
89,485
34,274
109,803
159,292
Hearing aids
1,905
388
0
22,239
6,734
15,817
Pacemakers
36,268
7,692
25,480
0
88,786
36,575
Other portable aids
68,061
8,758
64,005
12,035
14,283
106,900
THERAPEUTIC APPLIANCES
31,595
7,014
4,105
86,175
1,426
23,643
Mechano-therapy apparatus
11,615
1,214
1,443
46,282
681
8,385
Therapeutic respiration apparatus
19,980
5,800
2,662
39,893
745
15,258
607,369
114,175
103,948
60,511
35,431
425,827
WHEELCHAIRS
7,563
1,410
11
8,158
186
2,947
Wheelchairs, not mechanically propelled
3,444
568
11
4,009
186
1,695
Wheelchairs, mechanically propelled
4,119
842
0
4,149
0
1,252
OPHTHALMIC INSTRUMENTS
48,461
8,264
13
670
6,201
21,036
HOSPITAL FURNITURE
13,115
7,438
7
15,604
138
16,410
Dental cements
Artificial teeth Other dental fittings
OTHERS
© Espicom Business Intelligence
Page 78
Australia Medical Devices Report Q2 2014
Detailed Leading Medical Device Suppliers By Product Area (US$000s) - Continued
USA
Germany
Ireland
China
Switzerland
EU-27
MEDICAL, SURGICAL STERILISERS
3,345
3,993
0
292
960
12,737
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
2,512
209
0
91
17
1,004
OTHER INSTRUMENTS & APPLIANCES
532,373
92,861
103,917
35,696
27,929
371,693
Anaesthetic apparatus and instruments
24,126
5,655
2,509
6,961
372
27,118
1,701,060
386,383
367,586
306,725
TOTAL
291,571 1,406,378
Source: BMI Espicom
© Espicom Business Intelligence
Page 79
Australia Medical Devices Report Q2 2014
Monthly Medical Device Imports The latest Australian monthly trade data reveals that medical device imports increased by 2.2% in US dollar terms in the 12 months to October 2013, taking the running annual total to US$4,571.6mn. The highest growth was recorded in the patient aids sector, which increased by 9.0% over the 12 month period to US $749.0mn. Imports of orthopaedics & prosthetics and consumables also increased - by 6.1% and 3.3% respectively. The largest market segment, other medical devices, showed a marginal 0.5% increase to US $1,407.4mn.
Medical device imports grew by 1.2% to US$1,188.4mn over the three months to October 2013, compared with the corresponding period in 2012. Growth was achieved in the patient aids and orthopaedics & prosthetics sectors which increased by 15.1% and 4.1% respectively. All other sectors experienced a drop in imports over the quarter. The sharpest decline was in the demand for diagnostic imaging products which fell by 7.9%, followed by dental products which decreased by 6.9%.
Table: Monthly Medical Device Imports By Product Area, September 2010-October 2013 (US$mn)
Consumables
Diagnostic
Dental
Orthopaedics
Patient Aids
Others
Total
Sep-10
47.7
50.5
17.2
59.4
51.7
99.7
326.2
Oct-10
45.5
49.9
15.1
53.7
55.3
99.0
318.5
Nov-10
48.7
56.7
17.4
64.5
54.9
109.0
351.3
Dec-10
50.0
60.2
14.9
46.7
56.0
106.6
334.4
Jan-11
48.7
43.1
12.5
52.3
51.0
88.0
295.6
Feb-11
45.2
44.7
15.6
80.7
58.3
93.4
337.9
Mar-11
56.4
51.2
19.0
80.5
67.2
137.8
412.0
Apr-11
50.0
56.4
17.6
75.3
54.7
118.6
372.7
May-11
57.2
55.4
19.1
76.9
60.0
113.7
382.3
Jun-11
53.9
61.6
18.9
67.9
55.1
111.4
368.8
Jul-11
51.4
52.9
17.3
82.8
66.1
110.5
380.9
Aug-11
56.6
57.7
20.2
84.2
58.7
117.8
395.2
Sep-11
52.7
49.9
18.1
64.6
53.1
109.3
347.8
Oct-11
53.8
57.0
18.7
60.1
66.1
107.3
363.0
Nov-11
60.1
48.7
20.5
71.6
68.9
109.2
378.9
Dec-11
47.4
50.4
19.1
50.4
54.4
102.6
324.3
Jan-12
52.4
41.5
15.6
57.4
50.7
96.9
314.5
Feb-12
49.2
51.3
18.2
75.3
52.9
127.0
373.9
© Espicom Business Intelligence
Page 80
Australia Medical Devices Report Q2 2014
Monthly Medical Device Imports By Product Area, September 2010-October 2013 (US$mn) - Continued
Consumables
Diagnostic
Dental
Orthopaedics
Patient Aids
Others
Total
Mar-12
54.0
59.0
20.2
77.6
55.8
120.6
387.3
Apr-12
49.8
58.4
17.5
67.2
48.0
120.3
361.2
May-12
51.3
65.2
19.8
70.1
55.6
117.2
379.2
Jun-12
49.5
88.4
19.3
70.5
56.7
115.2
399.5
Jul-12
49.2
57.5
20.0
69.7
59.2
122.5
378.2
Aug-12
60.1
62.8
19.5
79.4
60.1
122.3
404.3
Sep-12
47.4
56.1
19.0
68.8
53.9
115.2
360.4
Oct-12
64.2
54.4
18.7
69.7
71.1
131.5
409.6
Nov-12
55.4
64.5
20.8
67.5
68.6
118.6
395.5
Dec-12
54.5
51.3
20.1
56.9
59.9
117.5
360.1
Jan-13
50.1
47.8
15.3
63.9
55.4
103.9
336.5
Feb-13
51.6
43.8
17.7
78.5
64.6
97.7
353.9
Mar-13
58.4
59.4
20.8
79.4
55.5
114.4
387.9
Apr-13
54.8
53.2
17.1
77.6
56.1
118.4
377.2
May-13
58.1
67.4
19.7
75.2
61.4
115.4
397.2
Jun-13
51.7
63.4
19.5
69.7
58.5
125.0
387.9
Jul-13
52.6
47.5
19.2
82.6
55.8
129.3
387.0
Aug-13
56.0
60.7
16.9
71.5
77.6
121.4
404.1
Sep-13
52.2
47.1
18.4
79.8
74.5
118.7
390.7
Oct-13
60.2
51.7
18.0
75.6
60.9
127.2
393.6
Oct-12
171.8
173.2
57.2
217.9
185.1
369.0
1,174.3
Oct-13
168.5
159.5
53.3
226.8
213.1
367.3
1,188.4
-1.9
-7.9
-6.9
4.1
15.1
-0.5
1.2
Oct-12
634.7
693.5
227.3
827.8
687.4
1,400.5
4,471.2
Oct-13
655.6
657.8
223.7
878.2
749.0
1,407.4
4,571.6
Quarter to
Qtr % +/-
Year to
© Espicom Business Intelligence
Page 81
Australia Medical Devices Report Q2 2014
Monthly Medical Device Imports By Product Area, September 2010-October 2013 (US$mn) - Continued
Consumables
Diagnostic
Dental
Orthopaedics
Patient Aids
Others
Total
3.3
-5.2
-1.6
6.1
9.0
0.5
2.2
12 months % +/-
Source: BMI Espicom
© Espicom Business Intelligence
Page 82
Australia Medical Devices Report Q2 2014
Annual Medical Device Exports Australian medical device exports bounced back strongly from the dip in 2009, recording strong growth over the 2010-2012 period. In 2012, exports rose by 10.5% to reach US$1,696.0mn.
The CAGR for medical device exports in US dollar terms, over the 2007-2012 period was 6.1%. Segments which outperformed the overall sector included orthopaedic & prosthetic products (19.5%) and dental products (11.8%).
The leading destination for Australian exports is the USA, which accounted for 32.4% of the total in 2012, importing goods to the value of US$549.4mn. Strong export markets also included New Zealand and the United Kingdom, which took 14.4% and 12.6% of the total, respectively.
Medical Device Exports, 2002-2012 US$mn
Source: BMI Espicom
© Espicom Business Intelligence
Page 83
Australia Medical Devices Report Q2 2014
Change In Medical Device Exports, 2003-2012 %
Source: BMI Espicom
Consumables
Australian exports of consumables reached US$59.0mn in 2012, making up just 3.5% of the total, and expanding at a CAGR of 4.0% over the 2007-2012. period. The largest segment within the consumables sector is syringes, needles & catheters with shipments totalling US$37.3mn in 2012.
Diagnostic Imaging
Diagnostic imaging exports totalled US$83.5mn in 2012, equal to 4.9% of total device exports. Much of this category's value lies in electrodiagnostic apparatus which totalled US$57.1mn in 2012. Exports fell by 17.5% in 2012 as a direct result of a 27.7% decline in shipments of electrodiagnostic apparatus.
© Espicom Business Intelligence
Page 84
Australia Medical Devices Report Q2 2014
Dental Products
Dental product exports represented 3.5% of total exports in 2012 at a value of US$59.1mn. Exports rose by 21.5% over the previous year and increased at a CAGR of 11.8% during the 2007-2012 period. Instruments & supplies account for almost the entire category, amounting to US$57.5mn in 2012.
Orthopaedics & Prosthetics
Orthopaedic & prosthetics exports fell by 11.7% to total US$86.4mn in 2012. The category made up just 5.1% of total Australian device exports in 2012. Most exports in this category are classed under artificial body parts, exports of which totalled US$78.2mn in 2012.
Patient Aids
Patient aids is by far the largest segment of Australia's medical device export sector. In 2012, it represented 61.7% of total exports, with a total value of US$1,047.2mn. The category is split fairly evenly between therapeutic appliances and portable aids.
The category rose by 9.8% in 2012, well ahead of the CAGR for the 2007-2012 period of 4.8%. The growth in 2012 was all due to a 21.8% rise in exports of portable aids to US$545.0mn. Exports of therapeutic appliances showed a slight decline in 2012.
The USA is the leading destination for Australian exports of patient aids. In 2012, these amounted to US $460.8mn, equal to 44.0% of the total. The UK is another important market, receiving exports valued at US $194.2mn in 2012. Exports to the Netherlands totalled US$104.1mn.
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s)
2008
2009
2010
2011
2012
CONSUMABLES
50,250
41,394
49,995
50,359
58,954
BANDAGES & DRESSINGS
12,024
10,238
13,057
11,771
7,522
7,702
2,570
4,601
3,597
2,655
25,590
23,804
25,607
29,269
37,267
4,934
4,782
6,730
5,722
11,510
SUTURING MATERIALS SYRINGES, NEEDLES & CATHETERS OTHER CONSUMABLES
© Espicom Business Intelligence
Page 85
Australia Medical Devices Report Q2 2014
Medical Device Exports By Product Area, 2008-2012 (US$000s) - Continued
2008
2009
2010
2011
2012
DIAGNOSTIC IMAGING
69,356
69,464
90,988
101,265
83,510
ELECTRODIAGNOSTIC APPARATUS
45,821
48,063
70,037
78,906
57,053
5,992
6,588
7,566
4,085
6,496
IMAGING PARTS & ACCESSORIES
17,543
14,813
13,385
18,274
19,961
DENTAL PRODUCTS
43,559
39,645
42,285
48,621
59,082
CAPITAL EQUIPMENT
1,707
1,450
1,457
4,639
1,619
INSTRUMENTS & SUPPLIES
41,852
38,195
40,828
43,982
57,463
ORTHOPAEDICS & PROSTHETICS
58,613
37,412
68,476
97,906
86,423
PATIENT AIDS
817,055
717,512
905,745
953,316
1,047,179
PORTABLE AIDS
347,622
296,097
399,755
447,578
544,980
THERAPEUTIC APPLIANCES
469,433
421,415
505,990
505,738
502,199
OTHERS
301,228
284,658
300,075
283,494
360,835
1,340,061
1,190,085
1,457,564
1,534,961
1,695,983
RADIATION APPARATUS
TOTAL
Source: BMI Espicom
Table: Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change)
CONSUMABLES BANDAGES & DRESSINGS SUTURING MATERIALS SYRINGES, NEEDLES & CATHETERS OTHER CONSUMABLES
© Espicom Business Intelligence
2008
2009
2010
2011
2012
3.9
-17.6
20.8
0.7
17.1
-8.4
-14.9
27.5
-9.8
-36.1
-13.7
-66.6
79.0
-21.8
-26.2
23.6
-7.0
7.6
14.3
27.3
-12.2
-3.1
40.7
-15.0
101.2
Page 86
Australia Medical Devices Report Q2 2014
Medical Device Exports By Product Area, 2008-2012 (US$000s, % Change) - Continued
2008
2009
2010
2011
2012
DIAGNOSTIC IMAGING
11.9
0.2
31.0
11.3
-17.5
ELECTRODIAGNOSTIC APPARATUS
25.2
4.9
45.7
12.7
-27.7
RADIATION APPARATUS
20.6
9.9
14.8
-46.0
59.0
-14.0
-15.6
-9.6
36.5
9.2
DENTAL PRODUCTS
29.0
-9.0
6.7
15.0
21.5
CAPITAL EQUIPMENT
-29.3
-15.1
0.5
218.4
-65.1
INSTRUMENTS & SUPPLIES
33.5
-8.7
6.9
7.7
30.7
ORTHOPAEDICS & PROSTHETICS
65.5
-36.2
83.0
43.0
-11.7
PATIENT AIDS
-1.4
-12.2
26.2
5.3
9.8
4.7
-14.8
35.0
12.0
21.8
THERAPEUTIC APPLIANCES
-5.4
-10.2
20.1
0.0
-0.7
OTHERS
19.9
-5.5
5.4
-5.5
27.3
6.4
-11.2
22.5
5.3
10.5
IMAGING PARTS & ACCESSORIES
PORTABLE AIDS
TOTAL
Source: BMI Espicom
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s)
2008
2009
2010
2011
2012
CONSUMABLES
60,095
52,996
54,459
48,787
56,928
BANDAGES & DRESSINGS
14,380
13,108
14,223
11,404
7,263
9,211
3,290
5,012
3,485
2,564
30,604
30,476
27,893
28,356
35,986
OTHER CONSUMABLES
5,901
6,122
7,331
5,543
11,114
DIAGNOSTIC IMAGING
82,945
88,934
99,112
98,105
80,640
ELECTRODIAGNOSTIC APPARATUS
54,799
61,534
76,290
76,444
55,092
SUTURING MATERIALS SYRINGES, NEEDLES & CATHETERS
© Espicom Business Intelligence
Page 87
Australia Medical Devices Report Q2 2014
Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s) - Continued
2008
2009
2010
2011
2012
7,166
8,435
8,242
3,958
6,273
IMAGING PARTS & ACCESSORIES
20,980
18,965
14,580
17,704
19,275
DENTAL PRODUCTS
52,093
50,757
46,060
47,104
57,051
CAPITAL EQUIPMENT
2,041
1,856
1,587
4,494
1,563
INSTRUMENTS & SUPPLIES
50,052
48,900
44,473
42,609
55,488
ORTHOPAEDICS & PROSTHETICS
70,097
47,898
74,590
94,851
83,453
PATIENT AIDS
977,137
918,620
986,613
923,566
1,011,187
PORTABLE AIDS
415,730
379,089
435,446
433,611
526,249
THERAPEUTIC APPLIANCES
561,407
539,531
551,166
489,956
484,938
OTHERS
360,246
364,443
326,867
274,647
348,433
1,602,614
1,523,648
1,587,700
1,487,060
1,637,691
RADIATION APPARATUS
TOTAL
Source: BMI Espicom
Table: Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change)
2008
2009
2010
2011
2012
4.0
-11.8
2.8
-10.4
16.7
-8.3
-8.8
8.5
-19.8
-36.3
-13.6
-64.3
52.3
-30.5
-26.4
23.7
-0.4
-8.5
1.7
26.9
OTHER CONSUMABLES
-12.1
3.8
19.7
-24.4
100.5
DIAGNOSTIC IMAGING
12.0
7.2
11.4
-1.0
-17.8
ELECTRODIAGNOSTIC APPARATUS
25.3
12.3
24.0
0.2
-27.9
RADIATION APPARATUS
20.7
17.7
-2.3
-52.0
58.5
-13.9
-9.6
-23.1
21.4
8.9
CONSUMABLES BANDAGES & DRESSINGS SUTURING MATERIALS SYRINGES, NEEDLES & CATHETERS
IMAGING PARTS & ACCESSORIES
© Espicom Business Intelligence
Page 88
Australia Medical Devices Report Q2 2014
Medical Device Exports By Product Area, 2008-2012 (Local Currency 000s, % Change) - Continued
2008
2009
2010
2011
2012
DENTAL PRODUCTS
29.2
-2.6
-9.3
2.3
21.1
CAPITAL EQUIPMENT
-29.3
-9.1
-14.5
183.2
-65.2
INSTRUMENTS & SUPPLIES
33.7
-2.3
-9.1
-4.2
30.2
ORTHOPAEDICS & PROSTHETICS
65.7
-31.7
55.7
27.2
-12.0
PATIENT AIDS
-1.3
-6.0
7.4
-6.4
9.5
4.8
-8.8
14.9
-0.4
21.4
THERAPEUTIC APPLIANCES
-5.4
-3.9
2.2
-11.1
-1.0
OTHERS
20.1
1.2
-10.3
-16.0
26.9
6.5
-4.9
4.2
-6.3
10.1
2008
2009
2010
2011
2012
CONSUMABLES
3.7
3.5
3.4
3.3
3.5
BANDAGES & DRESSINGS
0.9
0.9
0.9
0.8
0.4
SUTURING MATERIALS
0.6
0.2
0.3
0.2
0.2
SYRINGES, NEEDLES & CATHETERS
1.9
2.0
1.8
1.9
2.2
OTHER CONSUMABLES
0.4
0.4
0.5
0.4
0.7
DIAGNOSTIC IMAGING
5.2
5.8
6.2
6.6
4.9
ELECTRODIAGNOSTIC APPARATUS
3.4
4.0
4.8
5.1
3.4
RADIATION APPARATUS
0.4
0.6
0.5
0.3
0.4
IMAGING PARTS & ACCESSORIES
1.3
1.2
0.9
1.2
1.2
PORTABLE AIDS
TOTAL
Source: BMI Espicom
Table: Medical Device Exports By Product Area, 2008-2012 (% Distribution)
© Espicom Business Intelligence
Page 89
Australia Medical Devices Report Q2 2014
Medical Device Exports By Product Area, 2008-2012 (% Distribution) - Continued
2008
2009
2010
2011
2012
DENTAL PRODUCTS
3.3
3.3
2.9
3.2
3.5
CAPITAL EQUIPMENT
0.1
0.1
0.1
0.3
0.1
INSTRUMENTS & SUPPLIES
3.1
3.2
2.8
2.9
3.4
ORTHOPAEDICS & PROSTHETICS
4.4
3.1
4.7
6.4
5.1
PATIENT AIDS
61.0
60.3
62.1
62.1
61.7
PORTABLE AIDS
25.9
24.9
27.4
29.2
32.1
THERAPEUTIC APPLIANCES
35.0
35.4
34.7
32.9
29.6
OTHERS
22.5
23.9
20.6
18.5
21.3
100.0
100.0
100.0
100.0
100.0
Netherlands Japan
EU-27
TOTAL
Source: BMI Espicom
Table: Leading Medical Device Destinations By Product Area (US$000s)
USA
New Zealand
UK
3,942
21,972
1,756
1,128
3,568
11,075
283
4,567
1,105
0
0
1,178
3,481
13,366
221
1,123
3,556
9,206
OTHER CONSUMABLES
178
4,039
430
5
12
691
DIAGNOSTIC IMAGING
15,904
19,393
1,469
3,760
3,102
14,439
ELECTRODIAGNOSTIC APPARATUS
10,387
16,229
884
2,185
1,079
10,225
RADIATION APPARATUS
1,553
818
34
48
14
1,094
IMAGING PARTS & ACCESSORIES
3,964
2,346
551
1,527
2,009
3,120
DENTAL PRODUCTS
6,890
17,411
383
532
611
12,844
CONSUMABLES BANDAGES & DRESSINGS SUTURING MATERIALS SYRINGES, NEEDLES & CATHETERS
© Espicom Business Intelligence
Page 90
Australia Medical Devices Report Q2 2014
Leading Medical Device Destinations By Product Area (US$000s) - Continued
CAPITAL EQUIPMENT INSTRUMENTS & SUPPLIES
ORTHOPAEDICS & PROSTHETICS
USA
New Zealand
UK
Netherlands Japan
EU-27
152
903
262
0
4
388
6,738
16,508
121
532
607
12,456
12,055
15,883
4,743
1,499
2,557
41,705
PATIENT AIDS
460,837
28,678 194,234
104,122 55,943 318,454
PORTABLE AIDS
180,620
22,177 193,883
2,119 13,147 204,154
THERAPEUTIC APPLIANCES
280,217
6,501
351
49,734
140,659
10,486
OTHERS
TOTAL
549,362
243,996 213,071
102,003 42,796 114,300
4,378 27,836
68,900
115,419 93,617 467,417
Source: BMI Espicom
Table: Leading Medical Device Destinations By Product Area (% Distribution)
USA
New Zealand
UK
Netherlands
Japan
EU-27
CONSUMABLES
6.7
37.3
3.0
1.9
6.1
18.8
BANDAGES & DRESSINGS
3.8
60.7 14.7
0.0
0.0
15.7
SUTURING MATERIALS
0.0
0.0
0.0
0.0
0.0
0.0
SYRINGES, NEEDLES & CATHETERS
9.3
35.9
0.6
3.0
9.5
24.7
OTHER CONSUMABLES
1.5
35.1
3.7
0.0
0.1
6.0
DIAGNOSTIC IMAGING
19.0
23.2
1.8
4.5
3.7
17.3
ELECTRODIAGNOSTIC APPARATUS
18.2
28.4
1.5
3.8
1.9
17.9
RADIATION APPARATUS
23.9
12.6
0.5
0.7
0.2
16.8
IMAGING PARTS & ACCESSORIES
19.9
11.8
2.8
7.6
10.1
15.6
DENTAL PRODUCTS
11.7
29.5
0.6
0.9
1.0
21.7
CAPITAL EQUIPMENT
9.4
55.8 16.2
0.0
0.2
24.0
28.7
0.9
1.1
21.7
INSTRUMENTS & SUPPLIES
© Espicom Business Intelligence
11.7
0.2
Page 91
Australia Medical Devices Report Q2 2014
Leading Medical Device Destinations By Product Area (% Distribution) - Continued
USA
New Zealand
UK
Netherlands
Japan
EU-27
ORTHOPAEDICS & PROSTHETICS
13.9
18.4
5.5
1.7
3.0
48.3
PATIENT AIDS
44.0
2.7 18.5
9.9
5.3
30.4
PORTABLE AIDS
33.1
4.1 35.6
0.4
2.4
37.5
THERAPEUTIC APPLIANCES
55.8
1.3
0.1
20.3
8.5
22.8
OTHERS
13.8
39.0
2.9
1.2
7.7
19.1
TOTAL
32.4
14.4 12.6
6.8
5.5
27.6
Source: BMI Espicom
Table: Top 20 Medical Device Destinations (US$000s)
Country
2012
% of Total
1
United States of America
549,362
32.4
2
New Zealand
243,996
14.4
3
United Kingdom
213,071
12.6
4
Netherlands
115,419
6.8
5
Japan
93,617
5.5
6
China
91,789
5.4
7
Germany
75,067
4.4
8
Singapore
62,477
3.7
9
Denmark
29,968
1.8
10
South Korea
23,257
1.4
11
Panama
19,927
1.2
12
India
19,760
1.2
13
Papua New Guinea
12,327
0.7
14
Hong Kong
10,151
0.6
15
Ireland
9,667
0.6
16
Taiwan
9,664
0.6
© Espicom Business Intelligence
Page 92
Australia Medical Devices Report Q2 2014
Top 20 Medical Device Destinations (US$000s) - Continued
Country
2012
% of Total
17
France
8,917
0.5
18
Malaysia
8,192
0.5
19
Philippines
8,040
0.5
20
Brazil
7,344
0.4
1,612,012
95.0
83,971
5.0
1,695,983
100.0
Subtotal
Others
Total
Source: BMI Espicom
Table: Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s)
2008
2009
2010
2011
2012
CONSUMABLES
50,250
41,394
49,995
50,359
58,954
BANDAGES & DRESSINGS
12,024
10,238
13,057
11,771
7,522
Medical dressings (adhesive)
3,678
3,896
2,771
2,221
2,853
Medical dressings (non-adhesive)
8,346
6,342
10,286
9,550
4,669
SUTURING MATERIALS
7,702
2,570
4,601
3,597
2,655
25,590
23,804
25,607
29,269
37,267
3,919
2,293
3,937
4,416
6,678
Tubular metal needles/needles for sutures
11,484
5,443
735
6,641
14,581
Other needles, catheters, cannulae etc
10,187
16,068
20,935
18,212
16,008
OTHER CONSUMABLES
4,934
4,782
6,730
5,722
11,510
Blood-grouping reagents
2,496
2,593
1,525
1,529
1,910
896
820
1,434
594
952
SYRINGES, NEEDLES & CATHETERS Syringes (with/without needles)
First-aid boxes & kits
© Espicom Business Intelligence
Page 93
Australia Medical Devices Report Q2 2014
Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s) - Continued
2008
2009
2010
2011
2012
1,011
681
3,316
2,942
7,920
531
688
455
657
728
DIAGNOSTIC IMAGING
69,356
69,464
90,988
101,265
83,510
ELECTRODIAGNOSTIC APPARATUS
45,821
48,063
70,037
78,906
57,053
Electrocardiographs
1,504
1,304
1,026
1,994
1,454
Ultrasound
7,458
11,249
6,004
10,236
14,209
MRI
1,055
1,926
3,256
4,150
3,219
234
346
792
299
155
35,570
33,238
58,959
62,227
38,016
RADIATION APPARATUS
5,992
6,588
7,566
4,085
6,496
CT scanners
1,275
946
2,632
571
307
Other medical x-ray apparatus
3,637
3,269
3,738
2,149
3,531
A, B, C ray apparatus
1,080
2,373
1,196
1,365
2,658
17,543
14,813
13,385
18,274
19,961
1,007
738
334
835
484
Medical x-ray film (flat)
843
751
782
1,322
1,447
Medical x-ray film (rolled)
150
239
53
174
162
3,083
3,501
3,376
2,510
2,330
Other imaging parts & accessories
12,460
9,584
8,840
13,433
15,538
DENTAL PRODUCTS
43,559
39,645
42,285
48,621
59,082
CAPITAL EQUIPMENT
1,707
1,450
1,457
4,639
1,619
167
71
70
40
76
1,028
996
1,076
2,443
1,009
512
383
311
2,156
534
INSTRUMENTS & SUPPLIES
41,852
38,195
40,828
43,982
57,463
Dental cements
23,744
22,076
23,035
26,784
35,539
Ostomy products Surgical gloves
Scintigraphic apparatus Other electrodiagnostic apparatus
IMAGING PARTS & ACCESSORIES Contrast media
X-ray tubes
Dental drills Dental chairs Dental x-ray
© Espicom Business Intelligence
Page 94
Australia Medical Devices Report Q2 2014
Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s) - Continued
2008
2009
2010
2011
2012
12,428
12,404
15,335
15,235
18,214
5,680
3,715
2,458
1,963
3,710
167
124
182
310
100
5,513
3,591
2,276
1,653
3,610
58,613
37,412
68,476
97,906
86,423
FIXATION DEVICES
6,373
3,361
6,819
10,537
6,614
ARTIFICIAL JOINTS
2,157
796
1,321
1,367
1,581
50,083
33,255
60,336
86,002
78,228
PATIENT AIDS
817,055
717,512
905,745
953,316 1,047,179
PORTABLE AIDS
347,622
296,097
399,755
447,578
544,980
Hearing aids
61,232
57,549
154,057
170,361
234,399
Pacemakers
2,398
829
1,473
1,610
2,305
Other portable aids
283,992
237,719
244,225
275,607
308,276
THERAPEUTIC APPLIANCES
469,433
421,415
505,990
505,738
502,199
7,753
4,389
4,164
3,608
4,187
Therapeutic respiration apparatus
461,680
417,026
501,826
502,130
498,012
OTHERS
301,228
284,658
300,075
283,494
360,835
2,397
1,986
2,127
1,829
4,575
464
599
564
685
567
1,933
1,387
1,563
1,144
4,008
OPHTHALMIC INSTRUMENTS
36,561
30,676
30,695
27,963
31,488
HOSPITAL FURNITURE
10,634
7,513
7,989
7,793
8,528
1,607
1,505
1,453
3,175
3,078
Dental instruments Teeth & other fittings Artificial teeth Other dental fittings
ORTHOPAEDICS & PROSTHETICS
OTHER ARTIFICIAL BODY PARTS
Mechano-therapy apparatus
WHEELCHAIRS Wheelchairs, not mechanically propelled Wheelchairs, mechanically propelled
MEDICAL, SURGICAL STERILISERS
© Espicom Business Intelligence
Page 95
Australia Medical Devices Report Q2 2014
Detailed Medical Device Exports By Product Area, 2008-2012 (US$000s) - Continued
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
OTHER INSTRUMENTS & APPLIANCES
TOTAL
2008
2009
2010
2011
2012
293
213
125
1,109
457
249,736
242,765
257,686
241,625
312,709
1,340,061 1,190,085 1,457,564 1,534,961 1,695,983
Source: BMI Espicom
Table: Detailed Medical Device Export Trends By Product Area
2012 % of Total
Latest Year % Latest Year % Change Change, US$ (Local Currency)
5 Year % CAGR, US$
5 Year % CAGR (Local Currency)
CONSUMABLES
3.5
17.1
16.7
4.0
-0.3
BANDAGES & DRESSINGS
0.4
-36.1
-36.3
-10.5
-14.3
Medical dressings (adhesive)
0.2
28.5
28.0
-6.2
-10.1
Medical dressings (nonadhesive)
0.3
-51.1
-51.3
-12.7
-16.3
SUTURING MATERIALS
0.2
-26.2
-26.4
-21.5
-24.8
SYRINGES, NEEDLES & CATHETERS
2.2
27.3
26.9
12.5
7.8
Syringes (with/without needles)
0.4
51.2
50.7
21.0
16.0
Tubular metal needles/ needles for sutures
0.9
119.6
118.8
10.4
5.8
Other needles, catheters, cannulae etc
0.9
-12.1
-12.4
11.6
6.9
OTHER CONSUMABLES
0.7
101.2
100.5
15.4
10.6
© Espicom Business Intelligence
Page 96
Australia Medical Devices Report Q2 2014
Detailed Medical Device Export Trends By Product Area - Continued
2012 % of Total
Latest Year % Latest Year % Change Change, US$ (Local Currency)
5 Year % CAGR, US$
5 Year % CAGR (Local Currency)
Blood-grouping reagents
0.1
24.9
24.5
-4.6
-8.6
First-aid boxes & kits
0.1
60.3
59.7
14.8
10.0
Ostomy products
0.5
169.2
168.3
40.8
34.9
Surgical gloves
0.0
10.8
10.4
-10.7
-14.4
DIAGNOSTIC IMAGING
4.9
-17.5
-17.8
6.1
1.7
ELECTRODIAGNOSTIC APPARATUS
3.4
-27.7
-27.9
9.3
4.7
Electrocardiographs
0.1
-27.1
-27.3
-16.1
-19.6
Ultrasound
0.8
38.8
38.4
25.5
20.3
MRI
0.2
-22.4
-22.7
22.4
17.3
Scintigraphic apparatus
0.0
-48.2
-48.3
-19.8
-23.1
Other electrodiagnostic apparatus
2.2
-38.9
-39.1
7.2
2.7
RADIATION APPARATUS
0.4
59.0
58.5
5.5
1.1
CT scanners
0.0
-46.2
-46.4
-26.7
-29.7
Other medical x-ray apparatus
0.2
64.3
63.8
6.5
2.1
A, B, C ray apparatus
0.2
94.7
94.1
23.0
17.9
IMAGING PARTS & ACCESSORIES
1.2
9.2
8.9
-0.4
-4.6
Contrast media
0.0
-42.0
-42.2
-28.3
-31.3
Medical x-ray film (flat)
0.1
9.5
9.1
-2.3
-6.4
Medical x-ray film (rolled)
0.0
-6.9
-7.2
-0.7
-4.9
X-ray tubes
0.1
-7.2
-7.5
-4.5
-8.5
Other imaging parts & accessories
0.9
15.7
15.3
3.5
-0.9
DENTAL PRODUCTS
3.5
21.5
21.1
11.8
7.2
CAPITAL EQUIPMENT
0.1
-65.1
-65.2
-7.7
-11.5
© Espicom Business Intelligence
Page 97
Australia Medical Devices Report Q2 2014
Detailed Medical Device Export Trends By Product Area - Continued
2012 % of Total
Latest Year % Latest Year % Change Change, US$ (Local Currency)
5 Year % CAGR, US$
5 Year % CAGR (Local Currency)
Dental drills
0.0
90.0
89.4
-20.3
-23.6
Dental chairs
0.1
-58.7
-58.8
-12.7
-16.3
Dental x-ray
0.0
-75.2
-75.3
22.6
17.5
INSTRUMENTS & SUPPLIES
3.4
30.7
30.2
12.9
8.2
Dental cements
2.1
32.7
32.3
14.9
10.1
Dental instruments
1.1
19.6
19.2
10.8
6.2
Teeth & other fittings
0.2
89.0
88.4
6.8
2.3
Artificial teeth
0.0
-67.7
-67.8
-10.9
-14.6
Other dental fittings
0.2
118.4
117.7
7.6
3.2
ORTHOPAEDICS & PROSTHETICS
5.1
-11.7
-12.0
19.5
14.6
FIXATION DEVICES
0.4
-37.2
-37.4
4.0
-0.3
ARTIFICIAL JOINTS
0.1
15.7
15.3
1.0
-3.2
OTHER ARTIFICIAL BODY PARTS
4.6
-9.0
-9.3
22.4
17.3
PATIENT AIDS
61.7
9.8
9.5
4.8
0.4
PORTABLE AIDS
32.1
21.8
21.4
10.4
5.8
Hearing aids
13.8
37.6
37.1
41.0
35.1
Pacemakers
0.1
43.2
42.7
5.5
1.1
Other portable aids
18.2
11.9
11.5
1.4
-2.9
THERAPEUTIC APPLIANCES
29.6
-0.7
-1.0
0.2
-3.9
0.2
16.0
15.7
-11.7
-15.4
Therapeutic respiration apparatus
29.4
-0.8
-1.1
0.4
-3.8
OTHERS
21.3
27.3
26.9
7.5
3.0
Mechano-therapy apparatus
© Espicom Business Intelligence
Page 98
Australia Medical Devices Report Q2 2014
Detailed Medical Device Export Trends By Product Area - Continued
2012 % of Total
Latest Year % Latest Year % Change Change, US$ (Local Currency)
5 Year % CAGR, US$
5 Year % CAGR (Local Currency)
WHEELCHAIRS
0.3
150.1
149.3
16.8
11.9
Wheelchairs, not mechanically propelled
0.0
-17.2
-17.5
7.2
2.7
Wheelchairs, mechanically propelled
0.2
250.3
249.2
18.7
13.7
OPHTHALMIC INSTRUMENTS
1.9
12.6
12.2
-0.8
-4.9
HOSPITAL FURNITURE
0.5
9.4
9.1
0.0
-4.2
MEDICAL, SURGICAL STERILISERS
0.2
-3.1
-3.4
7.3
2.8
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
0.0
-58.8
-58.9
31.1
25.6
18.4
29.4
29.0
8.8
4.2
100.0
10.5
10.1
6.1
1.7
OTHER INSTRUMENTS & APPLIANCES
TOTAL
Source: BMI Espicom
The leading destination for Australian exports is the USA, which accounted for 32.4% of the total in 2012, importing goods to the value of US$549.4mn. Strong export markets also included New Zealand and the United Kingdom, which took 14.4% and 12.6% of the total, respectively.
The USA is the leading market as a result of its imports of patient aids which can be traced back to ResMed. In 2012, exports of patient aids to the USA totalled US$460.8mn, equating to 44.0% of the category total.
Although, second to the US overall, New Zealand is the leading importer of consumables, diagnostic imaging products, dental products, orthopaedic & prosthetic products and other medical devices from Australia.
© Espicom Business Intelligence
Page 99
Australia Medical Devices Report Q2 2014
Table: Detailed Leading Medical Device Destinations By Product Area (US$000s)
USA
New Zealand
Japan
EU-27
3,942
21,972
1,756
1,128
3,568
11,075
BANDAGES & DRESSINGS
283
4,567
1,105
0
0
1,178
Medical dressings (adhesive)
52
2,187
12
0
0
57
231
2,380
1,093
0
0
1,121
0
0
0
0
0
0
3,481
13,366
221
1,123
3,556
9,206
170
3,613
0
986
130
1,300
2,850
936
0
4
1,077
5,727
Other needles, catheters, cannulae etc
461
8,817
221
133
2,349
2,179
OTHER CONSUMABLES
178
4,039
430
5
12
691
Blood-grouping reagents
6
112
0
0
0
21
First-aid boxes & kits
3
172
189
5
0
194
169
3,348
241
0
12
476
0
407
0
0
0
0
DIAGNOSTIC IMAGING
15,904
19,393
1,469
3,760
3,102
14,439
ELECTRODIAGNOSTIC APPARATUS
10,387
16,229
884
2,185
1,079
10,225
842
160
73
11
0
312
2,723
2,585
94
491
157
2,346
175
281
3
89
203
282
32
0
0
0
0
0
Other electrodiagnostic apparatus
6,615
13,203
714
1,594
719
7,285
RADIATION APPARATUS
1,553
818
34
48
14
1,094
74
2
0
6
0
6
CONSUMABLES
Medical dressings (non-adhesive)
SUTURING MATERIALS
SYRINGES, NEEDLES & CATHETERS Syringes (with/without needles) Tubular metal needles/needles for sutures
Ostomy products Surgical gloves
Electrocardiographs Ultrasound MRI Scintigraphic apparatus
CT scanners
© Espicom Business Intelligence
UK Netherlands
Page 100
Australia Medical Devices Report Q2 2014
Detailed Leading Medical Device Destinations By Product Area (US$000s) - Continued
USA
New Zealand
Japan
EU-27
Other medical x-ray apparatus
897
461
34
42
14
536
A, B, C ray apparatus
582
355
0
0
0
552
3,964
2,346
551
1,527
2,009
3,120
131
93
0
0
0
35
Medical x-ray film (flat)
0
1,235
0
0
0
30
Medical x-ray film (rolled)
0
9
0
0
0
0
823
181
49
0
453
82
Other imaging parts & accessories
3,010
828
502
1,527
1,556
2,973
DENTAL PRODUCTS
6,890
17,411
383
532
611
12,844
CAPITAL EQUIPMENT
152
903
262
0
4
388
0
12
0
0
4
0
152
560
262
0
0
262
0
331
0
0
0
126
INSTRUMENTS & SUPPLIES
6,738
16,508
121
532
607
12,456
Dental cements
5,604
3,070
0
482
154
8,463
Dental instruments
956
11,325
121
0
12
3,906
Teeth & other fittings
178
2,113
0
50
441
87
0
68
0
0
3
0
178
2,045
0
50
438
87
12,055
15,883
4,743
1,499
2,557
41,705
FIXATION DEVICES
2,579
2,654
436
0
0
1,068
ARTIFICIAL JOINTS
419
421
6
0
0
282
9,057
12,808
4,301
1,499
2,557
40,355
PATIENT AIDS
460,837
28,678
194,234
104,122
55,943
318,454
PORTABLE AIDS
180,620
22,177
193,883
2,119
13,147
204,154
IMAGING PARTS & ACCESSORIES Contrast media
X-ray tubes
Dental drills Dental chairs Dental x-ray
Artificial teeth Other dental fittings
ORTHOPAEDICS & PROSTHETICS
OTHER ARTIFICIAL BODY PARTS
© Espicom Business Intelligence
UK Netherlands
Page 101
Australia Medical Devices Report Q2 2014
Detailed Leading Medical Device Destinations By Product Area (US$000s) - Continued
USA
New Zealand
Japan
EU-27
Hearing aids
156,128
2,993
0
0
3,639
538
Pacemakers
1,264
748
5
0
0
192
23,228
18,436
193,878
2,119
9,508
203,424
280,217
6,501
351
102,003
42,796
114,300
196
3,166
110
0
16
290
280,021
3,335
241
102,003
42,780
114,010
49,734
140,659
10,486
4,378
27,836
68,900
2,215
665
244
0
19
1,304
0
233
69
0
0
74
Wheelchairs, mechanically propelled
2,215
432
175
0
19
1,230
OPHTHALMIC INSTRUMENTS
7,460
1,446
1,088
409
6,882
6,204
522
2,477
544
281
239
1,199
MEDICAL, SURGICAL STERILISERS
37
1,510
181
0
0
576
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
50
96
0
0
0
5
39,450
134,465
8,429
3,688
20,696
59,612
549,362
243,996
213,071
115,419
93,617
467,417
Other portable aids
THERAPEUTIC APPLIANCES Mechano-therapy apparatus Therapeutic respiration apparatus
OTHERS
WHEELCHAIRS Wheelchairs, not mechanically propelled
HOSPITAL FURNITURE
OTHER INSTRUMENTS & APPLIANCES
TOTAL
UK Netherlands
Source: BMI Espicom
© Espicom Business Intelligence
Page 102
Australia Medical Devices Report Q2 2014
Table: Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s)
2008
2009
2010
2011
2012
CONSUMABLES
-399,703
-418,410
-470,043
-587,526
-578,127
BANDAGES & DRESSINGS
-101,388
-101,204
-124,204
-175,328
-142,008
Medical dressings (adhesive)
-46,483
-44,153
-53,403
-68,343
-66,667
Medical dressings (non-adhesive)
-54,905
-57,051
-70,801
-106,985
-75,341
SUTURING MATERIALS
-53,456
-57,303
-57,175
-72,712
-89,570
-226,028
-227,328
-232,008
-271,414
-282,894
Syringes (with/without needles)
-31,594
-42,049
-42,374
-46,299
-43,917
Tubular metal needles/needles for sutures
-14,982
-24,572
-27,766
-26,933
-21,069
-179,452
-160,707
-161,868
-198,182
-217,908
OTHER CONSUMABLES
-18,831
-32,575
-56,656
-68,072
-63,655
Blood-grouping reagents
-3,544
-1,466
-3,077
-4,828
-3,225
First-aid boxes & kits
-1,901
-1,563
-2,164
-3,889
-5,796
97
-16,901
-32,203
-32,541
-31,952
-13,483
-12,645
-19,212
-26,814
-22,682
DIAGNOSTIC IMAGING
-415,815
-429,044
-482,563
-523,950
-626,748
ELECTRODIAGNOSTIC APPARATUS
-187,391
-196,180
-208,064
-223,230
-260,664
-8,261
-8,481
-12,049
-13,217
-13,384
Ultrasound
-66,876
-66,973
-75,606
-77,629
-72,533
MRI
-26,089
-43,998
-48,551
-51,360
-68,998
-1,983
-1,350
-3,176
-3,160
-3,885
-84,182
-75,378
-68,682
-77,864
-101,864
-112,572
-121,063
-139,443
-149,310
-211,202
CT scanners
-22,441
-31,802
-40,967
-63,667
-93,067
Other medical x-ray apparatus
-83,895
-90,282
-97,038
-83,975
-112,701
SYRINGES, NEEDLES & CATHETERS
Other needles, catheters, cannulae etc
Ostomy products Surgical gloves
Electrocardiographs
Scintigraphic apparatus Other electrodiagnostic apparatus
RADIATION APPARATUS
© Espicom Business Intelligence
Page 103
Australia Medical Devices Report Q2 2014
Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s) - Continued
2008
2009
2010
2011
2012
-6,236
1,021
-1,438
-1,668
-5,434
-115,852
-111,801
-135,056
-151,410
-154,882
Contrast media
-25,737
-24,434
-30,688
-31,217
-33,346
Medical x-ray film (flat)
-19,898
-20,956
-22,322
-23,880
-21,788
-90
68
-87
-7
-191
X-ray tubes
-13,410
-14,665
-16,121
-18,596
-21,985
Other imaging parts & accessories
-56,717
-51,814
-65,838
-77,710
-77,572
DENTAL PRODUCTS
-121,269
-139,317
-154,555
-167,009
-169,647
CAPITAL EQUIPMENT
-18,304
-23,890
-33,833
-23,399
-26,881
Dental drills
-1,563
-3,004
-3,429
-2,327
-1,960
Dental chairs
-7,438
-7,368
-11,325
-7,549
-8,046
Dental x-ray
-9,303
-13,518
-19,079
-13,523
-16,875
-102,965
-115,427
-120,722
-143,610
-142,766
-4,800
-8,271
-9,747
-20,688
-17,425
Dental instruments
-58,780
-66,159
-59,721
-68,580
-70,798
Teeth & other fittings
-39,385
-40,997
-51,254
-54,342
-54,543
-5,129
-5,410
-11,198
-12,206
-13,424
-34,256
-35,587
-40,056
-42,136
-41,119
ORTHOPAEDICS & PROSTHETICS
-478,093
-516,043
-583,956
-747,556
-743,813
FIXATION DEVICES
-134,630
-106,863
-127,385
-209,004
-194,524
ARTIFICIAL JOINTS
-168,646
-155,592
-192,688
-243,368
-278,313
OTHER ARTIFICIAL BODY PARTS
-174,817
-253,588
-263,883
-295,184
-270,976
PATIENT AIDS
259,473
227,238
304,303
239,597
354,651
PORTABLE AIDS
-75,171
-67,914
-17,637
-63,092
50,185
Hearing aids
-14,222
-7,541
75,219
73,576
147,918
A, B, C ray apparatus
IMAGING PARTS & ACCESSORIES
Medical x-ray film (rolled)
INSTRUMENTS & SUPPLIES Dental cements
Artificial teeth Other dental fittings
© Espicom Business Intelligence
Page 104
Australia Medical Devices Report Q2 2014
Detailed Medical Device Balance Of Trade, 2008-2012 (US$000s) - Continued
2008
2009
2010
2011
2012
-118,774
-115,452
-129,141
-145,228
-175,101
57,825
55,079
36,285
8,560
77,368
THERAPEUTIC APPLIANCES
334,644
295,152
321,940
302,689
304,466
Mechano-therapy apparatus
-55,388
-49,057
-56,526
-65,861
-76,246
Therapeutic respiration apparatus
390,032
344,209
378,466
368,550
380,712
-663,877
-720,528
WHEELCHAIRS
-23,376
-21,738
-25,076
-28,526
-26,745
Wheelchairs, not mechanically propelled
-10,639
-9,274
-10,033
-12,137
-12,752
Wheelchairs, mechanically propelled
-12,737
-12,464
-15,043
-16,389
-13,993
OPHTHALMIC INSTRUMENTS
-24,425
-31,007
-33,478
-52,008
-59,003
HOSPITAL FURNITURE
-29,249
-26,466
-32,481
-40,926
-48,470
MEDICAL, SURGICAL STERILISERS
-14,444
-15,343
-16,926
-16,594
-18,768
-1,471
-1,296
-2,237
-1,119
-3,449
OTHER INSTRUMENTS & APPLIANCES
-570,912
-624,678
-729,751
-894,409
-907,510
Anaesthetic apparatus and instruments
-86,450
-91,379
-98,407
-96,152
-120,742
Pacemakers Other portable aids
OTHERS
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
TOTAL
-839,949 -1,033,582 -1,063,945
-1,819,284 -1,996,104 -2,226,763 -2,820,026 -2,827,629
Source: BMI Espicom
© Espicom Business Intelligence
Page 105
Australia Medical Devices Report Q2 2014
Monthly Medical Device Exports The latest Australian monthly trade data reveals that medical device exports showed a modest 1.7% increase to US$1,715.6mn in the 12 months to October 2013, when compared with the corresponding period to October 2012. The greatest movement occurred in the other medical devices segment, which increased by 17.2% to total US$406.2mn. The largest segment, patient aids, declined by 1.1% to US$1,025.5mn.
Medical device exports exhibited a slight improvement during the three months to October 2013, rising by 1.5% to US$476.9mn over the same quarter in 2012. Double digit growth was achieved in the diagnostic imaging and other medical devices segments, but exports decreased in all other areas. The largest segment, patient aids, fell by 0.1% to US$292.3mn. The heaviest fall was reported in the dental products segment which declined by 23.0% to US$14.4mn.
Table: Monthly Medical Device Exports By Product Area, September 2010-October 2013 (US$mn)
Consumables
Diagnostic
Dental
Orthopaedics
Patient Aids
Others
Total
Sep-10
4.4
9.1
3.7
7.0
76.5
26.0
126.8
Oct-10
5.8
8.7
4.2
7.1
86.7
29.1
141.5
Nov-10
5.0
8.8
3.9
7.4
84.6
27.9
137.6
Dec-10
4.2
7.3
5.6
7.8
95.1
31.4
151.4
Jan-11
4.6
4.9
2.8
4.7
59.1
19.5
95.7
Feb-11
4.5
8.4
3.3
9.8
75.9
21.3
123.1
Mar-11
4.2
10.1
4.7
9.2
91.2
28.7
148.1
Apr-11
4.2
9.8
4.3
9.2
84.0
25.8
137.4
May-11
4.0
11.5
7.2
9.0
86.8
24.3
142.9
Jun-11
4.4
9.3
5.1
9.8
86.6
26.9
142.1
Jul-11
5.2
9.6
4.3
9.3
91.1
29.2
148.9
Aug-11
4.6
9.0
4.1
10.1
101.8
27.0
156.6
Sep-11
4.7
9.4
4.3
8.5
105.8
34.4
167.2
Oct-11
5.1
9.3
4.4
8.2
88.7
23.7
139.4
Nov-11
5.1
10.3
4.3
11.3
87.7
24.6
143.3
Dec-11
5.1
11.3
6.6
9.8
83.5
27.5
143.7
Jan-12
4.1
6.1
3.7
5.1
61.9
18.5
99.5
Feb-12
5.6
8.0
5.1
6.1
86.4
27.9
139.1
Mar-12
6.5
7.9
4.8
8.0
83.6
30.4
141.2
Apr-12
3.9
5.3
4.6
5.0
76.4
28.1
123.2
© Espicom Business Intelligence
Page 106
Australia Medical Devices Report Q2 2014
Monthly Medical Device Exports By Product Area, September 2010-October 2013 (US$mn) - Continued
Consumables
Diagnostic
Dental
Orthopaedics
Patient Aids
Others
Total
May-12
5.3
5.6
3.8
7.0
89.4
31.0
142.2
Jun-12
4.0
11.2
4.2
5.7
89.7
28.3
143.1
Jul-12
5.3
6.3
5.4
6.8
85.4
33.2
142.5
Aug-12
5.5
6.4
5.5
7.6
94.6
29.6
149.3
Sep-12
5.2
7.0
6.8
9.2
107.6
30.0
165.8
Oct-12
4.7
7.2
6.4
8.4
90.3
37.6
154.7
Nov-12
4.4
6.4
3.9
9.3
95.7
33.4
153.2
Dec-12
4.5
6.0
4.7
8.2
86.0
32.8
142.2
Jan-13
4.0
3.8
3.2
5.4
48.2
27.9
92.5
Feb-13
4.4
4.9
4.2
6.4
69.5
33.4
122.8
Mar-13
4.9
5.8
5.0
8.6
84.6
38.5
147.4
Apr-13
4.6
7.4
4.1
9.8
88.9
32.8
147.7
May-13
4.8
6.8
5.4
8.6
76.9
33.1
135.7
Jun-13
5.1
6.2
4.2
8.4
97.4
34.6
155.9
Jul-13
4.7
5.8
5.2
8.0
85.9
31.8
141.4
Aug-13
5.3
8.4
5.0
8.3
108.0
35.8
171.0
Sep-13
3.8
7.5
4.7
7.2
81.3
34.7
139.2
Oct-13
5.1
7.8
4.7
8.6
103.0
37.4
166.7
Oct-12
15.4
20.7
18.7
25.3
292.5
97.2
469.9
Oct-13
14.3
23.8
14.4
24.2
292.3
107.9
476.9
Qtr % +/-
-7.4
14.9
-23.0
-4.3
-0.1
11.0
1.5
Oct-12
60.3
92.7
61.3
90.0
1,036.7
346.7
1,687.7
Oct-13
55.6
77.1
54.4
96.9
1,025.5
406.2
1,715.6
12 months % +/-
-7.7
-16.9
-11.4
7.7
-1.1
17.2
1.7
Quarter to
Year to
Source: BMI Espicom
© Espicom Business Intelligence
Page 107
Australia Medical Devices Report Q2 2014
Macroeconomic Forecasts BMI View: Several domestic and external factors have served to boost the level of economic activity in Australia. While we revised up our GDP growth forecasts for 2014 to 2.0% from 1.8% previously, this change masks our concerns for the ever-growing risks within the Australian economy. Given that an increasing proportion of capital is being invested in the housing sector despite the weak performance of business spending, (a turnaround in which is required to generate wage growth), this misallocation of capital increases the economy's vulnerability to external shocks, on top of the ongoing weakness in the mining sector.
Since the September elections, the Australia economy has recorded an uptick in activity levels and business sentiment from the lows recorded earlier in 2013, supported by both domestic and external factors. Domestically, prospects of lower regulatory burden, ranging from taxes to various regulatory procedures, have helped lift the outlook for certain industries, such as oil and gas. Moreover, September's readings of the performance indices showed that deterioration in the services and construction sectors were moderating, while activity in the manufacturing sector posted expansion in both September and October. The expansion recorded in the new order sub-indices for the manufacturing and construction sectors further suggests that this recent up-tick in activity could persist in the near term.
© Espicom Business Intelligence
Page 108
Australia Medical Devices Report Q2 2014
Signs Of Life Australia - Performance Of Manufacturing, Services And Construction Sector Indices
Source: BMI; Australian Industry Group
Externally, efforts by the Chinese authorities to stimulate their economy and the decision of the US Federal Reserve to postpone any reduction to its ongoing unconventional monetary stimulus have helped lift key commodity prices and import volumes, such as iron ore, from their earlier lows in June. Together with domestic factors, these trends suggest that economic growth could hold up until Q214, and as such, we have raised our 2014 forecast, expecting real GDP growth to come in at 2.0% versus our previous estimates of 1.8%. This upgrade, however, masks our downbeat medium-term outlook for the economy as risks of a sharp deflationary shock to the Australian economy continue to grow larger.
© Espicom Business Intelligence
Page 109
Australia Medical Devices Report Q2 2014
Households Driving Debt Demand Australia - Total Private Sector Credit Growth (% chg y-o-y) & Growth Contribution From Components (pp)
Source: BMI; Reserve Bank of Australia
Ongoing Misallocation Of Capital Increases Risks As we have highlighted before, Australia's high level of external portfolio debt makes its currency very vulnerable to external shocks. With much of this debt extended to the financial sector, the risks that a repricing of the creditworthiness of banks or a similar liquidity squeeze as seen in 2008-09 could have a significant impact on the Australian economy. Moreover, via the banks, much of this liquidity has continued to flow into the housing sector, even as households owe roughly two-thirds of the total private sector debt in the country that currently towers at 140.4% of GDP. In comparison, businesses have reined in their use of credit despite the Reserve Bank of Australia's (RBA) easing its cash rate, cutting 50 basis points (bps) to bring the cash rate to 2.50% as of end-October.
© Espicom Business Intelligence
Page 110
Australia Medical Devices Report Q2 2014
Divergent Performance Unlikely To Persist Australia - House Price Indices For Queensland, Sydney, Australia
Source: BMI; RP Data
Indeed, attribution analysis of the drivers of credit growth clearly shows the ongoing misallocation of capital within the Australia, where ever more liquidity is headed to the housing sector, driving up property prices. Although some observers have accredited the uneven house price growth in the different states to differing underlying supply and demand dynamics in each area, we believe that these factors are unlikely to hold up in the face of a weaker job market. We believe that demand for goods and services remain uncertain at best, and see room for input prices such as wages to head lower. Growth from the mining sector is likely to slow further as demand for resources tapers. As such, until businesses restart spending and hiring, we believe the current uptick in activity will be limited, and hence, we maintain that the current trajectory of house prices is built on shaky fundamentals and could correct should renewed worries of the economy come to the fore and/or the financial sector find itself in another funding squeeze.
Increasing Pressures For Greater Macro-Prudential Rules Given the disproportionate flows into the housing sector, we believe that there the RBA, in conjunction with the banking regulator, the Australian Prudential Regulatory Authority (APRA), will find it increasingly attractive to put in place macro-prudential rules and other limits to rein lending to the household sector. Indeed, as banks were announcing their quarterly earnings result at the end of October, the APRA warned the sector of handing out excessive dividends to shareholders, and further cautioned that it was looking at implementing a higher capital charge on domestic systematically important banks (DSIB).
© Espicom Business Intelligence
Page 111
Australia Medical Devices Report Q2 2014
Private Consumption: The mining sector slowdown is expected to weigh on overall economic growth in the country, which is likely to affect wage growth as well. Given that many businesses have adopted the wait and see approach to hiring and spending, we believe that softness in the job market is likely to persist, and weigh on household consumption. As such, we maintain our outlook for private consumption growth to slow from 3.7% in 2012 to 1.5% and 1.3% in 2013 and 2014 respectively.
Private Investment: We have long implied a slow growth in investment as business credit has remained slow, despite the aggressive rate cuts by the central bank this year, and cost cuts within industries like the auto manufacturers suggest that investment could remain weak. The tapering off of iron ore and coal investments will similarly weigh on fixed capital investment growth. That said, we have upgraded our forecast 2014 slightly to better reflect the accelerating pace of construction for several gas terminals, expecting fixed-capital formation to grow at 2.0% in 2014 versus 1.2% previously.
Public Consumption And Investment: The new coalition government remains keen on pushing through its infrastructure and spending plans even though this is likely to raise the amount of public debt. While we maintain our outlook for the government expenditure on goods and services (not infrastructure) to growth by 2.0% in 2013 and 2014, we highlight that upside risks could increase in 2014 should the economy falter once again.
Net Exports: While the stimulus in China helped lift its domestic steel industry and, correspondingly, Australian iron ore exports from contractionary territory in the near term, we believe that the ongoing rebalancing within the Chinese economy will lead to a gradual decline in demand for certain Australian commodity exports. Moreover, ongoing construction of gas terminals in Australia is likely to put upward pressure on import growth over 2014-2017. As such, we believe that the country's trade balance will see a much more gradual improvement in 2014, and we forecast real export and import growth to rise to 4.5% and 2.7% respectively, compared to estimates of 2.3% and 1.4% in 2013.
© Espicom Business Intelligence
Page 112
Australia Medical Devices Report Q2 2014
Table: Australia - Economic Activity
2008
2009
2010
2011e
2012e
2013f
2014f
2015f
2016f
2017f
Nominal GDP, AUDbn 1,3
1,233.40 1,254.60 1,356.00 1,444.60 1,488.30 1,559.50 1,623.70 1,703.80 1,798.50 1,902.40
Nominal GDP, US$bn 1,3
1,031.30
Real GDP growth, % change y-o-y 2,3
979.9 1,244.80 1,491.10 1,541.30 1,535.60 1,420.70 1,363.00 1,375.80 1,426.80
2.8
1.1
2.9
2.2
3.7
2.4
2
2.5
2.8
3
48,120
44,870
56,895
66,785
68,351
67,434
61,782
58,702
58,686
60,267
Population, mn 4
21.6
22
22.4
22.7
23.1
23.3
23.6
23.9
24.2
24.5
Industrial production index, % y-o-y, ave 3
2.3
-0.1
3.9
-0.6
3.6
2.5
1.2
1.6
2.1
2
Unemployment, % of labour force, eop 3
4.6
5.5
4.9
5.2
5.4
6
6.6
6.1
5.7
5.5
GDP per capita, US$ 1,3
Notes: e BMI estimates. f BMI forecasts. 1 Calendar Years; 2 Calendar Years, Base Year = FY2008/09 (July-June). Sources: 3 ABS/BMI calculation; 4 World Bank/UN/BMI.
© Espicom Business Intelligence
Page 113
Australia Medical Devices Report Q2 2014
Industry Risk Reward Ratings Australia is the most attractive market in the Asia Pacific region for commercialising a medical device, according to BMI Espicom's Medical Device Risk/Reward Ratings (RRRs). The country's overall score for Q214 is 75.8 out of 100, which is marginally ahead of Japan (75.7).
REWARDS
Industry Rewards: The Australian market ranks amongst the largest in the world, with per capita spending on a par with several developed West European markets. Manufacturing tends to be focused on niche areas, so demand is largely met by imports. Australia's score of 69.8 out of 100 for this component of the RRRs is only surpassed by China (79.3) and South Korea (74.1) in the context of the Asia Pacific region).
Country Rewards: Although the new government is looking to cut public spending, the existing commitment to the National Health Reform Plan will see significant investment in the hospital sector up to 2019-2020. This, coupled with a rising population and an aging demographic, presents Australia as a potentially rewarding market. Australia's score of 79.0 out of 100 for Country Rewards is the fourth highest in the region, behind Japan (81.0), Hong Kong (80.5) and Singapore (80.0).
RISKS
Industry Risks: The incoming conservative Liberal-National coalition is intent on cutting public expenditure and this is currently the main threat to the country's medical device industry. Australia's score of 80.0 out of 100 is one of the highest in the Asia Pacific region, on a par with Singapore and Taiwan, but less than Japan (86.7) and New Zealand (83.3).
Country Risks: Australia's medical device market is vulnerable on two fronts: the installation of a government committed to cutting public spending and a weakening economy. Although one of the world's larger markets, growth is forecast to be negligible over the next five years. Australia's score of 83.7 out of 100 for Country Risks is the second highest in the Asia Pacific region, behind New Zealand (88.2).
© Espicom Business Intelligence
Page 114
Australia Medical Devices Report Q2 2014
Table: Asia Pacific Medical Device Risk/Reward Ratings, Q214
Industry Rewards
Country Rewards
REWARDS
Industry Risks
Country Risks
RISKS
MEDICAL DEVICE RISK/ REWARD RATING
Australia
69.8
79.0
72.8
80.0
83.7
81.5
75.8
Japan
67.7
81.0
72.0
86.7
76.5
82.6
75.7
South Korea
74.1
70.5
72.9
73.3
70.6
72.2
72.7
New Zealand
57.3
75.2
63.1
83.3
88.2
85.3
70.9
Singapore
57.7
80.0
64.9
80.0
80.5
80.2
70.3
Taiwan
65.5
66.7
65.8
80.0
64.3
73.7
68.6
China
79.3
53.8
71.1
60.0
59.6
59.8
67.1
Malaysia
67.5
58.6
64.6
70.0
70.8
70.3
66.6
Hong Kong
47.3
80.5
58.0
76.7
80.4
78.2
65.1
Thailand
62.7
43.8
56.6
66.7
63.6
65.5
59.7
India
63.6
41.0
56.3
50.0
50.8
50.3
54.2
Indonesia
55.0
48.6
52.9
50.0
46.2
48.5
51.4
Vietnam
52.5
42.4
49.2
40.0
47.4
43.0
47.0
Philippines
36.1
43.3
38.5
56.7
48.0
53.2
43.6
Pakistan
36.6
43.3
38.8
33.3
42.7
37.1
38.2
Bangladesh
25.2
37.1
29.1
33.3
36.9
34.8
31.1
Regional average
57.4
59.0
57.9
63.8
63.1
63.5
59.9
Source: BMI Espicom
© Espicom Business Intelligence
Page 115
Australia Medical Devices Report Q2 2014
Market Overview Medical Device Market Overview Medical Market Analysis
Overview ■
Among top 15 largest medical markets in the world, behind only China, Japan and South Korea in the Asia-Pacific region
■
A strong steady economy with per capita GDP among top five highest worldwide
■
Health expenditure is strong, both as a percentage of GDP and in per capita terms
■
Much of spending is in the public sector; private spending equal to one third of the total
■
Domestic manufacturers tend to be small and focused on a few specialty areas
■
Therefore market is heavily reliant on imports, with the USA the major supplier
Australia represents a large and highly advanced medical device market. The country has a large number of medical device manufacturers, although these tend to be relatively small and concentrate on niche markets. Australia has a range of modern and sophisticated health facilities, and despite its geographical remoteness, represents a healthy market for imported medical equipment and supplies; over 90% of medical products are imported, principally from the USA. The position of the USA in the market was further strengthened with the free trade agreement approved in 2005.
Australia has a well-developed public hospital sector and a historically-strong private hospital sector. Issues of funding remain a key political concern but, in general, Australian hospitals are among the best in the Asia/Pacific region. These factors mean that the market should continue to be receptive to new technologies in the future.
The majority of public hospital purchasing is conducted along state lines, with purchasing procedures varying from state to state. In New South Wales and Queensland, purchasing is generally conducted centrally, while in other states, hospitals are allowed more freedom, purchasing medical equipment within a given budget.
© Espicom Business Intelligence
Page 116
Australia Medical Devices Report Q2 2014
Table: Medical Device Market, Key Ratios
2013 Market size, US$mn
4,814.3
As % of total health expenditure
3.6
As % of GDP
0.3
As % of world market
1.5
Supplied by imports (%) Projected CAGR (%)
Per capita (US$)
95.6 0.1
207.4
Source: BMI Espicom
The Market In 2013
The Australian market for medical equipment and supplies was estimated at US$4,814.3mn in 2013, equal to US$193.3 per capita. Australia accounts for around 1.5% of the total world market.
The market is over 90% dependent on imports, although there is a highly skilled domestic industry which supplies many basic hospital requirements. Advanced technologies, however, are almost always imported. The MTAA (Medical Technology Association of Australia) has estimated that the public sector accounts for around 55% of the total market.
© Espicom Business Intelligence
Page 117
Australia Medical Devices Report Q2 2014
Table: Medical Device Market By Product Area
2013 US$mn
2013
2013
As % of Total Per Capita (US$) Market
2013
2013
Local Currency Per Capita (mn) (Local Currency)
Consumables
646.8
13.4
27.9
647
27.9
Diagnostic Imaging
735.2
15.3
31.7
735.4
31.7
Dental products
247.1
5.1
10.6
247.2
10.6
Orthopaedics & prosthetics
864.7
18
37.2
865
37.3
Patient aids
792.1
16.5
34.1
792.4
34.1
Others
1,528.30
31.7
65.8
1,528.80
65.9
Total
4,814.30
100
207.4
4,815.70
207.5
Source: BMI Espicom
Medical Device Market By Product Area % Distribution
Source: BMI Espicom
© Espicom Business Intelligence
Page 118
Australia Medical Devices Report Q2 2014
Healthcare Overview Health Status The Australian population has increased over the last decade to reach an estimated 23.3mn in 2013. The birth rate of 13.1 per 1,000 population is more than double the death rate.
In 2013, 14.3% of the population were aged 65 and over, a figure which is increasing steadily year on year. Life expectancy is amongst the highest in the world, at an estimated 80.0 years for males and 84.5 years for females in 2013.
The infant mortality rate fell by a CAGR of 2.8% between 2008 and 2013, reaching 3.6 per 1,000 live births in 2013.
Healthcare System Organisation
The Australian healthcare system is complex, operating at three levels; Commonwealth (national) level, State/Territory level and local government level.
Commonwealth Level
The Commonwealth government is responsible for the overall co-ordination of the public health sector, principally through the Medicare system. It provides the funding for an estimated 67% of all health spending, through grants to States and Territories, for the running of public hospitals. Funding is also provided for specific programmes, such as mental health, aerial medical, aboriginal health and blood transfusion services. The Pharmaceutical Benefits Scheme is also run at Commonwealth level.
State/Territory & Local Governments
The main responsibility for the running of healthcare services rests with the State and Territory governments, either directly or via local authorities or semi-governmental bodies. Included within their remit are: ■
Management and supervision of public hospitals and nursing homes,
■
Community care, of children, the elderly and the mentally ill,
© Espicom Business Intelligence
Page 119
Australia Medical Devices Report Q2 2014
■
Dental health,
■
Health and safety in the workplace.
The federal nature of the system allows regional flexibility, but makes the co-ordination of any national policy or reform difficult. A major example is the failure at local level to implement Aboriginal health programmes. There are also concerns over cost-shifting from one sector to another.
National Policies
In August 2011, after months of negotiation, the Commonwealth Government signed an agreement with all States and Territories to formalise the National Health Reform plan. Designed to improve funding to hospitals and to reduce patient waiting times, the plan will see the Commonwealth Government invest at least A$16.4bn (US$16.0bn) in additional funding for public hospitals over the period 2014-15 to 2019-20. The Commonwealth Government will match 45% of efficient growth funding from July 2014, and 50% of efficient growth from July 2017.
As part of the reform, a new Independent Hospital Pricing Authority will set the "national efficient price" for public hospital services and will develop a national activity based funding system.
A single National Health Funding Pool will be established to improve the transparency of public hospital funding. The administrator of the Pool will report on Commonwealth, State and Territory funding flowing through the pool and the services delivered by this funding. This will ensure that all hospitals are funded under the same arrangements, allowing all Australians to clearly see how their taxes are being spent.
Local Hospital Networks are being established by State and Territory governments, and will ensure decisions about hospital management are devolved to the local level. In addition, local clinicians will be engaged to advise about patient pathways which best meet the needs of the local community.
The National Health Performance Authority will deliver further transparency on the performance of health and hospital services, by developing and publishing Hospital Performance Reports and Healthy Communities Reports. These reports will help to identify high-performing organisations, and will highlight on areas for further development and investment in the future.
The Commonwealth Government will also invest A$1.8bn to establish new targets for emergency departments and elective surgery, with funding dedicated to help states and Territories reach these targets
© Espicom Business Intelligence
Page 120
Australia Medical Devices Report Q2 2014
and reward them when they do. An additional investment of A$1.6bn is being provided to fully fund the capital and recurrent costs of 1,316 new sub-acute beds or equivalent services.
The targets to be implemented are: a four-hour target for emergency departments with the aim that 90% of patients across all age categories are seen, treated, admitted or discharged within four hours; and a 100% elective surgery target aimed at ensuring all patients waiting for elective surgery are treated within clinically recommended times. The emergency department target will be implemented over four years from 2012, and the elective surgery target will be implemented over five years from 2012.
Healthcare Funding
Social Security
Medicare
Medicare was introduced in 1984, and is the principal source of funding for hospital treatment. It is a special health fund administered by the Commonwealth government. The scheme sets out a schedule (the Medicare Benefits Schedule) which lists fees for different medical services. This schedule is under constant review and is updated twice yearly. Inpatients in public hospitals can receive Medicare benefits at 85% of the relevant Schedule fee. For low income groups, benefits are paid at 100%. Private patients choosing treatment in public hospitals receive benefits at 75%. Medicare was originally funded by a 1% levy on taxable income, but this amount has been raised several times since.
Health Expenditure
In 2013, Espicom estimates Australian healthcare expenditure at US$138.1bn, equal to US$5,917 per capita. Australia has long had a relatively high level of health spending and in 2013 it stood at 9.1% of GDP, having grown at a CAGR of 0.6% over the 2008-2013 period. Spending in US$ per capita terms has doubled since 2003.
Almost one third of spending is private, which is funded through a combination of private insurance and out-of-pocket payments.
© Espicom Business Intelligence
Page 121
Australia Medical Devices Report Q2 2014
Healthcare Resources Infrastructure
Australia had 1,363 hospitals in 2013, which were fairly evenly split between the public sector (753) and the private sector (610). The number of beds totalled 88,163 in 2013, equal to 3.8 beds per thousand population. This bed-to-population ratio is above the average for the Asia Pacific region, although significantly lower than the rates in prevalent in Japan, New Zealand and South Korea for example.
Medical Device Technology
In 2012, Australia made some notable investments in medical technology, more than doubling the number of MRI units installed and increasing the number of CT scanners by 16% and the number of PET scanners by 31%.
In 2012, there were 341 MRI units in operation, equating to 15.0 per mn population. This rate stands at one of the world's highest, ahead of the USA and most West European nations. The increase in the number of CT scanners in 2012 cemented Australia's position as having the second highest concentration in the world at 50.6 per mn, behind Japan.
The addition of 10 PET scanners in 2012 took Australia's installed base to 42, a rate of 1.9 per million which is similar to Australia and Ireland, but well below the USA, Switzerland and South Korea.
While the number of most types of imaging equipment has been increasing, the number of mammography units has fallen in each year since 2009. In 2012, there were 517 mammography units in Australia, a rate of 22.8 per mn population, a rate that compares well with most European countries.
© Espicom Business Intelligence
Page 122
Australia Medical Devices Report Q2 2014
Table: Diagnostic Imaging Technology By Type, 2006-2012
2006
2007
2008
2009
2010
2011
2012
CAGR
MRI units
100
108
120
124
125
127
341
22.69%
Gamma cameras
n/a
n/a
419
441
455
452
456
2.14%
PET scanners
n/a
n/a
15
24
31
32
42
29.36%
1160
n/a
n/a
849
949
990
1,148
-0.17%
DSA units
n/a
n/a
311
324
355
362
376
4.86%
Mammographs
506
508
500
534
533
520
517
0.36%
Radiation therapy equipment
127
n/a
168
193
205
205
221
9.67%
DIAGNOSTIC IMAGING
ELECTRODIAGNOSTIC APPARATUS
RADIATION APPARATUS
CT scanners
Source: BMI Espicom using OECD data
Table: Diagnostic Imaging Technology Per Million Population By Type, 2006-2012
2006
2007
2008
2009
2010
2011
2012
MRI units
4.8
5.1
5.6
5.7
5.7
5.7
15.0
Gamma cameras
n/a
n/a
19.6
20.3
20.6
20.3
20.1
PET scanners
n/a
n/a
0.7
1.1
1.4
1.4
1.9
DIAGNOSTIC IMAGING
ELECTRODIAGNOSTIC APPARATUS
RADIATION APPARATUS
© Espicom Business Intelligence
Page 123
Australia Medical Devices Report Q2 2014
Diagnostic Imaging Technology Per Million Population By Type, 2006-2012 - Continued
2006
2007
2008
2009
2010
2011
2012
56.0
n/a
n/a
39.0
43.0
44.4
50.6
n/a
n/a
14.5
14.9
16.1
16.2
16.6
24.5
24.2
23.4
24.5
24.2
23.3
22.8
6.1
n/a
7.9
8.7
9.3
9.2
9.7
CT scanners DSA units Mammographs Radiation therapy equipment
Source: BMI Espicom using OECD data
Healthcare Activity Inpatient admissions have grown at a CAGR of 2.9% since 2008, reaching almost 4.0mn in 2013, equal to 169.9 admissions per thousand population, which is one of the highest rates in Asia, though well behind Thailand, Hong Kong, South Korea and New Zealand. The number of surgical procedures has grown at a slightly higher CAGR of 3.3%, reaching an estimated 2.5mn in 2013.
Australia's total of 54.8mn outpatient visits in 2013 equates to 2,348 per thousand population, which is below the average for the Asia-Pacific region.
Healthcare Personnel The number of physicians in Australia is estimated to exceed 79,000, equal to a rate of 3.4 per thousand population in 2013. This is the highest rate in the Asia Pacific region.
The situation is the same for nurses, with Australia's rate of 12.6 per thousand population in 2013 being the highest in the Asia Pacific region, as well as being as one of the highest in the world, just behind Germany.
Key Data Table: Key Data, 2008-2013
Economic Data
GDP (US$ bn) Real growth (%) Per capita (US$)
© Espicom Business Intelligence
2008
2009
2010
2011
2012
2013 CAGR
1,031.3
980.0
1,244.8
1,491.1
1,541.3
1,509.6
7.9
2.8
1.1
2.9
2.2
3.7
2.4
n/a
48,121.2 44,871.6 56,895.2 66,786.2 66,073.9 62,054.6
5.2
Page 124
Australia Medical Devices Report Q2 2014
Key Data, 2008-2013 - Continued
Economic Data
2008
2009
2010
2011
2012
2013 CAGR
Health Expenditure (US$ bn)
91.8
91.3
116.2
134.3
140.5
138.1
8.5
4,240.4
4,141.9
5,187.3
5,907.6
6,096.9
5,917.1
6.9
Health expenditure % of GDP
8.9
9.3
9.3
9.0
9.1
9.1
0.6
Public % of health expenditure
67.9
68.5
68.5
68.5
68.1
67.8
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Private % of health expenditure
32.1
31.5
31.5
31.5
31.9
32.2
n/a
Out of pocket % of private
56.4
59.0
59.4
63.0
n/a
n/a
n/a
Private insurance % of private
25.1
24.9
24.9
24.9
n/a
n/a
n/a
1.2
1.3
1.1
1.0
1.0
1.0
-2.9
Population Data
2008
2009
2010
2011
2012
2013 CAGR
Population (mn)
21.6
22.0
22.4
22.7
23.1
23.3
1.5
1.9
1.8
1.7
1.5
1.4
1.3
n/a
% of population aged 65+
13.1
13.3
13.4
13.7
14.0
14.3
1.7
Demographic Data
2008
2009
2010
2011
2012
2013 CAGR
Live Births (000s)
296.6
295.7
297.9
301.6
303.3
305.0
0.6
Per 000 population
13.7
13.4
13.3
13.3
13.2
13.1
-0.9
143.9
140.8
143.5
146.9
148.8
150.6
0.9
Per 000 population
6.7
6.4
6.4
6.5
6.5
6.5
-0.6
Infant mortality/000 live births
4.1
4.3
4.1
3.8
3.7
3.6
-2.8
Male life expectancy at birth
79.2
79.3
79.5
79.7
79.9
80.0
0.2
Female life expectancy at birth
83.7
83.9
84.0
84.2
84.3
84.5
0.2
Healthcare Data
2008
2009
2010
2011
2012
2013 CAGR
Per capita (US$)
Social security % of public
Exchange rate, national currency per US$
Population growth (%)
Deaths (000s)
© Espicom Business Intelligence
Page 125
Australia Medical Devices Report Q2 2014
Key Data, 2008-2013 - Continued
Economic Data
2008
2009
2010
2011
2012
2013 CAGR
Hospitals
1,314
1,320
1,334
1,345
1,354
1,363
0.7
Public
762
756
753
752
753
753
-0.2
Private
552
564
581
593
601
610
2.0
83,396
83,702
84,648
86,123
87,205
88,163
1.1
3.9
3.8
3.8
3.8
3.8
3.8
-0.4
3,445.2
3,503.9
3,613.4
3,732.1
3,877.3
3,965.4
2.9
159.2
159.0
161.3
164.1
168.2
169.9
1.3
6.2
6.0
5.9
5.8
5.8
5.7
-1.5
2,151.7
2,221.4
2,304.9
2,358.8
2,443.9
2,525.3
3.3
49,986.5 50,681.0 51,548.0 52,379.0 53,574.5 54,800.5
1.9
Beds Per 000 population
Inpatient admissions (000s) Per 000 population Average length of stay (days) Surgical procedures (hosp.-000s)
Outpatient visits (hosp.-000s) Per 000 population
2,309.4
2,299.8
2,300.8
2,303.3
2,324.2
2,347.7
0.3
Physicians (employed)
68,689
72,739
74,342
75,980
77,654
79,366
2.9
3.2
3.3
3.3
3.3
3.4
3.4
1.4
272,741
276,751
280,820
284,949
289,138
293,389
1.5
12.6
12.6
12.5
12.5
12.5
12.6
-0.1
10,923
11,192
11,467
11,750
12,039
12,336
2.5
0.5
0.5
0.5
0.5
0.5
0.5
0.9
16,041
16,332
16,604
16,853
17,083
17,299
1.5
0.7
0.7
0.7
0.7
0.7
0.7
0.0
Per 000 population
Nurses (employed) Per 000 population
Dentists Per 000 population
Pharmacists Per 000 population
Source: BMI Espicom
© Espicom Business Intelligence
Page 126
Australia Medical Devices Report Q2 2014
Industry Trends & Developments Industry Trends & Developments Imports Grow By Just Over 1% In Last Quarter
The latest Australian monthly trade data reveals that medical device imports grew by 1.2% to US $1,188.4mn over the three months to October 2013, compared with the corresponding period in 2012. Growth was achieved in the patient aids and orthopaedics & prosthetics sectors which increased by 15.1% and 4.1% respectively. All other sectors experienced a drop in imports over the quarter. The sharpest decline was in the demand for diagnostic imaging products which fell by 7.9%, followed by dental products which decreased by 6.9%.
Medical device imports increased by 2.2% in US dollar terms in the 12 months to October 2013, taking the running annual total to US$4,571.6mn. The highest growth was recorded in the patient aids sector, which increased by 9.0% over the 12 month period to US$749.0mn. Imports of orthopaedics & prosthetics and consumables also increased - by 6.1% and 3.3% respectively. The largest market segment, other medical devices, showed a marginal 0.5% increase to US$1,407.4mn.
Limited Growth In Exports Over Last Quarter
The latest Australian monthly trade data reveals that medical device exports exhibited a slight improvement during the three months to October 2013, rising by 1.5% to US$476.9mn over the same quarter in 2012. Double digit growth was achieved in the diagnostic imaging and other medical devices segments, but exports decreased in all other areas. The largest segment, patient aids, fell by 0.1% to US$292.3mn. The heaviest fall was reported in the dental products segment which declined by 23.0% to US$14.4mn.
Medical device exports showed a modest 1.7% increase to US$1,715.6mn in the 12 months to October 2013, when compared with the corresponding period to October 2012. The greatest movement occurred in the other medical devices segment, which increased by 17.2% to total US$406.2mn. The largest segment, patient aids, declined by 1.1% to US$1,025.5mn.
© Espicom Business Intelligence
Page 127
Australia Medical Devices Report Q2 2014
Medical Device Market Growth Set For Sluggish Growth
The Australian market for medical equipment and supplies is estimated at US$4,814.3mn in 2013, equal to US$193.3 per capita. After a phase of strong growth since 2008, a CAGR for 2013-2018 of 0.1% is projected to edge the market to US$4,836.5mn by 2018, equal to US$196 per capita. Australia is expected to be amongst the top 20 largest medical device markets in the world by 2018.
Government Allocates A$559mn For Medical Research
In October 2013, the Prime Minister, Tony Abbott, announced funding of A$559.1mn to Australian health and medical researchers to generate new health discoveries across Australia.
The new funding will support 963 grants across three National Health and Medical Research Council (NHMRC) research support schemes and five fellowship schemes. The importance of tackling national health priorities to researchers is reflected in the funding support to research in these areas. As an example, A$21.7mn has been committed to dementia research, while A$31.8mn continues the NHMRC's commitment to research to improve Aboriginal and Torres Strait Islander health.
Victoria will receive the highest amount of funding, with A$236.4mn allocated for 414 grants. The University of Melbourne is the research institution receiving the greatest amount of funding, with A $80.1mn earmarked for 145 grants.
NSW Medical Devices Fund Announces Grants
In July 2013, the New South Wales Minister for Health and Minister for Medical Research presented grants totalling over A$10.3mn to five organisations in the inaugural round of the NSW Government's Medical Devices Fund.
The five grant recipients were chosen from a shortlist of 13, which was drawn from 147 applications. The five recipients are: ■
Elastagen: for pioneering elastatherapy (using human protein elastin to naturally repair the skin, particularly for severe burns).
■
Endoluminal: for developing a breakthrough technology for the treatment of failing heart valves.
■
HearWorks: for HearLab, the world's first fully-automated test for hearing. It attaches to a laptop and can be used in any clinic to conduct complex electrophysiology for the assessment of hearing.
© Espicom Business Intelligence
Page 128
Australia Medical Devices Report Q2 2014
■
MobiLife: for MobiDRIP, an innovative, portable intravenous (IV) pump to allow patients to be treated at home.
■
Saluda Medical: for developing world-first technology for an implantable device, which supplies constant pain relief to people suffering chronic neuropathic pain.
The New South Wales Medical Devices Fund has been established to help encourage and support investment in the development and commercialisation of medical devices and related technologies in New South Wales.
Central Government Budget Reveals Increased Investment The Australian Government announced its 2013-2014 budget on 14th May 2013 which confirmed its ongoing commitment to investment in healthcare. Funding for public hospitals is set to reach record levels, with a budget of A$14.9bn (US$14.9bn), an increase of A$871mn over the previous year.
Cancer care received a boost with an extra A$226.4mn to be provided over four years under its World Cancer Care Package. Within this figure, A$55.7mn will go towards an expanded BreastScreen Australia programme, A$18.5mn will be spent on a new Prostate Cancer Research Institute and A$29.6mn over two years will go to help with the dispensing of chemotherapy medicines.
Australia, Brazil, Canada And The USA Plan Shared Medical Device Audit Programme
The medical device regulatory agencies of Australia, Brazil, Canada and the US have signed a statement of co-operation to develop a single audit programme for medical devices.
The US Food and Drug Administration (FDA), Australian Therapeutic Foods Administration (TGA), ANVISA of Brazil and Health Canada plan to make their respective quality management system auditing processes more efficient and less burdensome by establishing the Medical Device Single Audit Program (MDSAP). Upon implementation of the MDSAP programme, the audit of a medical device manufacturer's quality system in any one of the four participating countries will meet the regulatory requirements of each of the four countries
Among the MSDAP's stated objectives are promoting work-sharing arrangements and mutual acceptance among participating regulators to allow more efficient and flexible use of resources among the FDA, Health Canada, ANVISA and TGA regarding medical device quality system audits; standardising participants' market oversight practices regarding third-party auditing entities; and leveraging existing conformity assessment structures when appropriate.
© Espicom Business Intelligence
Page 129
Australia Medical Devices Report Q2 2014
New Royal Adelaide Hospital
Heralded as the future centrepiece of South Australia's A$2.2bn (US$2.3bn) Health Care Plan 2007-2016, the construction of the new Royal Adelaide Hospital started in September 2011 with completion scheduled in 2016. The new hospital is expected to receive more than 80,000 patient admissions per year. It will have a capacity of 800 beds (700 multi-day beds and 100 same-day beds). All overnight stay beds will be singleroom. Specialty care services at the proposed hospital will include trauma, renal transplantation, major burns and spinal injury care, in addition to an ambulatory care centre, operating theatre suite and all necessary clinical and non-clinical support services.
New Perth Children's Hospital
Work started in January 2012 on the construction of a new children's hospital in Perth which will replace the original Princess Margaret Hospital for Children (PMHM), at a total cost of A$1.2bn (US$1.3bn). Facilities will include a bed capacity of 274 beds and one of Western Australia's only paediatric trauma centres. The hospital will also offer double the number of surgical theatres, with inpatient and outpatient care, as well as ambulatory services. Construction is due to be completed in 2015.
Sydney Teaching Hospital Redevelopment
The Royal North Shore Hospital, one of Sydney's leading teaching hospitals, has been undergoing a A $1.1bn (US$1.1bn) redevelopment programme. Under the programme, a range of outdated buildings on the site are being transformed into new purpose-built facilities. The new developments include 18 new operating theatres and a 58-bed intensive care unit.
The redevelopment scheme will finish with the completion of a new A$153mn (US$153mn) Clinical Services Building, scheduled to open in late 2014, which will contain a new burns unit, women's and children's health and mental health units.
Other developments under the programme have included a new Acute Services Building which was opened to patients in December 2012.
Sydney Children's Hospital Wing Opened
A new A$27.8mn (US$27.8mn) clinical services wing was opened at Sydney Children's Hospital in July 2013. The new five-level Ainsworth Building contains:
© Espicom Business Intelligence
Page 130
Australia Medical Devices Report Q2 2014
■
A 28-bed short-stay surgical unit;
■
An eight-bed purpose-built child and adolescent mental health unit;
■
A comprehensive rehabilitation centre;
■
A world-class respiratory laboratory, which includes the only infant lung function laboratory in Sydney.
■
Ronald McDonald House Charities Family Centre for parents and carers;
■
A child protection unit;
■
New clinical office space for health care professionals from a range of disciplines.
The NSW Government contributed almost A$12.3mn (US$12.3mn) to construct the new wing. The Sydney Children's Hospital Foundation pledged A$15mn (US$15mn), with A$500,000 (US$500,000) from the Motor Accidents Authority for the rehabilitation centre.
Sydney Children's Hospital cares for more than 39,000 children each year. It provides comprehensive a range of services in paediatric and adolescent medicine and surgery, treating children with conditions including cancer, trauma, HIV/AIDS, congenital abnormalities, disabilities, heart disease and respiratory disorders.
© Espicom Business Intelligence
Page 131
Australia Medical Devices Report Q2 2014
Regulatory Development Medical Device Regulations Competent Authority Medical products are regulated in Australia by the Therapeutic Goods Administration (TGA). The TGA is part of the Department of Health & Ageing. Medical devices are the responsibility of the Office of Devices, Blood and Tissues (ODBT), within the TGA.
Regulations Australia introduced a new set of medical device regulations in October 2002. The system used prior to this dated to the Therapeutic Goods Act, 1989, and differed markedly from the international norm. It did not divide devices into Classes, but instead divided all devices into one of two categories; Registerable or Listable. Registerable devices were deemed to be high-risk. They only comprised around 5% of all devices on the market. All devices had to be placed on the Australian Therapeutic Goods Register (ARTG), but only Registerable devices generally had to undergo a detailed product evaluation.
Reform of the 1989 Therapeutic Goods Act was first proposed in 1996 report by the Australian Industry Commission. The report highlighted the following problems:
The existing legislation was poor at dealing with technological change, since it dealt with devices product to product, according to specified groupings. This was considered a major shortcoming in such a rapidly evolving industry.
Many low risk products were unnecessarily included within the TGA's remit due to the nature of the legislation. Such goods are already covered adequately under the Trade Practices Act.
Certain standards were mandated by the current legislation, but a range of standards offering different routes to compliance was not. This was inflexible and increased industry costs.
The detailed requirements for devices in Australia 'differ markedly from those of its major trading partners', making trade more costly and onerous than it needed to be.
Conformance assessment of medical devices was not open for any form of competition; there was therefore little pressure on the TGA to improve both the speed and cost-effectiveness of the review process.
© Espicom Business Intelligence
Page 132
Australia Medical Devices Report Q2 2014
The government approved the new regulatory system in 1999. It is very much based on the EU MDDs, following the 1998 mutual recognition agreement. For the first time, a Class I, II, III risk based system will be introduced. Originally the new system was due to be operating in September 2000. However, it was delayed by a year, and came into effect on 4th October 2002. Since October 2002, all new devices have been regulated under the new system. Products already on the register were given until October 2007 to move to the new system.
Many devices classified 'exempt' from inclusion in the ARTG (such as non-powered hospital furniture & simple non-powered surgical instruments) are now classified in Class I, while some devices classified as 'listable' under the current system (such as thermometers & dressings) are also Class I devices. Other 'listable' devices (such as hearing aids & dental filling materials) become Class IIa devices. Higher-risk devices, including some classified 'listable' and most of those classified 'registerable' under the current system are now registered as Class IIb and III devices.
Changes introduced under the new system include: ■
Minimum requirements for exempt Class I devices. These may require inclusion on the ARTG, unlike prior to October 2002.
■
A more comprehensive pre-market assessment of new technologies, high-risk active devices and implantables. The 1989 system required only registerable devices to undergo extensive testing. The new system introduces some form of conformity assessment for all medical device classes. TGA testing may well be required in the case of the highest-risk products, but in practice the new regulations allow for EUapproved Notified Bodies to be used when submitting evidence of conformity assessment.
■
An extension of quality systems requirements to more devices.
■
A greater reliance on international standards, such as EN 46000 or ISO 13485/88. Similarly to the USA system, compliance with these standards will be mandatory.
■
Better reporting by sponsors of device-related problems. A mandatory adverse event reporting system for all device classes ('Vigilance System') will be introduced. Adverse events must be reported by the manufacturer within 10 days, and within 30 days for a near adverse event. These are defined as under the EU directives.
The introduction of a tracking system for high risk implantables, for which there was previously no provision. Manufacturers will be responsible for tracking devices such as active implantable cardiac devices, prosthetic heart valves, intravascular stents, annuloplasty rings, silicone gel prostheses, hip/knee prostheses, and implantable devices of biological origin.
The TGA keeps a number of detailed guidance documents relating to the new regulations on its web site, at:
http://www.tga.gov.au/devices/devices.htm
© Espicom Business Intelligence
Page 133
Australia Medical Devices Report Q2 2014
Australia New Zealand Therapeutic Products Authority Overview
In December 2003, the Australian and New Zealand governments signed a treaty to form a single therapeutic agency for the regulation of therapeutic products, including medical devices, OTC, prescription and complementary medicines. This was to be named the Australia New Zealand Therapeutic Products Authority (ANZTPA).
The bi-national agency was to replace the Australian Therapeutic Goods Administration (TGA) and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe). While the basic principles were easy to establish, the details of the proposed merger have proved complex, leading to more than one slip on the legislative timetable. Progress appeared to be made, however, with legislation being presented in New Zealand in December 2006, and in Australia in April 2007.
In June 2011, the Prime Ministers of Australia and New Zealand reaffirmed their commitment to the establishment of the Australia New Zealand Therapeutic Products Agency (ANZTPA) to administer a joint regulatory scheme for therapeutic products. This reaffirmation acknowledged that the New Zealand Government will introduce a separate scheme to regulate certain natural health products in the New Zealand market.
The Prime Ministers have agreed that a three stage approach over a period of up to five years will be adopted to progressively achieve this goal by mid-2016. The three stages involve the two countries' regulators, the TGA and Medsafe.
In December 2013, the TGA and Medsafe announced they completed a series of joint projects that promises to deliver improved access to information about therapeutic products in both countries, as well as enhanced cooperation between the regulators ahead of the proposed Australia New Zealand Therapeutic Products Agency (ANZTPA).
The TGA and Medsafe have now commenced a further programme of harmonisation work that will be undertaken over the next two and a half years, which includes 14 activities across six regulatory areas. This new phase of joint work will progressively increase aspects of regulatory alignment between TGA and Medsafe that will facilitate business planning and align aspects of regulatory practice for the transition to ANZTPA. It will involve consultation with stakeholders as these activities are progressed.
© Espicom Business Intelligence
Page 134
Australia Medical Devices Report Q2 2014
For medical devices, the targets would be: ■
The publication of guidance on the requirements for the submission and assessment of manufacturers' evidence on the TGA, Medsafe and ANZTPA websites, by December 2014.
■
To identify the extent of product overlap in the Australian & New Zealand markets for medical devices in Class III and Active Implantable Medical Devices and the impacts for transition, by February 2015.
Early Warning System For Product Safety Issues
In June 2013, the TGA and Medsafe developed an early warning system to communicate potential safety concerns with therapeutic products. This scheme will operate in parallel in Australia and New Zealand.
The TGA and Medsafe will apply the agreed communication process independently to potential safety concerns identified with therapeutic products through their existing therapeutic product vigilance processes. These communications will be country specific and may differ reflecting different legislative requirements, and different availability and/or usage of certain therapeutic products between Australia and New Zealand.
© Espicom Business Intelligence
Page 135
Australia Medical Devices Report Q2 2014
Competitive Landscape Domestic Medical Device Production Australia has a large number of small manufacturers, mostly making hospital consumables and supplies.. Production is generally high quality, but low tech; advanced products are almost always imported. The majority of production is consumed locally, although there are some exceptions; Cochlear and Resmed for example, export most of their output.
According to the MTAA (Medical Technology Association of Australia), the Australian industry includes over 500 medical technology companies with products listed on the Australian Register of Therapeutic Goods (ARTG). It employs around 19,000 people with turnover of around A$10.8bn in 2010-11, although this includes distribution activity.
MTAA
The Medical Technology Association of Australia (MTAA, formerly the Medical Industry Association of Australia, MIAA) is the country's leading medical device industry association. It was formed 25 years ago, as the Australian Medical Device and Diagnostics Association, taking its current name in March 2008. It has over 80 members, comprising local companies and multinational subsidiaries. Many do not manufacture locally, but concentrate on importing and distribution. The MTAA claims that its members account for over 90% of the value of non-pharmaceutical healthcare products distributed in Australia.
National Medical Device Manufacturers Advanced Surgical Design & Manufacture
Advanced Surgical Design & Manufacture (ASDM) manufactures a range of orthopaedic and spinal implants, as well as undertaking contract manufacturing of medical devices. The company reported an 18% increase in revenues to A$8.7mn (US$9.1mn) in fiscal 2012 (year ended June 2012). ASDM is based in St. Leonards, New South Wales.
In August 2013, ASDM announced the execution of a 12 month Transitional Services Agreement (TSA) with Orthofix Australia. Under the TSA, ASDM will provide distribution services as Orthofix Australia develops a direct sales force. As a result of the new arrangements, the existing spinal business held by ASDM has been acquired by Orthofix Australia.
© Espicom Business Intelligence
Page 136
Australia Medical Devices Report Q2 2014
Ansell
Ansell is a global manufacturer of protection wear including gloves and personal protection products such as condoms. Ansell's healthcare activities include the manufacture of examination gloves, surgical gloves and a range of surgical room safety devices. Ansell's Medical business unit achieved revenues of A $349.5mn (US$315.5mn) in fiscal 2013, a decrease of 1.9% on the 2012 figure. This represented 25.5% of group revenues. During fiscal 2013, Ansell continued to exit from the natural rubber latex (NRL) examination gloves sector. Synthetic surgical gloves sales volume rose by 16%, while surgical safety products grew by 11% in volume terms.
Ansell has been active in acquiring companies as part of an evident expansion programme.
In December 2012 it acquired companies in the US and Brazil: ■
Hércules Equipamentos de Protecao, a privately held Brazilian company located in São Paulo, with annual sales of approximately US$30mn. Hércules is a leading manufacturer of Personal Protective Equipment (PPE) in Brazil with approximately 350 employees. It has a plant located outside São Paulo and wide distribution network across Brazil.
■
Preferred Surgical Products, a privately held US product and technology company producing infection prevention products. The PSP range aims to improve infection control, protect the patient's skin and optimise room turnover time, while reducing total cost per procedure.
In September 2012, Ansell announced the settlement of its purchase of Comasec and its subsidiaries for EUR 101.5mn. Comasec is a privately owned French group with annual sales of around EUR 100mn, manufacturing operations in Portugal and Malaysia and over 1,200 employees globally. It is a leading player in the European Personal Protective Equipment (PPE) Glove Market, has a presence in North America and specialises in gloves for chemical protection, food handling, cut protection, mechanical protection, dry box and thermal protection. Major brands are Comasec, Marigold, and Marigold Industrial.
In May 2012, Ansell concluded the acquisition of Trelleborg's Protective Products (TPP) business for EUR 23.7mn. Ansell will operate the former Trelleborg business under the name Ansell Protective Solutions (APS), and as part of its Specialty Markets Global Business Unit.
© Espicom Business Intelligence
Page 137
Australia Medical Devices Report Q2 2014
Cochlear
Based in Lane Cove, New South Wales, Cochlear manufacturers cochlear implants. The company has manufacturing/R&D facilities in Australia and Belgium. The company's latest product is the Nucleus Freedom, launched in major markets in 2005. The company has around 1,655 employees.
The Nucleus Freedom cochlear implant system features both an internal component and an external speech processor. The Nucleus Freedom is designed to mimic functions of the human ear. The implant features the Contour Advance electrode, a self-curling electrode array that allows the electrodes to be placed close to the hearing nerve for targeted stimulation and increased power efficiency, while applying minimal pressure on the cochlear structures. According to Cochlear, the Contour Advance is the only electrode array designed to protect cochlear structures during surgery.
In July 2009, Cochlear began construction of a new A$128mn Global Headquarters and manufacturing and research facility on the Macquarie University Campus, North Ryde, Sydney. The first part was completed in October 2010. It forms part of a world-first hearing research, treatment and development precinct which will link over 2,000 professionals involved in the hearing industry across academia, government as well as rehabilitation and research.
In March 2005, Cochlear acquired Entific Medical systems for A$195.3mn. This represented the company's first major acquisition. Entific is a Swedish developer of the Baha system, an implant which allows hearing through bone conduction. In May 2006, Cochlear signed a major A$270mn six year contract to supply implants to children in Taiwan and China. The company anticipates that the majority of sales will take place towards the end of the contract term.
For fiscal year 2013 (ended June 2013), Cochlear reported sales of A$752.7mn (US$679.5mn), a reduction of 3.4% from the A$779.0mn recorded in 2012. After the sharp fall in net profit from A$180.1mn in 2011 to A$56.8mn in 2012, Cochlear was able to report a 133% rise to A$132.6mn in fiscal 2013. The company achieved record cochlear implant unit sales of 26,674 in 2013, a rise of 16%.
Sales in the Americas amounted to A$284.4mn, a fall of 4% compared with 2012. Sales in EMEA (Europe, Middle East and Africa) also fell, by 1% to A$283.0mn. For the second consecutive year, the Asia-Pacific region bucked the negative trend, with revenues rising by 20% to reach A$147.6mn. This result was supported by a Chinese tender sale of approximately 2,800 units.
© Espicom Business Intelligence
Page 138
Australia Medical Devices Report Q2 2014
Dynamic Hearing
Dynamic Hearing is based in Richmond, Victoria. It is a spin-off company from the Cooperative Research Centre (CRC) for Cochlear Implant and Hearing Aid Innovation, a body linked to the University of Melbourne. Dynamic Hearing has developed the ADRO software system for digital hearing aids, which aims to improve sound output quality. Companies using the technology include Intertron (Germany) and Gennum (Canada). In August 2006, Dynamic Hearing announced a new product in the US, the Freedom AD, in collaboration with America Hears.
In October 2005, Dynamic Hearing signed an exclusive multi-year licence agreement with the US-based House Ear Institute (HEI) to develop and commercialise its patented feedback cancellation technology for use in hearing aids and auditory implants.
Dynamic Hearing was acquired by Wolfson Microelectronics of the UK in 2011.
Elastagen
Elastagen is a Sydney based pioneer in technologies to repair and augment skin using Elastin, a naturally occurring protein that is responsible for the skin's elasticity and supple properties. In July 2013, Elastagen received funding from the New South Wales Medical Devices Fund for its pioneering elastatherapy (using human protein elastin to naturally repair the skin, particularly for severe burns).
Endoluminal
In July 2013, Endoluminal received funding from the New South Wales Medical Devices Fund for developing a breakthrough technology for the treatment of failing heart valves. Endoluminal was established in 2007 and is based in Eveleigh, NSW.
HearWorks
HEARworks Pty Ltd. manages the intellectual property and commercial activity of the HEARing Cooperative Research Centre (CRC), an international consortium of research, clinical and industry organisations, constituting five core and 21 support members. The CRC was funded in 2007 through Australia's Commonwealth Government Cooperative Research Centre programme. The HEARing CRC is investing AU$115mn over seven years into hearing healthcare research and utilisation.
© Espicom Business Intelligence
Page 139
Australia Medical Devices Report Q2 2014
In July 2013, HearWorks received funding from the New South Wales Medical Devices Fund for its development of the world's first fully-automated test for hearing. It attaches to a laptop and can be used in any clinic to conduct complex electrophysiology for the assessment of hearing.
mobiLIFE
Based in the Hunter Valley, NSW, Australia, mobiLIFE was started in 2002 as a joint venture to take ideas and concepts from the University of Newcastle into the medical device industry. The company draws upon a 50+ strong team of design and engineering project staff - based in Sydney, Chicago and in China (with associated manufacturing facilities).
In July 2013, mobiLIFE received funding from the New South Wales Medical Devices Fund for MobiDRIP, its innovative, portable intravenous (IV) pump to allow patients to be treated at home.
Saluda Medical
Saluda Medical has developed a versatile implant that both stimulates and senses nerve responses. The Implanted Neural Sensing & Stimulation product (INS2) is the platform for neurostimulation therapies. The initial target market for this product is Spinal Cord Stimulation (SCS) for the control of chronic back and lower limb pain. The implant is designed to nestle alongside the dorsal processes of the spine.
In July 2013, Saluda Medical received A$5mn in funding from the New South Wales Medical Devices Fund for developing world-first technology for an implantable device, which supplies constant pain relief to people suffering chronic neuropathic pain.
Multinational Medical Device Manufacturers Multinational Manufacturers
Baxter
Baxter manufactures renal and medication delivery products at its facility in Toongabbie, New South Wales.
© Espicom Business Intelligence
Page 140
Australia Medical Devices Report Q2 2014
CareFusion
CareFusion manufactures critical care technology products at its facility in Seven Hills, New South Wales.
Danaher
Danaher's Invetech subsidiary undertakes contract manufacturing of diagnostic instruments and medical devices at its facility in Mt. Waverley, Victoria.
Fresenius
Fresenius has a 5,350 square-metre manufacturing plant and warehouse for haemodialysis concentrate in Smithfield, New South Wales. FMS Australia Pty Ltd. had 364 employees at the end of 2012 and achieved revenues of €143.2mn.
Paul Hartmann
Hartmann acquired Unomedical's custom procedure packs business in 2010 and continues to manufacture these products at the former Unomedical facility in Mona Vale, New South Wales.
ResMed
ResMed is a respiratory medical device manufacturer, specialising in products for the diagnosis and treatment of sleep disordered breathing (SDB). The company was formed in 1989, primarily to commercialise a device for treating obstructive sleep apnoea (OSA), a major subset of SDB. Developed in 1981 by Professor Colin Sullivan and colleagues at the University of Sydney, nasal continuous positive airway pressure (CPAP) provided the first successful non-invasive treatment of OSA.
Resmed has its headquarters in the USA, although the company's production base is in Australia. Manufacturing is also undertaken in Singapore and the USA. In 2011, the company employed around 3,450 people worldwide.
In 2004, the company moved to a new manufacturing site in Australia. The new ResMed campus, set on 30 acres of land to the north-west of Sydney, is a purpose-built site, designed to meet long term manufacturing needs. It triples the size of the company's production area. The campus is being built in two stages, with
© Espicom Business Intelligence
Page 141
Australia Medical Devices Report Q2 2014
stage one housing production and stage two housing administration. Stage one was completed in April 2004 and was immediately set up for production. New research and development and office facilities were completed in May 2006.
In May 2005, ResMed acquired Saime, a developer and distributor of ventilation products in France and Germany. The transaction was valued at around 86mn euros. Saime has annual revenues of around 28mn euros. ResMed and Saime have had a relationship since 1996, when ResMed bought its original French sleep therapy distribution assets from Saime.
ResMed sales in fiscal 2013 (year ended 30th June 2013) amounted to US$1.5bn, a rise of 11% over 2011. Net income in fiscal 2013 was US$307.1mn, an increase of 21%.
In August 2012, ResMed announced that it had acquired a data services technology provider, Umbian, which is headquartered in Halifax, Canada. Umbian offers a comprehensive patient compliance management solution called U-Sleep, which monitors continuous positive airway pressure (CPAP) devices and provides a suite of interactive follow-up services for healthcare providers.
Multinational Market Activity The top ten leading multinational companies all have at least a local representative office in Australia in charge of marketing, distribution and service for their respective products. In terms of manufacturing, only Fresenius has activities in Australia.
Table: Multinational Market Activity, 2014
Company
Operations
Baxter International
Baxter's Australian operations commenced in 1963 and now comprise a manufacturing plant in Western Sydney; distribution and warehousing depots in New South Wales, Queensland, Victoria, South Australia, Western Australia and Tasmania; and aseptic compounding facilities in New South Wales, Queensland, Victoria, South Australia and Western Australia.
B.Braun
B.Braun Australia Pty, based in Bella Vista, NSW, is a fully-owned subsidiary with 124 employees. In 2012, the company achieved sales of €64.6mn.
Boston Scientific
Boston Scientific has no manufacturing plant in the country. There is a representative office serving both Australia and New Zealand, Boston Scientific ANZ, in New South Wales.
Covidien
Covidien Australia Pty Ltd is the country head office based in Sydney, New South Wales. The company does not manufacture medical devices locally.
Fresenius
Fresenius has a 5,350 square-metre manufacturing plant and warehouse for haemodialysis concentrate in Smithfield, New South Wales. The head office is based
© Espicom Business Intelligence
Page 142
Australia Medical Devices Report Q2 2014
Multinational Market Activity, 2014 - Continued
Company
Operations in Sydney. The company's 71.6%-owned subsidiary, FMS Australia Pty Ltd., had 364 employees at the end of 2012 and achieved revenues of €143.2mn.
General Electric
GE Healthcare, which comes under GE Technology Infrastructure in Australia and New Zealand, has representative offices in Melbourne, Sydney, Perth and Brisbane.
Johnson & Johnson
J&J has a local presence in Australia through Johnson & Johnson Medical Pty. Ltd. and Synthes Australia. Synthes Australia employs 140 staff and has its head office in Sydney.
Medtronic
The company's Australasian headquarters is located in North Ryde, Sydney, New South Wales. There are other offices in Melbourne, Brisbane, Adelaide, Perth and Auckland (New Zealand). There is no manufacturing activity.
Philips
Philips Healthcare has an office in North Ryde, New South Wales, which serves both Australia and New Zealand. There is no local manufacturing.
Siemens
The company has several subsidiaries in Australia; from a medical devices perspective it has two companies, Siemens Healthcare Diagnostics Ltd and Siemens Hearing Instruments Pty. Ltd, in Bayswater, Australia. There is no local manufacturing.
Smith & Nephew
The company does not have a manufacturing facility for medical devices in Australia but has representative offices in New South Wales, Queensland, Victoria, South Australia and Western Australia.
Stryker
The company has a representative office, Stryker South Pacific, in St Leonards, New South Wales. There is no manufacturing activity.
Source: BMI Espicom
© Espicom Business Intelligence
Page 143
Australia Medical Devices Report Q2 2014
Methodology Medical Device Market Methodology
The medical device market reports use a wide definition of medical equipment, similar to that used by the US FDA or EU EMA. In short, it is defined as any piece of equipment or apparatus used to treat or diagnose an illness that comes into direct contact with the patient. Pharmaceuticals, IV diagnostics and laboratory equipment are not within the scope of these reports.
BMI Espicom has estimated national medical device markets at ex-factory prices for the 2008-2012 period in current US dollar and local terms. The markets have been estimated using a trade-based approach, looking at imports, and then adding in domestic production, minus any exports. Import and export data have been sourced from national customs authorities, as compiled by the International Trade Centre.
BMI Espicom has estimated production data as including range of factors such as the value of exports, the known presence of local and multinational manufacturers, sales data when available, and officially published estimates of production, again when available. Production data have been adjusted to take into account re-exporting, stockpiling and differences in the definition of domestic production.
BMI Espicom has forecast national medical device markets at ex-factory prices for the 2014-2018 period. BMI Espicom has derived market estimates in US dollar terms for the base year, which is 2013 for the purposes of these reports. Compound Annual Growth Rates (CAGRs) in local terms have been calculated for each product area, major category and sub-category for the 2014-2018 period. These CAGRs have been applied to the market in local currency terms, and then converted back to US dollar terms, using average exchange rate projections.
BMI Espicom has calculated CAGRs by looking at a number of factors. These include macro-economic performance; health expenditure levels; medical device import trends; domestic medical device manufacturing size; provision of medical personnel, infrastructure and services; national healthcare development plans; and international aid projects, when applicable.
© Espicom Business Intelligence
Page 144
Australia Medical Devices Report Q2 2014
Trade Code Classifications International trade is universally classified according to the Harmonised System (HS). This began to be used in the 1990s, and is overseen by the World Customs Organisation. Medical equipment is generally well-defined in the HS. There is one major code, HS9018, named Medical Equipment, but there are a number of other codes for products with a specifically medical use. These are listed in detail the following table. For the majority of countries, it is not possible to provide a more detailed breakdown than this.
Table: Used HS Trade Codes, 2014
Code
Product
'300510
Medical dressings (adhesive)
'300590
Medical dressings (non-adhesive)
'300610
SUTURING MATERIALS
'300620
Blood-grouping reagents
'300630
Contrast media
'300640
Dental cements
'300650
First-aid boxes & kits
'300691
Ostomy products
'370110
Medical x-ray film (flat)
'370210
Medical x-ray film (rolled)
'401511
Surgical gloves
'841920
MEDICAL, SURGICAL STERILISERS
'871310
Wheelchairs, not mechanically propelled
'871390
Wheelchairs, mechanically propelled
'901811
Electrocardiographs
'901812
Ultrasound
'901813
MRI
'901814
Scintigraphic apparatus
'901819
Other electrodiagnostic apparatus
'901820
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
'901831
Syringes (with/without needles)
'901832
Tubular metal needles/needles for sutures
'901839
Other needles, catheters, cannulae etc
'901841
Dental drills
'901849
Dental instruments
© Espicom Business Intelligence
Page 145
Australia Medical Devices Report Q2 2014
Used HS Trade Codes, 2014 - Continued
Code
Product
'901850
OPHTHALMIC INSTRUMENTS
'901890
OTHER INSTRUMENTS & APPLIANCES
'901910
Mechano-therapy apparatus
'901920
Therapeutic respiration apparatus
'902110
Orthopaedic or fracture appliances
'902121
Artificial teeth
'902129
Other dental fittings
'902131
Artificial joints for orthopaedic purposes
'902139
Artificial parts of the body (excl. artificial teeth and dental fittings)
'902140
Hearing aids
'902150
Pacemakers
'902190
Other portable aids
'902212
CT scanners
'902213
Dental x-ray
'902214
Other medical x-ray apparatus
'902221
A, B, C ray apparatus
'902230
X-ray tubes
'902290
Other imaging parts & accessories
'940210
Dental chairs
'940290
HOSPITAL FURNITURE
BMI Espicom has rearranged the data from its original code order, to create six major product areas: CONSUMABLES, DIAGNOSTIC IMAGING, DENTAL PRODUCTS, ORTHOPAEDICS & PROSTHETICS, PATIENT AIDS AND OTHER MEDICAL PRODUCTS. These have been sub-divided into categories and sub-categories. BMI Espicom has used them to present the medical device market, import and export data in these reports. Their relation to the trade codes is shown on the following table.
© Espicom Business Intelligence
Page 146
Australia Medical Devices Report Q2 2014
Table: Rearranged HS Trade Codes, 2014
Code
Product
CONSUMABLES
BANDAGES & DRESSINGS '300510
Medical dressings (adhesive)
'300590
Medical dressings (non-adhesive)
'300610
SUTURING MATERIALS
SYRINGES, NEEDLES & CATHETERS '901831
Syringes (with/without needles)
'901832
Tubular metal needles/needles for sutures
'901839
Other needles, catheters, cannulae etc
OTHER CONSUMABLES '300620
Blood-grouping reagents
'300650
First-aid boxes & kits
'300691
Ostomy products
'401511
Surgical gloves
DIAGNOSTIC IMAGING
ELECTRODIAGNOSTIC APPARATUS '901811
Electrocardiographs
'901812
Ultrasound
'901813
MRI
'901814
Scintigraphic apparatus
'901819
Other electrodiagnostic apparatus
RADIATION APPARATUS '902212
© Espicom Business Intelligence
CT scanners
Page 147
Australia Medical Devices Report Q2 2014
Rearranged HS Trade Codes, 2014 - Continued
Code
Product
'902214
Other medical x-ray apparatus
'902221
A, B, C ray apparatus
IMAGING PARTS & ACCESSORIES '300630
Contrast media
'370110
Medical x-ray film (flat)
'370210
Medical x-ray film (rolled)
'902230
X-ray tubes
'902290
Other imaging parts & accessories
DENTAL PRODUCTS
CAPITAL EQUIPMENT '901841
Dental drills
'940210
Dental chairs
'902213
Dental x-ray
INSTRUMENTS & SUPPLIES '300640
Dental cements
'901849
Dental instruments Teeth & other fittings
'902121
Artificial teeth
'902129
Other dental fittings
ORTHOPAEDICS & PROSTHETICS
'902110
FIXATION DEVICES
'902131
ARTIFICIAL JOINTS
'902139
OTHER ARTIFICIAL BODY PARTS
© Espicom Business Intelligence
Page 148
Australia Medical Devices Report Q2 2014
Rearranged HS Trade Codes, 2014 - Continued
Code
Product PATIENT AIDS
PORTABLE AIDS '902140
Hearing aids
'902150
Pacemakers
'902190
Other portable aids
THERAPEUTIC APPLIANCES '901910
Mechano-therapy apparatus
'901920
Therapeutic respiration apparatus
OTHERS
WHEELCHAIRS '871310
Wheelchairs, not mechanically propelled
'871390
Wheelchairs, mechanically propelled
'901850
OPHTHALMIC INSTRUMENTS
'940290
HOSPITAL FURNITURE
'841920
MEDICAL, SURGICAL STERILISERS
'901820
ULTRA-VIOLET OR INFRA-RED RAY APPARATUS
'901890
OTHER INSTRUMENTS & APPLIANCES
10 digit
Blood pressure monitors
10 digit
Endoscopy apparatus
10 digit
Dialysis apparatus
10 digit
Transfusion apparatus
10 digit
Anaesthetic apparatus and instruments
© Espicom Business Intelligence
Page 149
Australia Medical Devices Report Q2 2014
Rearranged HS Trade Codes, 2014 - Continued
Code
Product TOTAL
Source: International Trade Centre
Risk/Reward Ratings Methodology BMI Espicom's Risk/Reward Ratings (RRR) provide a comparative regional ranking system evaluating the ease of doing business and the industry-specific opportunities and limitations for potential investors in a given medical device market. The RRR system is divided into two distinct categories:
1.Rewards: Evaluation of the medical device industry's size and growth potential in each country, and also broader industry/country characteristics that may encourage its development. This is further broken down into two sub-categories: ■
Industry Rewards (this is an industry specific sub-category taking into account the current industry size, per capita expenditure, growth forecasts, import reliance and import growth to provide an overall score for potential returns for companies operating in the medical device industry)
■
Country Rewards (this is a country specific sub-category whose score factors in demographic indicators such as urbanisation and population age and growth conditioning the medical device industry)
2.Risks: Evaluation of industry-specific dangers and those emanating from the country's political/economic profile that call into question the likelihood of anticipated returns being realised over the assessed time period. This is further broken down into two sub-categories: ■
Industry Risks (this is an industry specific sub-category whose score covers potential operational risks to medical device companies operating in the healthcare sector, regulatory issues inhibiting the industry, and the relative maturity of a market in terms of pricing & reimbursement)
■
Country Risks (this is a country specific sub-category in which political and economic stability, legislation and the overall business environment are evaluated to provide an overall score)
A medical device market's RRR score is made up of a sum of the Rewards score (Industry Rewards + Country Rewards) and the Risks score (Industry Risks + Country Risks), which provides a globally comparative and numerically-based assessment of a market's attractiveness and highlights the rewards and risks a company will face in a particular country.
For each category and sub-category, each medical device market is scored out of 100 (100 being the best), with the overall RRR score being a weighted average. Importantly, as many countries are considered by
© Espicom Business Intelligence
Page 150
Australia Medical Devices Report Q2 2014
BMI Espicom to be 'emerging markets', our rating is revised on a regular basis. This ensures that the rating draws on the latest information and data across our broad range of sources, and the expertise of our analysts.
BMI Espicom's approach in assessing the risk/reward balance for medical device companies looking to launch a product within a market is fourfold: ■
Firstly, we identify current industry/country trends and forecast industry/country growth that represent opportunities to companies looking to launch a medical device.
■
Secondly, we identify industry-specific and country traits that pose or could pose operational risks to companies looking to launch a medical device.
■
Thirdly, we attempt, where possible, to identify objective indicators that may serve as proxies for issues/ trends to avoid subjectivity.
■
Finally, we use BMI's proprietary Country Risk Ratings (CRR) in a nuanced manner to ensure that only the aspects most relevant to the medical device industry are incorporated. Overall, the system offers an industry-leading, comparative insight into the opportunities and risks for companies across the globe.
Table: Medical Devices Risk/Reward Ratings Indicators, 2014
Indicator
Rationale
REWARDS
~
65
Industry Rewards
~
44
Sales, US$mn
Denotes breadth of the medical device market. Larger markets score higher than smaller ones
20
Sales Per Capita, US$
Denotes depth of the medical device market. High value markets score higher than low value ones
8
% Forecasted CAGR
Denotes the anticipated performance of the medical device market over the 2013-2018 period. Markets with higher CAGRs score better than those with lower CAGRs
7
% Import Reliance
Denotes import reliance of the medical device market. Highly reliant markets score higher than lowly reliant markets
3
% Y-T-D Import Growth
Denotes year-to-date medical device import growth. Markets with fastgrowing imports score higher than those with slow-growing imports
6
Country Rewards
~
% Urban/Rural Split
Evaluates urbanisation as a proxy for development of medical facilities. Predominantly urban countries score higher than rural countries
8
% Aged 65+ Population
Evaluates proportion of the population over 65 years of age as an expenditure ratio. Countries with ageing populations tend to have higher per capita medical device expenditure and score higher
8
© Espicom Business Intelligence
Weighting
21
Page 151
Australia Medical Devices Report Q2 2014
Medical Devices Risk/Reward Ratings Indicators, 2014 - Continued
Indicator
Rationale
Weighting
% Population Growth
Evaluates long-term prospects associated to population growth. Fastgrowing countries suggest better long-term growth across the medical device industry and score higher
RISKS
~
35
Industry Risks
~
21
Healthcare Access
Evaluates health policies, health insurance coverage, health expenditure and access to health resources, activity and personnel. Markets with a good healthcare access score higher
7
Regulation
Evaluates the strength of the competent authority, national regulations and regulations aligned regionally, if existing. Markets with a strong regulation score higher
7
Government Spending/P&R
Evaluates the level of government spending on medical devices and the attractiveness of P&R policies. Markets with good government spending and friendly P&R policies score higher
7
Country Risks
~
Economic Diligence
CRR evaluates the structural balance of the economy, noting issues such as reliance on single sectors for exports/growth, and past economic volatility. Countries with a strong economy score higher
3
Policy Continuity
CRR evaluates the risk of a sharp change in the broad direction of government policy. Stable political countries score higher
3
Lack Of Bureaucracy
CRR evaluates ease of conducting business in the country. Less bureaucratic countries score higher
3
Legal Diligence
CRR evaluates the strength of legal institutions in the country. Security of investment can be a key risk in some emerging markets. Countries with strong legal institutions score higher
3
Business Transparency
CRR evaluates the risk of additional illegal costs/possibility of opacity in tendering/business operations affecting companies' ability to compete. Countries with business transparency score higher
2
5
14
Source: BMI Espicom
Sources Historical and forecast macro-economic, political, demographic and healthcare data, where indicated, are sourced from: ■
Business Monitor International (BMI).
The medical device market reports have been analysed using, where possible, primary qualitative and quantitative data from local sources. These include:
© Espicom Business Intelligence
Page 152
Australia Medical Devices Report Q2 2014
■
multinational medical device companies,
■
national medical device companies,
■
national medical device trade associations,
■
national ministries (or departments) of health, and
■
national statistical institutes.
The medical device market reports may also make reference to a number of secondary sources, such as those listed below: ■
Eurostat, http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home/
■
Inter-American Development Bank (IDB), http://www.iadb.org
■
International Trade Centre (ITC), http://www.intracen.org
■
Organisation for Economic Co-operation and Development (OECD), http://www.oecd.org
■
United Nations (UN), http://www.un.org
■
World Bank (WB), http://www.worldbank.org
■
World Customs Organisation (WCO), http://www.wcoomd.org
■
World Health Organisation (WHO), http://www.who.org
■
World Trade Organisation (WTO), http://www.wto.org
Contact
BMI Espicom welcomes feedback on all the medical device market reports. If you have any further questions, comments or suggestions about the contents of this report, please send them to:
Jamie Davies
Head of Medical Device Market Analysis
[email protected]
© Espicom Business Intelligence
Page 153